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ABSTRACT 
Escherichia coli O157 is a food borne pathogen of increasing public health 
concern worldwide. Cattle have been implicated as the primary reservoir of E. coli 
O157. The fact that the livestock industry has rapidly expanded in Saskatchewan makes 
it imperative to have a clear scientific understanding of the prevalence of E. coli O157 in 
this province as well as its survival in soil under ambient conditions. 
Longitudinal and point studies were employed to determine the prevalence of E. 
coli O157 among Saskatchewan’s cattle. During a 2-year period, 23 feedlot and cattle 
operations were examined and an overall prevalence of 15.6% was reported. The most 
important finding was that the prevalence rates were highly dependent on cattle density. 
All E. coli O157 isolates obtained from this study were characterized by using multiplex 
PCR, RAPD fingerprinting, a Vero cell cytotoxicity assay and antibiotic susceptibility 
tests. This characterization revealed a surprisingly highly virulent and heterogenous 
population of E. coli O157 isolates.  
Subsequently, the survival characteristics of E. coli O157:H7 ATCC 43894 in 
sterile soil and manure-amended soil microcosms, as well as in situ under ambient 
environmental conditions were examined. Findings from this work indicated that 
desiccation had the most lethal effect on cell viability, whereas nutritionally-rich soils 
significantly increased survival times of the pathogen population.  
A final study was designed to examine the survival strategy of hyper- and 
hypothermally adapted E. coli O157 cells exposed to high and low temperatures, with 
specific focus on the role of RpoS. Using wild type and its rpoS null allele E. coli O157 
strains, in combination with 2D PAGE, It was found that both heat and cold post-
acclimation stimulons consisted of two large sub-groups: (i) stress proteins, and (ii) 
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housekeeping proteins. Comparative proteomic analyses revealed that the GroEL/S 
chaperonin complex and Pnp ribonuclease played a crucial role in growth resumption 
during high and low temperatures, respectively. Notably, RpoS had no control over key 
stress proteins in either stress stimulon. RpoS, however, showed a significantly more 
pronounced role during cold temperatures, where it was seen to regulate key proteins 
involved in homoeoviscous adaptation as well as various housekeeping proteins of both 
stress stimulons.  
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1. GENERAL INTRODUCTION 
Mammals are generally colonized by Escherichia coli at birth and these normally 
harmless bacteria become part of their intestinal community for the rest of their lives. 
Under certain circumstances, E. coli can produce disease in animals and humans. The 
most common disease caused by E. coli is gastroenteritis. Based on virulence 
mechanisms or diagnostic features of this pathogen, E. coli has been divided into five 
major groups (Janda and Abbott, 1998). The enterohemorrhagic group (EHEC), a group 
that has attracted the most attention world wide, is distinguished from the other 
virulence groups by the production of extracellular cytolytic toxins called 
verocytotoxins, or Shiga-like toxins, first described by Konowalchuk et al. (1977).  The 
enterohemorrhagic strains of E. coli are also defined by the presence of specific 
virulence factors: all strains produce hemolysin (Shmidt et al., 1994) and many produce 
intimin, a 97-kDa attachment and effacement protein (Louie et al., 1993).  
In 1982, two outbreaks of bloody diarrhea occurred in Oregon and Michigan 
(USA) (Riley et al., 1983), and another in Ottawa (Canada) (Stewart et al., 1983), 
leading to the recognition of a new EHEC serotype, E. coli O157:H7. Escherichia coli 
O157:H7 is currently the most common EHEC strain in many regions of the world 
(Armstrong et al., 1996). According to the Public Health Agency of Canada (2005), the 
majority (95%) of pathogenic E. coli isolates from human cases were serovar O157. A 
critical element in the emergence of E. coli O157:H7 as a foodborne pathogen was the 
evolution of acid resistance, an attribute that promotes survival in acidic environment 
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and results in efficient transmission with a low infective dose. Enterohemorrhagic E. coli 
strains, especially strain O157, have a low infectious dose of 1 to 100 CFU (Paton et al., 
1996).  Escherichia coli O157:H7 causes a wide spectrum of clinical symptoms, 
including haemorrhagic colitis (bloody diarrhea), haemolytic-uremic syndrome (HUS), 
non-bloody diarrhea and thrombotic thrombocytopaenic purpura (TTP) (Su and Brandt, 
1995). Haemorrhagic colitis is the most common symptom associated with E. coli 
O157:H7, typically appearing 1 to 5 days after ingestion with most patients recovering 
within 10 days. In some cases, infection may result in life-threatening complications, 
such as HUS and TTP. After oral consumption, E. coli O157 enters the intestines where 
it attaches to the intestinal mucosa and produces Shiga-like toxins (stx1/stx2). These 
toxins cause the walls of the intestines to become porous, allowing further toxin to enter 
the bloodstream and induce the clinical manifestation known as HUS. The toxin 
subsequently damage red blood cells and blood transfusions are required in more than 
70% of HUS cases. In addition, kidney damage occurs from which about 50% of HUS 
patients suffer acute kidney failure and require dialysis (Siegler, 1995). 
It is well documented that the primary reservoir of E. coli O157 in the 
environment is cattle, although other farm animals, including sheep and pigs, have also 
been shown to be carriers of the pathogen (Wallace et al., 1997). Faecal excretion rates 
of E. coli O157 from infected cattle typically range from 102 to 106 CFU per g (Wang et 
al., 1996). The faecal excretion of E. coli O157 by cattle appears to be seasonal, with 
excretion rates being highest in spring and late summer (Shere et al., 1998). Escherichia 
coli O157:H7 can remain viable in non-aerated cattle manure for greater than 12 months 
and for approximately 2 months in aerated manure piles (Kudva et al., 1998). The 
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behavior of the pathogen in different soil types and the influence of environmental 
conditions and management strategies on the pathogen remains largely unknown. 
Infections of humans with the E. coli O157:H7 serotype occurs most frequently 
as food-borne outbreaks. In 1993, E. coli O157:H7 became indelibly linked with the 
Jack-in-the-Box hamburger chain in the U. S. Northwest after an outbreak killed four 
and sickened some 700, an outbreak that directly or indirectly led to dramatic changes in 
meat inspection in the U.S., including much higher levels of public accountability. Food 
safety has since become a presidential-level priority. Traditionally, industry and 
regulators have depended on spot-checks of manufacturing conditions and random 
sampling of final products to ensure safe food. This approach, however, tends to be 
reactive, rather than preventive. In 1998, the U.S. Department of Agriculture 
implemented a new system known as Hazard Analysis and Critical Control Point, or 
HACCP.  
Implimentation of the Hazard Analysis and Critical Control Point system led to 
the following changes: 
(i) Federally mandated microbial testing of meat for E. coli O157:H7 to provide 
control of this food pathogen prior to entry into food stream, 
(ii) Federal and state laws requiring health providers and public health agencies 
to report E. coli O157:H7-related illnesses to aid in quick identification of 
when and where problems are occurring, 
(iii) Federal and state regulations mandating cooking temperatures of at least 
150°F for ground beef and/or heat treatments sufficient to destroy E. coli 
O157:H7, and 
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(iv) Mandatory food-safety training for all food service workers or any person 
preparing or serving food to the public. 
Most major U.S. food companies already use HACCP in their manufacturing 
processes, and this approach is increasingly being adopted in other countries, including 
Canada. Recently, an outbreak of E. coli O157:H7 that occurred in Walkerton, Ontario, 
where seven people were killed and some 2500 sickened, demonstrated the importance 
of water, and associated manure-contaminated soils, as a significant vector of 
transmission of this pathonen to municipal drinking water. It also highlighted the need 
for improved government regulation of the production and delivery of safe food and 
water. 
 
1.1. Study rationale 
The frequency of occurrence of E. coli O157 in cattle housed in Saskatchewan 
feedlots is presently poorly understood. In order to assess health risks associated with 
Saskatchewan cattle production, as well as to design strategies for controlling the spread 
of this pathogen, province-specific information is required. Accordingly, the prevalence 
rate of E. coli O157 in Saskatchewan, the sensitivity and reliability of two different 
techniques designed to detect E. coli O157 in naturally-infected samples was 
determined. These experiments are described in the first two studies of my thesis 
(chapters 2 and 3). Chapter 4 examined how different soil conditions influenced the 
survival of E. coli O157 under in vitro and in situ conditions. Lastly, the 5th chapter 
characterized the general stress response of E. coli O157 to prolonged cold and heat 
shocks, and also delineated the role of the RpoS sigma factor during these stress 
situations.  
These studies were based on the following hypothesis and technical objectives:  
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1.2. Hypotheses 
1.  The genetic relatedness of E. coli O157 strains isolated from Saskatchewan 
feedlots will reflect the geographic location of the feedlots from which the 
isolates were obtained, 
2. Increased soil temperature will result in decreased numbers of viable E. coli 
O157 over time, and 
3. RpoS, as a general stress response factor, will have a significant role in a 
prolonged heat and cold shocks response of E. coli O157.  
 
1.3. Technical objectives 
1. To conduct a province-wide survey of the prevalence of E. coli O157 in cattle 
housed in Saskatchewan feedlots, and to characterize isolates in terms of their 
biochemical and molecular traits, 
2. To elucidate the effects of temperature, time, soil type, and competing microflora 
on the survival of E. coli O157, 
3. To evaluate culture-based techniques for the enhanced isolation of E. coli O157 
from manure samples, and 
4. To examine the general stress response of E. coli O157 and functional role of 
RpoS under prolonged heat and cold shocks by comparing the physiological and 
proteomic state of wild-type and rpoS null mutant E. coli O157 strains. 
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2. LITERATURE REVIEW 
2.1. Historical perspectives on the species, Escherichia coli 
In 1885, a German physician named Theodor Escherich, using aseptic techniques 
learned from Robert Koch, was able to isolate several microorganisms from the 
gastrointestinal contents of infants, one of which he named Bacterium coli commune 
(Sussman, 1985). By 1919, Castellani and Chalmers recognized that Bacterium coli 
could not satisfy the biochemical and morphologic criteria for inclusion within this 
genus (Bettelheim, 1991). To honor Escherich’s contributions to this area of study, the 
genus Escherichia was proposed by the same authors. To the present day, the genus 
Escherichia consists of five species: E. coli, E. hermannii, E. fergusonii, E. vulneris and 
E. blattae (Scheutz and Strockbine, 2001). 
 
2.2. Morphology and metabolism of E. coli 
Escherichia coli are straight, cylindrical, Gram-negative rods with rounded ends 
that are 1.1-1.5 μm in diameter and 2.0-6.0 μm in length. This organism occurs singly or 
in pairs and can be motile or nonmotile. Motile E. coli possess 5 to 10 peritrichously-
distributed flagella per cell. The flagellar filament is 20 nm in diameter and up to 20 μm 
long. It is made of subunits of a single protein, flagellin, which is encoded by the fliC 
gene. Unlike Salmonella, most E. coli strains have only one flagellin gene and do not 
undergo phase variation. The flagellin possesses antigenic features and according to 
Orskov and Orskov (1984), fifty-three antigenically distinct types of flagellin exist. 
Using the electron microscope, Lawn et al. (1977) revealed differences in surface 
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structure of antigenically distinct filaments, indicating the importance of flagellar 
morphology in antibody-antigen reactions. Flagellar, or H, antigens make up the third 
main group of serotyping antigens in E. coli, after O and K. In addition to flagella, most 
strains of E. coli have fimbriae (pili) extending from the bacterial surface in great 
numbers. For instance, E. coli K-12 cells each contain 100-500 type 1 fimbriae, with a 
diameter of 7 nm and a length of 0.2-2.0 μm. So far, more than 30 different fimbriae 
have been described in E. coli, with the common presence of more than one type at a 
time. The main role of fimbriae is attachment to the intestinal mucosal surface as well as 
to various inflammatory cells. They bind to oligomannoside-containing glycoproteins 
present on mucosal surfaces, including the Tamm-Horsfall glycoprotein (Orskov et al., 
1980), and lamin, a glycoprotein present in basement membranes (Kukkonen et al., 
1993). A rigid cell wall known as the outer membrane (OM) surrounds E. coli cells. The 
outer membrane consists of three covalently-linked domains: (1) lipid A, (2) the core 
region of phosphorylated non-repeating oligosaccharides and (3) the immunogenic O 
antigen polymer of repeating oligosaccharides (1-40 units). Structurally, the OM is 
organized as two opposing phospholipid-protein leaflets. Its inner leaflet consists of 
ordinary phospholipids, but these are replaced in the outer leaflet by lipopolysaccharide 
(LPS). LPS consists of lipid A which can produce fever and a shock syndrome called 
Gram-negative shock or endotoxic shock. Proteins called porins, or matrix proteins, 
form pores through the outer membrane that make it possible for hydrophilic solute 
molecules of molecular weight less than 800 to diffuse through it and into the periplasm. 
In addition to the porins, E. coli possess the most abundant outer membrane protein 
called Braun’s, or murein, lipoprotein, the function of which is to attach the murein 
layer, a single covalently-bonded molecule, to the outer membrane of the wall. The 
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murein sacculus is responsible for the shape of the cell and is also vital for its integrity. 
Internal to the murein is the periplasm, a space containing concentrated solutions of 
proteins and oligosaccharides. The proteins in the periplasmic space consist of enzymes 
with hydrolytic functions, sometimes antibiotic-inactivating enzymes, different binding 
proteins with roles in stress response and active transport of solutes into the cell. The 
cytoplasmic membrane is the boundary between the cytoplasm and OM, and structurally 
is a bileaflet like most other biological membranes with an exception that it possesses a 
very high percentage of proteins (up to 70% of its weight). 
E. coli is a facultative anaerobe that has both a respiratory and fermentative type 
of metabolism. Cells produce strong acids and usually gas during the fermentation of D-
glucose. Most strains of E. coli ferment lactose rapidly and produce indole. These, and 
other, biochemical reactions are sufficient to differentiate E. coli from other species. 
 
2.3.  Pathogenic groups of E. coli 
 Escherichia coli has been suspected to cause diarrheal syndromes in humans 
since the beginning of modern bacteriology (1890-1910). However, it took the antigenic 
typing scheme of Kauffmann coupled with epidemiologic surveys of E. coli-associated 
infantile diarrhea in the 1940s and 1950s, to unequivocally establish this species’ 
enteropathogenic capability (Levine, 1987). In recent years, the number of types of E. 
coli associated with gastroenteritis has greatly expanded and includes six major 
pathogenic classes: – enteropathogenic (EPEC), enterotoxigenic (ETEC), enteroinvasive 
(EIEC), Shiga toxin-producing (STEC), the enteroadherent E. coli (EAEC) and a sixth, 
newly-described agent (see Table 2.1.).  
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Table 2.1. Pathogenic groups of E. coli associated with gastroenteritis. 
Current terminology Acronym Prior Designations/Inclusive Groups 
Enteropathogenic E. coli EPEC  
Enterotoxigenic E. coli ETEC  
Enteroinvasive E. coli EIEC  
Shiga toxin-producing  
E. coli STEC 
Enterohemorrhagic E. coli (EHEC), verocytotoxin-
producing E. coli (VTEC), Shiga-like toxin-
producing E. coli (SLTEC) 
Enteroadherent E. coli EAEC Enteroaggregative E. coli (EAggEC), diffuse adhering E. coli (DAEC) 
“Reputed agents” - 
Cytotoxic necrotizing factor (CNF)-producing E. 
coli, cytolethal distending toxin (CLDT)-producing 
E. coli 
From: The Enterobacteria; Janda and Abbot, 1998. 
 
The terminology for EPEC, ETEC and EIEC has remained unchanged for many years, 
implying that these three enterovirulent groups were discovered a long time ago and 
their pathogenicity and epidemiology have been well-characterized. On the other hand, 
STEC is more recently discovered and it has undergone an evolution in terminology. 
These organisms were reclassified according to toxin type rather than disease 
manifestation (hemorrhagic colitis). The main features of the currently recognized 
groups associated with gastroenteritis are listed in Table 2. 2 
 
Table 2.2. Major chracteristics of diarrheagenic E. coli groups 
  Nature of Diarrhea   
Group Disease Produced Early  Late Frequency 
Pathogenic 
mechanisma 
EPEC Enteritis Watery Watery + Adherence 
ETEC Enteritis Watery Watery ++ Toxin(s) 
EIEC Dysentery Watery Bloody + Invasion 
STEC Colitis Watery Bloody +++ Toxin(s) 
EAEC Enteritis Watery Watery Unknown Adherence 
From: The Enterobacteria; Janda and Abbot, 1998. 
aVirulence mechanism or diagnostic feature of each pathogenic group. 
  +++, common; ++, occasionally isolated; + rare. 
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All five groups of E. coli initially cause a secretory type of gastroenteritis, but only 
EIEC and STEC are capable of producing bloody diarrhea in the later stages of 
infection, a major feature that distinguishes them from other enterovirulent E. coli 
groups. It is important to note that only STEC, among all pathogenic groups of E. coli, 
possess a potent cytolytic toxin almost identical to that produced by Shigella 
dysenteriae. Other notable clinical differences among these pathogenic groups of E. coli 
are listed in Table 2.3 
Table 2.2. Clinical properties of E. coli groups associated with gastroenteritis 
 Duration of Illness (d)  Presence in Stool 
Group 
Infectios 
Dose 
(cfu) 
Incubation 
Period (h) Mean Range Attack Rate (%) Mucus Blood 
EPEC 106-1010 9-19 5 3-14 33-72 + - 
EIEC ≥108 <24 2-4 1-12 33-56 + + 
ETEC 108-1010 3-166 4-7 1-53 16-77 - - 
STEC 50-700 24-336 4-5 6-9 28-75 - + 
EAEC ~1010 14-46 5 3->14 ? - - 
From: The Enterobacteria; Janda and Abbot, 1998. 
 
2.4. Shiga toxin-producing E. coli (STEC) – E. coli O157:H7 
In 1982 two outbreaks of bloody diarrhea in Oregon and Michigan (USA) (Riley 
et al., 1983) and another in Ottawa (ON Canada) (Stewart et al., 1983) led to the 
recognition of a new pathogenic serotype, E. coli O157:H7. Escherichia coli O157:H7 is 
the archetypal serotype for a series of E. coli strains capable of producing at least two 
distinct extracellular cytolytic Shiga-like toxins (Stx1 and Stx2), first described by 
Konowalchuk et al. (1977). This pathogen had previously been isolated from one case of 
bloody diarrhea in California in 1975. In Canada, the first isolation of E. coli O157:H7 
was made in 1978 and by the end of 1981, five strains of this serotype were identified. 
Shiga toxin-producing E. coli strains (STEC) are also defined by the presence of specific 
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virulence factors; almost all strains produce hemolysin and many produce intimin 
(Schmidt et al., 1994), a 97-kDa attachment and effacement protein (Louie et al., 1993). 
Today, numerous serotypes represent the STEC group (see Table 2.4.).  
 
Table 2.3. Serotypes of Shiga toxin-producing E. coli (STEC) 
Health category and related isolates 
Caused hemolytic uremic syndrome1 Caused other illnesses2 
O2:H5 O2:H6 O2:H7 O2:H29 O1:H2 O1:H20 O2:H27 O8:H- 
O5:H-3 O6:H- O8:H2 O8:H19 O8:HUT O15:H- O20:H7 O22:H16 
O8:H21 O20:H19 O22:H8 O25:H2 O22:H- O26:H2 O26:H21 O26:H32 
O26:H11 O26:H- O26:HUT4 O45:H2 O28:H- O39:H8 O45:H- O70:H11 
O49:H- O55:H- O84:H- O86:H- O74:H- O75:H8 O76:H7 O77:H18 
O91:H10 O91:H21 O91:H- O98:H- O82:H8 O84:H2 O88:H- O91:H14 
O103:H2 O103:H- O105:H18 O105ac:H185 O91:HUT O103:H25 O104:H7 O112:H21 
O111:H8 O111:H- O112ac:H19 O113:H21 O113:H4 O113:H7 O113:H- O117:H7 
O118:H16 O118:H- O119:H2 O119:H6 O117:H19 O119:H- O126:H20 O128ab:H8 
O121:H19 O125:H- O128:H2 O128ab:H26 O128:H12 O128:HUT O132:H- O141:H- 
O145:H25 O145:H28 O145:H- O146:H21 O146:H28 O146:H- O150:H- O156:H25 
O153:H25 O154:H- O157:H7 O157:H- O163:H- O171:H2 OR:H19 OR:HUT 
O161:H- O163:H19 O165:H25 O165:H- OUT:H1 OUT:H4 OUT:H7 OUT:H8 
O171:H- O172:H- O174:H27 O174:H21 OUT:H10 OUT:H14 OUT:H16 OUT:H18 
O174:H- O177:H- OR:H4  OR:H25 OUT:H19 OUT:H21 OUT:H28 OUT:H33 
OR:H- OUT:H28 OUT:H11 OUT:H25 OUT:H41 OUT:HUT   
OUT:H-        
Modified from Hussein, 2007. 
1 The STEC serotypes were isolated from humans suffering from hemolytic uremic 
syndrome (WHO, 1998; Blanco et al., 2003).  
2 The STEC serotypes were isolated from humans suffering from a wide range of 
illnesses such as mild diarrhea, bloody diarrhea, abdominal pain, ulcerative colitis, 
hemorrhagic colitis and thrombotic thrombocytopenic purpura (WHO, 1998; Blanco et 
al., 2003). 
3 A nonmotile strain. 
4 An untypeable H antigen. 
5 Certain antigenic relationships are represented by ‘a’ a common factor and ‘c’ a 
specific factor (Lior, 1994). 
6 Certain antigenic relationships are represented by ‘a’ a common factor and ‘b’ a 
specific factor (Lior, 1994). 
7 A rough O antigen. 
8 An untypeable O antigen. 
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Since their discovery as etiologic agents of hemorrhagic colitis in 1982, the clinical 
importance of E. coli O157:H7 and STEC has grown rapidly. To illustrate this fact, the 
U.S. Department of Health and Human Services (1994) constructed a logarithmic time 
line describing significant epidemiological events involving E. coli O157:H7. In little 
more than a decade, the notoriety of E. coli O157:H7 had undergone a major 
transformation from that of a newly described agent of diarrheal disease (1982) to the 
leading bacterial cause of bloody diarrhea in the United States in 1992 (see Figure 2.1.; 
Janda and Abbott, 1998). Escherichia coli O157:H7 is the most common STEC serotype 
in many regions of the world (Armstrong et al., 1996). It has been estimated that E. coli 
O157:H7 cause 73,000 illnesses annually in the United States and non-O157 STEC 
cause 37,000 illnesses and that 91 deaths occur each year in the USA (Mead et al., 
1999). In Canada, according to the Public Health Agency of Canada (2005), the majority 
(95%) of pathogenic E. coli isolates from human cases were serovar O157. Escherichia 
coli O157 has the ability to cause both sporadic and large outbreaks. The city of Sakai in 
Japan experienced the largest outbreak of O157 STEC ever recorded in July 1996, which 
was part of several outbreaks that summer with an estimated 8000 cases and 6 deaths 
(Infectious Disease Surveillance Center, Japan, 1997). From an epidemiological point of 
view it is interesting that STEC infections in humans seem to be different worldwide. 
Escherichia coli O157:H7 is the predominant serotype of STEC in the United States, 
Canada, the United Kingdom and Japan, but in continental Europe, Australia and Latin 
America non-O157:H7 STEC serotypes are much more common than E. coli O157:H7 
(O’Brien and Kaper,1998).  
Escherichia coli O157:H7 is serologically determined by two antigens. The 
somatic O157 antigen reflects the nature of the phospholipid-polysaccharide complex 
 and the order in which it occurs in the repeating units of the polysaccharide chain. The 
flagellar H7 antigen is determined by the nature of the repeating flagellar subunits, 
flagellin. Escherichia coli O157:H7 cause a wide spectrum of clinical symptoms 
including haemorrhagic colitis (bloody diarrhea), haemolytic-uremic syndrome (HUS), 
non bloody diarrhea and thrombotic thrombocytopaenic purpura (TTP) (Su and Brandt, 
1995). 
 
Figure 2.1.Time line of major clinical and epidemiologic events associated with E. coli 
O157:H7 infections. (from: Addressing Emerging Infectious Disease Threats, Atlanta 
1994). 
 
Hemorrhagic colitis is the most common symptom associated with E. coli 
O157:H7, typically appearing 1 to 5 days after ingestion with most patients recovering 
within 10 days. In some cases, infection may result in life-threatening complications 
such as HUS and TTP. In addition, kidney damage occurs from which about 50% of 
HUS patients suffer acute kidney failure and require dialysis (Siegler, 1995). The 
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treatment of individual patients with STEC infections is mainly based on plasma 
exchange in order to reduce the concentration of Stx1 and/or Stx2 in a patient’s body. 
The use of antibiotic therapy is questionable. It has been reported that the use of 
antibiotics in STEC infections may increase the risk of developing HUS (Carter et al., 
1987; Cimolai et al., 1990), as antibiotic-mediated cell lysis would actually increase the 
amount of free Stx in the gut lumen available for absorption. Two in vitro studies have 
shown that treatment of O157:H7 STEC with subinhibitory concentrations of antibiotics 
resulted in significant increases (up to 50-fold) in the amount of free Stx in the culture 
medium. According to Cordovez et al. (1999), a high rate of antibiotic resistance exists 
among STEC, and so empirical treatment with an inappropriate drug might confer a 
selective advantage on the STEC over other members of the gut flora and cause over-
growth. Future prospects for treatment and prevention of STEC infection may include 
binding or neutralization of Stx (Armstrong et al., 1991), as well immunization against 
STEC disease (Bosworth et al., 1996). 
 
2.5.  Pathogenesis 
2.5.1 Acid resistance 
The importance of gastric secretions as an early line of defense against enteric 
pathogens was recognized for a nearly century, with the primary bactericidal barrier 
being acid dependent (Peterson et al., 1989). Clearly, the infectious dose of different 
enteric pathogens corresponds to their relative abilities to withstand acid. The oral 
infectious doses of Vibrio cholerae, non-typhi Salmonella spp. and Shigella flexneri are 
approximately 109, 105 and 102 cells, respectively (Blaser and Newman, 1982). These 
doses agree with the relative levels of acid resistance of the bacteria, with V. cholerae 
being the least resistant and S. flexneri being the most resistant. Shiga toxin-producing 
  17
E. coli strains, especially serotype O157, have a low infectious dose of 1 to 100 CFU 
(Griffin et al., 1994; Paton et al., 1996), similar to those of Shigella spp. A critical 
element in the emergence of E. coli O157:H7 as a foodborne pathogen was the evolution 
of acid resistance, an attribute that promotes survival in acidic environments and results 
in efficient transmission with a low infective dose. For instance, successful colonization 
of the intestine by this organism requires transient survival through the stomach at pH 
values of 1 to 2 (fasting) or 2 to 7 (during feeding) (Dressman et al., 1990). Waterman 
and Small (1996) found that 76% of 38 E. coli O157:H7 strains had greater than 10% 
survival after a 2 hour exposure to pH 2.5. Another study revealed that under laboratory 
conditions, the percentage survival in synthetic gastric fluid (pH 1.5) for E. coli 
O157:H7 exceeded 95% for 1 hour acid exposures of stationary phase cultures (Arnold 
and Kaspar, 1995). Although the authors observed some variation among E. coli 
O157:H7 strains, the average survival was greater than that observed in other pathogenic 
groups of E. coli and greatly exceeded nonpathogenic controls. The findings of Leyer et 
al. (1995) suggested that E. coli O157:H7 cells exposed to acidic conditions (pH 5.0) for 
short periods were better able to survive in acidic food than unexposed cells. This 
phenomenon, named acid adaptation or acid habituation, requires active metabolism 
during incubation (Foster, 1991). 
Escherichia coli in general have multiple genetic systems that respond to 
physical and chemical challenges and that confer resistance to low and lethal pH. The σs 
(or RpoS) subunit of RNA polymerase is a master regulator of the general stress 
response in E. coli. While nearly absent in rapidly growing cells, σs is strongly induced 
during entry into stationary phase and/or many other stress conditions, and is essential 
for the expression of multiple stress responses (Hengge-Aronis, 2002). Detailed studies 
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of acid resistance mechanisms in E. coli O157:H7 have revealed three systems that can 
protect cells against pH 2 to 2.5 (Hersh et al., 1996; Lin et al., 1995). The first is a 
glucose repressed system (acid-induced oxidative system) induced in Luria-Bertani 
broth that is dependent on the alternative sigma factor σs, encoded by the gene rpoS. 
Consistent with glucose repression, this system has also proven to be dependent in many 
situations on the cyclic AMP receptor proteins (Castanie-Cornet et al., 1999). The other 
two clearly defined systems are: i) a glutamate – dependent system, and ii) an acid – 
induced arginine – dependent system. The glutamate – dependent system is induced in 
response to low environmental pH and upon entry into stationary phase and consists of 
two glutamate decarboxylase isoforms, GadA and GadB, and a glutamate γ-
aminobutyrate antiporter GadC (Smith et al., 1992; Hersh et al., 1996). GadA and GadB 
catalyse the decarboxylation of glutamate to γ-aminobutyrate by replacing the α-
carboxyl group with a proton. The decarboxylation product is exported via the GadC 
antiporter (Hansen et al., 2005). Additional protection from acid comes from the 
periplasmic protein HdeA and the isomer HdeB that have been suggested to have a 
chaperone-like function, suppressing the aggregation of periplasmic proteins under 
extreme acidic conditions (Gajiwala and Burley, 2000; Merrell and Camilli, 2002). 
Acid-induced acid resistance factors also include envelope proteins such as OsmY 
(Maurer et al., 2005), and redox modulators such as Tpx (Stancik et al., 2002; Tucker et 
al., 2002). A study conducted by Chang and Cronan (1999) revealed that cyclopropane 
fatty acid (CFA) plays a major role in protection of E. coli from acid shock. According 
to the same authors, an explanation of the CFA acid protective mechanism can be found 
in “the bilayer permeability model” (Paula et al., 1996), where proton permeability in 
lipid bilayers is inversely proportional to bilayer thickness. Formation of CFA is post-
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synthetic modification where unsaturated fatty acids are converted to CFA, which 
consequently increase bilayer thickness and lead to acid resistance. 
 
2.5.2 Adherence mechanisms 
Escherichia coli O157:H7, after exposure to the harsh conditions of the stomach, 
must become established in the gut by adhering to intestinal epithelial cells. The 
principal sites of E. coli O157:H7 colonization in humans are the colon and the distal 
small intestine (Paton and Paton, 1998). It appears that different E. coli O157:H7 strains 
express different adherence phenotypes to epithelial cells. Sherman et al. (1987) 
reported marked quantitative differences (up to 250-fold) in the adherence of five E. coli 
O157:H7 strains to both HEp-2 (human laryngeal epithelioma) and Henle 407 (human 
colonic carcinoma) cell lines. Some strains of E. coli O157 adhered in a diffuse fashion, 
with bacteria being distributed evenly over the surface of the epithelial cells (diffuse 
adherence [DA]). Other strains formed tight clusters at a limited number of sites on the 
epithelial surface (localized adherence [LA]). Interestingly, Sherman and colleagues 
(1987) in the same study showed that a given strain did not exhibit the same pattern of 
adherence on both cell lines. At present, the best characterized E. coli O157:H7 
adherence phenotype is intimate or attaching and effacing (A/E) adherence. The process 
of A/E lesion formation involves an initial phase of DA or LA adherence followed by 
loss of enterocyte microvilli and intimate attachment of the bacterium to the cell surface. 
All of the genes necessary for generation of A/E lesions are encoded on a pathogenicity 
island called the Locus of Enterocyte Effacement (LEE) (Elliot et al., 1998). The LEE 
contains sep and esc genes encoding a type III secretion system (Jarvis et al., 1995) 
which plays a critical role in the intimate attachment process by providing a specialized 
conduit for secretion of the effector proteins from the bacterium into the host cell. 
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Further, LEE possesses the eae gene encoding an adhesin called intimin, a 934-amino 
acid product that is responsible for the intimate attachment of the bacteria to the host cell 
(Jerse and Kaper, 1991), and the espABD genes that encode proteins secreted by the type 
III secretion system with EspA having the role of forming a filamentous-like structure 
that facilitates translocation of effector proteins (Kenny et al., 1996). EspB and EspD, 
which have hemolytic activity, play roles as pore-forming molecules that provide a 
portal for the EspA secretion tube to breach the host cell membrane (Warawa et al., 
1999). The Locus of Enterocyte Effacement also contains the tir gene, which encodes 
the translocated intimin receptor. After the translocation of Tir protein from the E. coli 
O157:H7 cell to the host cell cytoplasm via the EspA tube, it localizes to the plasma 
membrane of the host cell where it serves as the receptor for attachment of the bacterium 
(DeVinney et al., 1999). In addition to serving as a receptor for intimin, the 78-kDa 
plasma membrane-bound Tir coordinates remodeling of the host cell cytoskeleton by 
binding to the host cell protein Nck (Gruenheid et al., 2001) further leading to actin 
polymerization and increase of its apparent size to 90 kDa generating formations named 
“pedestals”. The intimin –Tir interaction is crucial to the pathogenesis of E. coli 
O157:H7 and strains lacking either gene are avirulent in animal models (Marches et al., 
2000; Dean-Nystrom et al., 1998). The Locus of Enterocyte Effacement in E. coli 
O157:H7 also possesses the ler gene (LEE-encoded regulator) which encodes a positive 
regulator of LEE genes (Mellies et al., 1999). The majority of the LEE genes are 
organized into five major polycistronic operons named LEE1 through LEE4 and tir 
(Elliot et al., 1999). Transcription of these operons is coupled to at least two different 
regulatory systems. The Ler protein encoded by the first gene in the LEE1 operon 
activitates expression of the LEE2, LEE3 and tir operons in a regulatory cascade 
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(Mellies et al., 1999). A quorum-sensing molecule, whose synthesis is encoded by the 
luxS gene, appears to regulate expression of these operons. According to Sperandio and 
co-workers (1999), LEE1 and LEE2 are directly activated by the quorum sensing 
system, while LEE3 and tir are indirectly activated via the enhanced levels of Ler 
produced from the LEE1 transcripts.  
 
2.5.3 Shiga toxins and their role in pathogenesis 
Synthesis and secretion of the Shiga toxins is the most potent virulence feature of 
E. coli O157:H7. The toxin name is derived from the prototype Shiga toxin from 
Shigella dysenteriae. Not only E. coli and S. dysenteriae can produce Shiga toxins; 
Citrobacter freundii, Aeromonas hydrophila, Aeromonas caviae and Enterobacter 
cloacae have been reported to be able to express these toxins as well (Paton and Paton, 
1998). Shiga toxins all belong to the AB family of protein toxins, which share a similar 
three dimensional structure of a pentameric binding (B) component, composed of five 
identical StxB subunits, and a one monomeric enzymatically-active part (A) (Sandvig, 
2001). Two main types of toxins, Stx1 and Stx2, are produced by E. coli O157:H7. 
Furthermore, several Stx2 variants have been found, including Stx2c, Stx2d, Stx2e and 
Stx2f, which range from 99-63 % identity in the A subunit and 95-75 % identity in the B 
subunit of the Stx2 toxin (Schmidt et al., 2000). The molecular weight of the intact toxin 
is about 70 kD, with the A subunit of about 32 kD and each B subunit of 7.7 kD (Paton 
and Paton, 1998). The binding pentamers of Shiga toxins are specific for the glycolipid 
receptor, globotriosyl ceramide (Gb3) (Lindberg et al., 1987), and further serve to 
deliver the catalytic subunit to the appropriate cellular compartment. One variant toxin, 
Stx2e binds to the Gb4 receptor (Sandving, 2001). The importance of the B-pentamer-
Gb3 interaction is clearly illustrated by the fact that all cells which are susceptible to 
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STX express Gb3 on their cell surface, whereas cells that do not express Gb3 are resistant 
to the toxin (Weinstein et al., 1989). The A chain of STX has two domains that can be 
separated proteolytically with trypsin: an enzymatically active A1 domain and an A2 
domain that serves a structural role in tethering the A1 chain to the B pentamer (Saxena 
et al., 1989).  
After toxin synthesis and secretion, they are transported by transcytosis through 
the lumen and spread by hemotogenous routes to their primary target organs, the kidney 
and central nervous system tissue (Wadolkowski et al., 1990). All these organs possess 
numerous Gb3 receptors on their surface. After toxin-receptor binding, the toxin is 
transported via retrograde transport to the Golgi apparatus and endoplasmatic reticulum 
(ER) (Sandving and van Deurs, 1996). During this process, the A subunit is nicked by a 
membrane-bound protease known as furin, generating a catalytically-active a 27 kD 
active N-terminal A1 fragment and a 4 kD C-terminal A2 fragment, which remains 
linked by a disulfide bond. The disulfide bond is subsequently reduced, thereby 
releasing the active A1 component. The released A1 fragment has RNA N-glycosidase 
activity and removes one adenine from adenosine in position 4324 from the 5’ terminus 
in 28S ribosomal RNA, thereby inhibiting binding of amino-acyl-tRNA to the 60S 
ribosomal subunit resulting in inhibition of protein synthesis and cell death by apoptosis 
(Yoshida et al., 1999). In addition to their function as cytotoxins, Shiga toxins cause 
tissue necrosis in the intestine (Thorpe et al., 2001). Although both Stx1 and Stx2 share 
similarity in structure and mechanism of action, a couple of epidemiological studies 
suggest that Stx2 is more toxic than Stx1, and has a higher propensity to cause HUS than 
does Stx1 (Boerlin et al., 1999; Tesh et al., 1993). One possible explanation for this is 
that the level of transcription of stx2 in vivo is higher than that of stx1. Transcription of 
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stx1 is known to be iron repressible in vitro and its promoter region includes a 
recognition site for the fur gene product (Weinstein et al., 1988). On the other hand, stx2 
promoter activity is unaffected by osmolarity, pH, oxygen tension, acetate, iron level 
and carbon source (Muhldorfer et al., 1996), factors that ultimately result in a higher 
synthesis and concentration of Stx2 over Stx1 in vivo. 
 
2.5.4 Putative accessory virulence factors 
Almost all E. coli O157:H7 strains harbor a large 60-65 MDa plasmid (Johnson 
et al., 1983), designated as a “virulence plasmid” (pO157), which plays an important 
role in virulence of this organism. The large plasmid of O157 encodes the EHEC-
hemolysin (Ehx), a novel hemolytic phenotype which is distinct from that associated 
with the E. coli alpha-hemolysin (Schmidt et al., 1995). In contrast to alpha-hemolysin, 
Ehx can be detected on blood agar plates containing washed sheep erythrocytes 
supplemented with Ca2+. The zones of hemolysis on these plates are smaller and more 
turbid than those caused by alpha-hemolysin and require over night incubation before 
they become visible (Beutin, 1991). The hemolysin gene is encoded in a polycistronic 
operon containing four open reading frames designated EHEC-hlyCABD (Schmidt et al., 
1995). Within this operon, hlyA presents the structural gene for the hemolysin, which is 
synthesized as an inactive precursor with a predicted size of 107 kD and converted to its 
active form by the product of the hlyC gene (Paton and Paton, 1998). The secretion of 
HlyA is signal peptide-independent and mediated by both a specific membrane 
translocator system encoded by the hlyB and hlyD genes (Welch, 1991). A role for Ehx 
in the pathogenesis of diarrheal disease has not been clearly demonstrated. According to 
Law and Kelly (1995) the Ehx may contribute to pathogenesis by enzymatically 
releasing hemoglobin which provides a source of iron, thereby enhancing the growth of 
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E. coli O157:H7 in the gut. Another putative virulence factor encoded on pO157 is a 
novel catalase-peroxidase, KatP (Braunder et al., 1997). The katP gene encodes a 1300-
amino acid protein, which is subsequently subjected to N- and C-terminal processing 
during secretion. The mature form has an apparent size of 104 kD, (Paton and Paton, 
1998). There are several lines of evidence suggesting a virulent nature of the KatP 
protein. Brunder et al. (1997) found that KatP is able to cleave human coagulation factor 
V, leading to exacerbation of hemorrhagic disease. Another virulent feature of KatP is 
expressing the cytotoxic effect on Vero cells (Djafari et al., 1997). In addition, this 
organism possesses a small 6.6 kb plasmid which encodes a gene that can synthesize 
colicin D (Bradley et al., 1991). Last on the list of E. coli O157:H7 virulence factors is a 
39-amino-acid enterotoxin, encoded by the astA gene that contributes to the 
pathogenesis of watery diarrhea commonly seen during the early stages of E. coli 
O157:H7 infection (Savarino et al., 1991).  
 
2.6.  Diagnosis 
The low infectious dose (Willshaw et al., 1994) in combination with the nature 
of HUS disease, where the typical clinical signs may only become apparent a week or 
more following the onset of gastrointestinal symptoms, can complicate diagnosis as the 
numbers of E. coli O157:H7 at this time may be very low (Paton and Paton, 1998). 
Thus, there is an imperative need to develop very sensitive diagnostic tests for this 
organism. Diagnostic procedures are based on both detection of Shiga toxins or their 
genes in different samples as well as the isolation of E. coli O157:H7. Although 
information on the presence of E. coli O157:H7 cells can be obtained by molecular 
analysis of mixed cultures, isolation of E. coli O157:H7 is considered as the definitive 
diagnostic procedure. While isolation of this pathogen may have limited clinical 
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application, it is of great importance from an epidemiological point of view, as isolation 
permits additional characterization typing of this organism that may help in an outbreak 
setting.  
In the initial report where E. coli O157:H7 was associated with food-borne 
outbreaks of hemorrhagic colitis, Wells et al. (1983) used direct plating of fecal material 
onto MacConkey agar from human patients in order to isolate this organism. The authors 
revealed that E. coli O157:H7 was not able to ferment D-sorbitol within seven days of 
incubation, whereas previous reports had indicated that 93% of all E. coli of human 
origin did so. Two years later, Farmer and Davis (1985) exploited this feature to 
differentiate E. coli O157:H7 from other E. coli by directly plating samples onto 
MacConkey base plus 1% D-sorbitol (SMAC). Chapman et al. (1991) improved the 
isolation rate of E. coli O157:H7 by supplementing SMAC with 0.05 μg/mL cefixime to 
inhibit mainly Proteus spp. Furthermore, Zadik et al. (1993) reported more 
improvements in recovery rates of this organism by adding potassium tellurite at a 
concentration of 2.5 μg/mL to create CT-SMAC. Potassium tellurite inhibits 
Providencia spp. and Aeromonas spp., both of which are prevalent in the feces of 
humans and cattle, while E. coli O157:H7 strains carry a pathogenicity island termed 
TAI (tellurite resistance and adherence-conferring island) that encodes for tellurite 
resistance (Tarr et al., 2000). At present, CT-SMAC agar remains the standard media for 
the isolation of E. coli O157:H7 strains.  
Sanderson et al. (1995) revealed that enrichment of bovine feces in tryptic soy 
broth (TSB) containing cefixime (0.05 μg/mL) and vancomycin (40 μg/mL) prior to 
plating on CT-SMAC significantly increased the sensitivity of E. coli O157:H7 
detection in bovine feces. Generally, the enrichment procedure has a dual purpose: i) to 
  26
selectively increase numbers of target organisms by suppressing the growth of 
background microorganisms, and ii) to dilute inhibitors for downstream procedures that 
are normally present in fecal samples. It is well known that bilirubin and bile salts, 
which are present at high concentrations in fecal samples, inhibit Taq polymerase and 
can lead to false-negative results. Inhibitors of Taq polymerase are also present in meat 
samples. For both feces and food samples, the sensitivity of PCR assays is significantly 
increased if template DNA is extracted from broth enrichment cultures (Gannon et al., 
1992).  
In an attempt to improve the sensitivity, a company named Dynal from Norway 
developed immunomagnetic separation (IMS) techniques for the isolation of E. coli 
O157:H7 from low-abundance specimens. The procedure involves coating magnetic 
beads with anti-E. coli O157 antibodies and mixing them with a suspension of incubated 
selective enrichment broth and specimen. The beads and bound bacteria are trapped in a 
magnetic field (magnetic separation), and after a couple of washing steps the bead-
bacteria complex are released and plated onto CT-SMAC agar. Chapman et al. (1994) 
found that IMS was 100 times more sensitive than direct culture plating on either 
cefixime-rhamnose SMAC or CT-SMAC for isolation of E. coli O157 from bovine fecal 
samples. In a recent study performed by Vidovic et al. (2007), it was shown that IMS 
may be highly variable in the recovery rate of naturally-occurring bovine fecal sample E. 
coli O157 isolates. The variations in the recovery rates of IMS may be due to the high 
sensitivity of particular isolates to antibiotics that were present in the enrichment broth, 
implying the importance of appropriate selection of antibiotics during enrichment steps.  
In the initial investigation in which E. coli O157:H7 was associated with 
hemorrhagic colitis, isolates were serotyped by standard procedures (Wells et al., 1983). 
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In the late 1980s, latex agglutination reagents for detection of E. coli O157 and H7 
became available commercially and were shown to be a rapid and economical 
alternative to tube agglutination (Chapman, 1989).  
Polymerase chain reaction (PCR) has been used both to confirm the identity of E. 
coli O157:H7 isolates and to directly detect the organism in suspected samples. Among 
many PCR protocols designed to identify STEC organisms, Paton and Paton (1998b) 
developed a multiplex PCR that detected eaeA, ehx and all known subtypes of Shiga 
toxins. In several studies it was reported that existing DNA sequence polymorphisms in 
particular stx2-related genes may significantly reduce the efficiency of primer annealing, 
with large effects on the sensitivity of the PCR reaction (Gannon et al., 1990). Primers 
designed for stx genes must be selected from the conserved domains of the gene to avoid 
regions where sequence heterogeneity has been reported. 
Tissue culture cytotoxicity assays play an important role in detecting E. coli 
O157 and other STEC organisms in samples where isolation of these organisms is 
difficult. Konowalchuk et al. (1977) first observed that Vero cells possess profound 
sensitivity to STX and to the present time this cell line remains the “gold standard” for 
confirmation of the cytotoxicity of putative STX-producing organisms. Vero cells 
possess a high concentration of both Gb3 and Gb4 receptors on the surface of their 
plasma membranes, which makes this cell line ideal to detect all known STX variants. 
The assay involves treatment of Vero cells at the confluent stage with sterile culture 
extracts and observing cells for a cytopathic effect after 48 to 72 h of incubation 
(Karmali, 1989). Karmali et al. (1985) reported that treating mixed fecal cultures with 
the antibiotic polymyxin B, to release cell-associated STX, improved the sensitivity of 
the Vero cell assay. 
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2.7.  Ecology of E. coli O157:H7  
 The primary habitat of E. coli O157:H7 is the gastro – intestinal tract, principally 
the bowel of mammals and birds. When found in nature, either in soil or water, it is 
derived from its primary habitat, usually by fecal contamination. Cattle are one of the 
most important hosts and sources of E. coli O157:H7. Matthews et al. (1997) have 
shown that 1 to 4% of UK cattle herds are infected with E. coli O157:H7. Another study 
also carried out in the UK showed that the regional incidence of this pathogen in cattle 
may be as large as 16% (Chapman et al., 1997). According to the National Animal 
Health Monitoring System (2001), prevalence of this pathogen in U.S.A feedlot cattle 
ranged from 10-23%. Two recent studies performed in Western Canada found 
approximately 15% of feedlot cattle carrying E. coli O157:H7 (LeJeune et al. 2004; 
Vidovic and Korber, 2006). The prevalence of fecal shedding of E. coli O157:H7 
appears to vary by age, with higher prevalence reported in younger animals in field 
studies (Hancock et al., 1994). Longitudinal studies have shown that individual animals 
shed E. coli O157:H7 transiently (Zhao et al., 1995; Shere et al., 1998). Studies in cattle 
have also documented a seasonal pattern to fecal shedding, with the two highest 
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execretion rates being in spring and in late summer (Shere et al., 1998). The period of 
high excretion rate in cattle has been shown to correlate with the start of the peak cases 
of human infection (Wallace et al., 2000). At present, it is not known whether a direct 
link exists between seasonal patterns in cattle and humans. Using molecular typing, it 
has been found that multiple subtypes of E. coli O157:H7 may be present within a farm 
at a single point in time, and that some subtypes appear to be unique to a specific herd or 
feedlot (Rice et al., 1999; Vidovic and Korber, 2006). The subtypes found in a herd may 
change over time (Faith et al., 1996). This diversity may be caused by mutation events 
or introduction of subtypes that briefly exist in a cattle operation but fail to be 
maintained within a new environment. Many animals in addition to cattle shed E. coli 
O157:H7, including domestic sheep, goats, horses, dogs and reindeer as well as wild 
deer, birds and rabbits (Hancock 1998). A single study carried out in the UK showed 
that fecal material from between 1 to 3% of birds was contaminated by the pathogen 
(Wallace et al., 1997). The finding of identical genetic strains of E. coli O157:H7 in 
isolates from a human case of illness, deer jerky consumed by the patient and the source 
carcass for the jerky illustrates that wildlife may be a direct source of infection (Keene et 
al., 1997). 
Possible routes of entry of E. coli O157:H7 into the environment include the 
direct deposition of feces by pastured cattle, fertilization of agriculture land with 
manure, and leaching of bacteria from fertilized soil into water. Escherichia coli 
O157:H7 appears to have unique growth and survival characteristics which enable it to 
survive under a wide range of environmental conditions. Wang et al. (1996) found that 
E. coli O157:H7 may replicate in bovine feces at 22˚C and 37˚C and survive for up to 
eight weeks at 5˚C. Another study performed by Kudva et al., (1998) revealed that E. 
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coli O157:H7 can remain viable in non-aerated cattle manure for 12 months and for 
approximately 2 months in aerated manure. Survival rates of E. coli O157 are greatly 
reduced in cattle manure slurry compared to cattle manure (Maule, 1997); the main 
reason for this decline are changes in the chemical slurry composition (accumulation of 
NH4 and organic acids, reduction in oxygen and available carbon). Although E. coli 
O157:H7 do not naturally belong to the microbial community of aquatic systems, this 
pathogen has been identified in various types of cattle water sources, including troughs, 
ponds, tanks and creeks (Sargeant et al., 2000; LeJeune et al., 2001). According to 
Wang and Doyle (1998), E. coli O157:H7 can survive for up to 90 days in river water, 
with persistence highly-dependent upon water source and temperature. In bottled water 
this pathogen may survive as long as 300 days (Warburton et al., 1998). 
 
2.8.  Sigma s factor and its role in stress response of E. coli O157:H7 
2.8.1 Background 
 Different unfavorable environmental conditions trigger a bacterial expression of 
an appropriate set of genes in order to survive. External stimuli cause exchange of sigma 
subunits in the RNA polymerase (RNAP) complex and gene expression is adjusted to 
newly emerged needs. The RNA polymerase of E. coli is composed of the core enzyme 
(including α2, β and β’ with the catalytic activity of RNA polymerization), and one of 
seven different species of σ subunit (see Table 2.5.). Sigma species may clearly 
recognize distinguishable gene promoters thereby activating distinct gene sets, known as 
regulons. Most housekeeping genes expressed during exponential-phase growth are 
transcribed by the holoenzyme containing the rpoD gene product, while the holoenzyme 
σS is essential for transcription of certain stationary-phase specific genes (Lange and 
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Hennge-Aronis, 1991). The σS or RpoS subunit is considered the general stress sigma 
factor. It is strongly induced when a cell is in stationary phase or in exponential phase 
exposed to various stress conditions, including: ultra-violet radiation, hyperosmolarity, 
pH downshift, and non-optimal high or low temperature regimes (Hengge-Aronis 2000). 
The σS increase is often accompanied by a reduction or cessation of growth and provides 
cells with the ability to survive the actual stress as well as additional stresses not yet 
encountered, (“cross-protection”). The dual nature of the σS stress response is opposite 
to other specific stress responses, which are triggered by a single stress signal and result 
in the induction of proteins that allow cells to overcome only a specific stress.  
Table 2.4. Sigma subunits of E. coli 
Sigma 
subunit 
Protein 
size (aa) 
Kd(nM) 
(RNAP-σ) 
Intracellular 
concentration 
(molecules/cell) 
Genes under 
the control of each sigma 
RpoD 613 0.26 700 Growth related genes (~1000) 
RpoN 477 1.55 110 Nitrogen regulated genes (~15) 
RpoS 330 4.26 <1 Stationary phase/stress response (~140) 
RpoH 284 1.24 <10 Heat shock/stress response (~40) 
RpoF 239 0.74 370 Flagella-chemotaxis genes (~40) 
RpoE 202 2.43 <10 Extreme heat shock/extracytoplasmic genes (~5) 
Fecl 173 1.73 <1 Ferric citrate transport (~5) 
The sigma factors of E. coli are listed in their RNAP dissociation constant (Kd) determined by 
core enzyme binding in mixed reconstitution experiments (Lange and Hennge-Aronis, 1991).  
 
The rpoS gene occurs in the γ branch of the proteobacteria, a group of Gram negative 
bacteria that includes many human pathogen species and also some beneficial 
organisms. With minor variations, the general function of σS in these bacteria appears to 
be similar to that in E. coli. The synthesis and accumulation of σS are controlled at 
multiple levels, including transcription, translation, proteolysis and activity. 
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2.8.2 Regulation of rpoS transcription 
Analysis of rpoS transcription using different experimental approaches revealed 
that several promoters are involved in rpoS transcription. Two closely-spaced and 
relatively weak promoters (nlpDp1 and nlpDp2) located upstream of the nlpD gene 
(Lange et al., 1995) encode a lipoprotein of unknown function (Lange and Hengge-
Aronis, 1994), and generate a bicistronic nlpD-rpoS message. The major rpoS promoter 
(rpoSp) is located within the nlpD gene and produces a monocistronic rpoS transcript 
with a 5’ untranslated leader region of 567 nucleotides (Takayanagi et al., 1994). The 
operon promoters nlpDp1 and nlpDp2 are not regulated by growth phase, whereas rpoSp 
is subject to stationary-phase induction in Luria broth-grown cells (Lange et al., 1995). 
The global transcription regulation of rpoS is mostly influenced by the catabolite 
repressor protein (CRP), guanosine tetraphosphate (ppGpp) and inorganic polyphosphate 
(poly-P). 
Many bacteria use catabolite repression as a way to use the most energetically 
favorable carbon source available. Low catabolite concentration in E. coli triggers 
formation of cyclic AMP (cAMP) via catalytic activity of membrane-associated 
adenylate cyclase (encoded by the cya gene) (Neidhardt, 1996). Higher concentrations of 
cAMP subsequently cause binding and activation of CRP leading to transcriptional 
activation or repression of the rpoS gene, dependant on the growth phase of organism. 
Performing experiments with cya (encoding adenylate cyclase) or crp (encoding the 
cAMP protein receptor) mutants, it was found that σS levels and the activities of an 
rpoS::lacZ fusion were high in exponential phase, implying the repressive nature of 
cAMP-CRP on rpoS transcription. Unpublished results from Scheller and Hengge-
Aronis however indicate that cAMP-CRP positively control transcription of rpoS during 
entry into stationary phase. The major rpoS promoter is flanked by two putative cAMP-
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CRP binding sites which most likely have opposite roles in rpoS gene transcription. The 
upstream location of the cAMP-CRP binding site is similar to that of the lac promoter, 
and corresponds to the classical activator position (Busby and Ebright, 1999), while the 
second cAMP-CRP box is positioned downstream from the transcriptional start site, and 
has an inhibitory function.  
Inorganic polyphosphate is present in most microorganisms and often 
accumulates during stationary phase or other stress conditions (Kornberg et al., 1999). 
During exponential growth of E. coli, the concentration of inorganic phosphate follows 
the scheme Pi>PPi>poly-P (Neidhardt, 1996). The importance of poly-P for E. coli 
exposed to different stress conditions (Crooke et al., 1994) is linked in part to rpoS 
transcription. Polyphosphate accumulation is positively affected by ppGpp, which seems 
to inhibit the ppx-encoded exopolyphosphatase, an enzyme that degrades polyphosphate. 
In E. coli, ppGpp increases in response to amino acid limitation as well as carbon, 
nitrogen and phosphorus starvation. Transcriptional rpoS::lacZ fusion experiments 
revealed a positive role of ppGpp in rpoS transcription (Lange et al., 1995), where 
artificial induction of ppGpp in exponential phase caused an approximate 50-fold 
increase of RpoS (Brown et al., 2002). Due to the pleiotropic nature of ppGpp, its 
mechanism of action remains mostly unresolved. According to Lange et al. (1995), 
ppGpp does not specifically target promoters involved in rpoS transcription but rather 
transcriptional elongation or transcript stability via altered levels of inorganic 
polyphosphate (Shiba et al., 1997). 
 
2.8.3 Regulation of rpoS translation  
Using translational rpoS::lacZ fusions it was found that rpoS translation is 
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stimulated by certain stress conditions, including: hyperosmolarity (Lange and Hengge-
Aronis, 1994b), low temperature (Sledjeski et al., 1996) and low pH (Kampmann and 
Hengge-Aronis, unpublished data) as well as entry into stationary phase (Lange and 
Hengge-Aronis, 1994b). The most important elements in control of rpoS translation 
include secondary structure of rpoS mRNA, Hfq and H-NS proteins and small regulatory 
RNAs. 
Monocistronic transcripts originating from the main promoter of rpoS carry an 
unusually long nontranslated 5’ region (leader region) which plays a crucial role in 
translation of rpoS mRNA. Approximately 340 nucleotides at the 5’ end of an rpoS 
transcript fold into a very stable and complex cruciform-type structure with further 
downstream folding of the translational initiation region (TIR) into two less-stable 
structures. The first structure contains a large hairpin, including the Shine-Dalgarno 
sequence with no function in rpoS translation control, whereas the second structure 
located near the Shine-Dalgarno sequence is partially complementary to an “internal 
antisense” region located further upstream (Hengge-Aronis, 2002). At present, it is 
believed that the topology of TIR plays an important role in the control of rpoS 
translation by changing access to the ribosome during different growth/stress conditions. 
During optimal growth conditions, TIR is poorly accessible to the ribosome, while under 
certain stress conditions the secondary structure of rpoS mRNA undergoes changes that 
permit TIR access to the ribosome, with subsequent initiation of translation (Hengge-
Aronis, 2002).  
Almost 40 years ago, Franze de Fernandez et al. (1968) identified the Hfq 
protein (host factor I [HF-I]), a 11.2 kDa protein essential for replication of the phage 
Qβ RNA. The exact molecular function of Hfq in rpoS translation still remains 
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unknown. There are several hypotheses regarding possible action of Hfq protein in rpoS 
translation. Epistasis experiments led to the conclusion that Hfq was directly involved in 
translation initiation (Muffler et al., 1996). A key feature of Hfq is the possession of at 
least two RNA binding domains that prefer adenosine-uracil rich sequences (Vytrytska 
et al., 1998) leading to high binding affinity to several sites in a large 5’ rpoS transcript 
(Cunning et al., 1998). By binding to several positions of rpoS mRNA, Hfq may 
stabilize the transcript’s secondary structure thereby providing a structural condition for 
additional activators of rpoS translation. Another possible explanation is that Hfq acts 
like a “platform” bound to rpoS mRNA, and thus recruiting additional factors involved 
in rpoS translational control (Hengge-Aronis, 2002). Sledjeski and coworkers (2001) 
found that Hfq may control rpoS translation through another regulatory RNA species, in 
particular a small regulatory DsrA RNA molecule. A hypothetical model of Hfq-DsrA 
action includes first binding of Hfq to rpoS mRNA which recruits DsrA into a ternary 
complex that would sequentially lead to alteration of the secondary structure of rpoS 
transcript and initiation of rpoS mRNA translation (Hengge-Aronis, 2002). Possibly, the 
pleiotropic nature of Hfq protein implies a multifunctional role in the rpoS translational 
process. 
Histone-like protein H-NS primarily function in nucleoid organization (form a 
large nucleoprotein complex) and in gene regulation as a repressor (Zhang et al., 1996). 
The homodimer form of H-NS specifically binds to curved regions of DNA, thereby 
blocking transcription initiation of more than 100 genes that are involved in 
environmental adaptation (Hommais et al., 2001). Experiments with H-NS-deficient 
mutants have demonstrated a H-NS repression of the RpoS post-transcriptional 
mechanism, where increased σS levels in exponential phase were similar to those 
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reached by the wild-type in stationary phase (Barth et al., 1995). At present, the 
mechanism by which H-NS down-regulates rpoS translation is still unclear. 
 Several small regulatory RNAs control rpoS translation in E. coli, mostly via 
fine-tuning functions. Two RNAs, DsrA and RprA, promote rpoS translation, while 
OxyS acts as a repressor. DsrA is an 87-nucleotide RNA that folds into a three-stem-
loop structure (Sladjeski and Gottesman, 1995). The main function of DsrA in E. coli 
physiology may be thermoregulation. Although it plays a minor role for rpoS translation 
in cells grown at 37 or 42˚C, it becomes the major factor at ≤30˚C (Sledjeski et al., 
1996). The essence of rpoS induction at low temperature lies in enhanced transcription 
of dsrA and six-fold increase in transcript stability under low temperature conditions 
(Repoila and Gotssman, 2001). It is believed that the stem-loop 1 of DsrA binds to the 5’ 
untranslated leader sequence of the rpoS transcript, leading to an increase translation rate 
via opening the secondary structure of rpoS mRNA (Majdalani et al., 1998). Sladjeski 
and coworkers (2001) reported that Hfq protein binds to DsrA causing stabilization and 
changes in its secondary structure that finally lead to association with rpoS mRNA.  
RprA is a small RNA involved in rpoS translation. Transcription of rprA is 
controlled by the phosphorelay system that regulates capsular polysaccharide synthesis 
genes, RcsB / RcsC, in which RscC is a transmembrane sensor and RcsB is the response 
regulator (Majdalani et al., 2001). The mechanism by which RprA stimulates rpoS 
mRNA translation is unknown.   
The small 109-nucleotide untranslated RNA named OxyS plays a repressive role 
in rpoS transcription (Altuvia et al., 1997). It is believed that OxyS binds to Hfq with an 
A-rich 26 bp linker region and prevents Hfq from activating RpoS in response to 
oxidative stress (Zhang et al., 1998). 
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2.8.4 Regulation of σS proteolysis 
Other regulatory pathways under RpoS control are proteolytic degradation in 
exponentially growing cells (Schweder et al., 1996), and inhibition of proteolysis 
triggered by high osmolarity (Muffler et al., 1996b), low pH (Lee et al., 1995) 
temperature (Repoila and Gottesman, 2001) and carbon starvation (Takayanagi et al., 
1994). According to Lange and Hengge-Aronis (1994) the half-life of RpoS in 
exponential growing cells is approximately 1.4 minutes, while upon entry into stationary 
phase the half-life of the same protein increases to 16.5 minutes or even more under 
osmolarity stress (45 minutes). 
Several lines of evidence suggest that a barrel-shaped ClpXP processive protease 
is a key regulator of RpoS degradation (Zhou et al., 2001). Two six-subunit rings 
identifed as ClpX act as a chaperone discriminating and unfolding proteins to the inner 
chamber consisting of two seven-subunit rings of ClpP where proteolysis takes place 
(Kim et al., 2000). Mutations in either the clpP or clpX genes result in stabilization of σS 
(Schweder et al., 1996). Pratt and Silhavy (1996) demonstrated both in vivo and in vitro 
that σS cannot be recognized by ClpXP alone. The two-component regulatory RssB 
protein is required for recognition of RpoS by the ClpXP complex (Bearson et al., 
1996). Activity of the RssB is modulated by phosphorylation of a conserved aspartyl 
residue in the N-terminal of the protein, which results in direct interaction with RpoS 
(Becker et al., 1999). Acetyl phosphate is a phosphate donor that triggers RssB activity 
and results in a proteolytic rate of RpoS (Bouche et al., 1998). Mutation in RssB has 
been shown to lead to a ten-fold increase of RpoS level during exponential phase, 
implying the degradable nature of RssB in σS physiology (Muffler et al., 1996c). 
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2.8.5 Regulation of σS activity 
In in vivo or in vitro experiments, more than 100 promoters have been identified 
that may be recognized by RNAP containing σS, with no consensus promoter sequence 
(Ishihama, 2000). In addition, a number of σD-dependent promoters can be transcribed in 
vitro by the EσS holoenzyme (Hiratsu et al., 1995). The current view of this “sigma 
selectivity paradox” (Weber et al., 2005) is that the EσS holoenzyme recognizes a 
specific DNA conformation such as bent DNA regions (Espinosa-Urgel and Tormo, 
1993). Another explanation for the sigma selectivity paradox is that EσS and EσD 
holoenzymes use very similar promoters but that minor differences in the extended -10 
region (Becker and Hengge-Aronis, 2001) may shift the preference towards one or the 
other holoenzyme. The most recent findings suggest that interaction between the EσS 
holoenzyme and its target promoters is more complex. Changes in the cytoplasmic 
composition (increased level of trehalose and potassium glutamate) result in decreased 
superhelicity of template DNA that further enhances transcription by EσS (Ishihama, 
2000). The overall findings lead to the conclusion that a variety of sigma S promoter 
sequences may be recognized under different specific conditions or in the presence of a 
specific factor. 
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BRIEF INTRODUCTION TO CHAPTER 3 
This study was designed to provide fundamental information on the prevalence 
of E. coli O157 in cattle housed across Saskatchewan. To achive this goal, a two-year 
study was conducted, where in total 23 feed lots were screened for the presence of E. 
coli O157. Accordingly, two approaches were employed: (i) a longitudinal study, where 
3 feedlot-cattle operations were examined over a 10-month period, and (ii) a point study, 
where 20 feedlots were examined once. In addition, all isolates obtained from the 
longitudinal and point prevalence studies were characterized in terms of their genetic 
relatedness, antimicrobial susceptibility, virulence profiles, and cytotoxicity.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
3. PREVALENCE OF ESCHERICHIA COLI O157 IN SASKATCHEWAN 
CATTLE: CHARACTERIZATION OF ISOLATES USING RAPD-PCR, 
ANTIBIOTIC RESISTANCE PROFILES, AND PATHOGENICITY 
DETERMINANTS 
 
Abstract 
 The prevalence of Escherichia coli O157 associated with feedlot cattle in 
Saskatchewan was determined over a 10 month longitudinal study (3 feedlots) and a 
point prevalence study (20 feedlots). The prevalence of E. coli O157 at the three 
different sites in the horizontal study varied from 2.5-45%. The point prevalence of E. 
coli O157 among Saskatchewan cattle from 20 different feedlots ranged from 0% to a 
high of 57%. A statistically significant (P = 0.003) positive correlation was determined 
to exist between the density of cattle and the E. coli O157 prevalence rate. A significant 
correlation (P = 0.006) was also found between E. coli O157 percent prevalence and the 
number of cattle housed: capacity ratio. All 194 E. coli O157 isolates obtained were 
highly virulent, and RAPD PCR analysis revealed the isolates grouped into 39 different 
E. coli O157 subtypes, most of which were indigenous to specific feedlots. Two of the 
most predominant subtypes were detected in 11 different feedlots and formed distinct 
clusters in two geographic regions in the province. Antimicrobial susceptibility testing 
of the E. coli O157 isolates revealed that 10 were multidrug resistant, 73 and 5 of which 
were resistant to sulfisoxazole and tetracycline, respectively. 
 
Reprinted with permission from Applied and Environmental Microbiology, 72: 
4347-4355, 2006 
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3.1. Introduction 
 
In 1982 two outbreaks of bloody diarrhea in Oregon and Michigan (41) and 
another in Ottawa (47) led to recognition of a new pathogenic serotype, Escherichia coli 
O157:H7. Since its discovery as an etiologic agent of hemorrhagic colitis in 1982, the 
clinical importance of E. coli O157:H7 has escalated rapidly. In little more than a 
decade, recognition of E. coli O157:H7 underwent a major transformation from that of a 
newly described agent of diarrheal disease (1982) to the leading bacterial cause of 
bloody diarrhea in United States in 1992 (18). 
The pathogenicity of E. coli O157:H7 is associated with a powerful combination 
of different virulence factors. Several inducible mechanisms of acid resistance (23, 24) 
potentially contribute to the low infectious dose of this organism (1 to 100 CFU; 16, 36), 
and its survival in the harsh environment of the stomach. In addition, E. coli O157:H7 
efficiently adhere to the intestine epithelial cells causing attaching and effacing lesions 
(AE) (46). The host cells undergo dramatic changes, losing microvilli on the cell 
surface, followed by the tight attachment of cells to the epithelial surface and 
deformation of cell cytoskeletal structure resulting in the formation of pedestals (29). A 
cluster of genes involved in the generation of the AE lesions are chromosomally 
encoded on a “pathogenicity island” named the Locus of Enterocyte Effacement (28). 
This pathogenicity island also encodes the eae gene which is responsible for the 
generation of an outer membrane protein called intimin necessary for attachment to 
enterocytes. Undoubtedly, the most potent virulence feature of E. coli O157:H7 is the 
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ability to produce Shiga toxins (Stx1 and/or Stx2 and variants), a family of unique, 
heterodimeric protein toxins (32) that cause a wide spectrum of clinical symptoms 
including hemorrhagic colitis (bloody diarrhea), life-threatening complications such as 
hemolytic-uremic syndrome (HUS) and thrombotic thrombocytopenic purpura (48). 
Ruminants, especially cattle, have been implicated as the primary reservoir of E. 
coli O157:H7 that infect humans. The fecal excretion of this organism by cattle appears 
to be seasonal, with excretion rates highest in spring and late summer (17, 45). Human 
infection with E. coli O157:H7 has been associated with various transmission routes, 
including: direct exposure to infected animals (40), person-to-person passage (4) and 
mostly by consumption of contaminated foods and waters (5, 10, 20). From an 
epidemiological point of view it is interesting that Shiga toxin-producing Escherichia 
coli (STEC) infections in humans seem to be different worldwide. Escherichia coli 
O157:H7 is the predominant serotype of STEC in the United States, Canada, the United 
Kingdom and Japan but in continental Europe, Australia and Latin America non-
O157:H7 serotypes are much more common than E. coli O157:H7 (33). Incidence of E. 
coli O157:H7 disease have risen in Canada. According to the Public Health Agency of 
Canada (2005) the majority (95%) of pathogenic E. coli isolates from human cases were 
serovar O157.  
As a consequence of the fast growth of the cattle industry in Western Canada, the 
health risk from E. coli O157:H7 has increased, especially among residents of rural 
communities. There is virtually no information on the occurrence of E. coli O157 in 
Saskatchewan cattle herds and its presence in adjacent environments. This study was 
conducted to determine the frequency of occurrence of E. coli O157 in Saskatchewan 
cattle and environmental samples (pristine soil and those soils treated with cattle 
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manure, water from dugouts) by combination of a longitudinal (time course) and a point 
prevalence (multiple feedlots analyzed at approximately the same time) studies over a 
two year period. This study also sought to characterize the E. coli O157 isolates obtained 
in terms of their virulence profiles, antibiotic susceptibilities, cytotoxicity potential and 
RAPD genomic profiling. RAPD DNA banding patterns, in conjunction with virulence 
and antibiotic resistance patterns, may assist in the epidemiologic tracing of E. coli O157 
isolates of medical concern. 
 
3.2.  Materials and methods 
3.2.1 Longitudinal prevalence study 
A longitudinal study was designed to examine the prevalence of E. coli O157 
over a ten-month period at two feedlots (randomly given the identifiers L and V) and a 
cow-calf operation (WB). At each sampling time, twenty cattle fecal samples were 
randomly collected from the pen floor from each facility (for a total of 400 fecal 
samples). An additional 15 environmental samples, consisting of soil samples from 
fields treated with manure as well as water from dugouts and natural runoff, were 
collected per sampling period (for a total of 165 environmental samples). 
 
3.2.2 Point prevalence study 
  The point prevalence study targeted a number of feedlots which ranged in size 
from 80 to 5,800 head of cattle. Twenty Saskatchewan feedlots were sampled once 
during the summer of 2004 (from late June 2004 to the end of September 2004).  Forty 
fecal samples were collected from each feedlot. The percent prevalence of E. coli O157 
in the point and longitudinal (above) studies was calculated as: [(number of samples 
positive of E. coli O157 / total number of samples tested in a feedlot) x 100]. 
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3.2.3 Collection of samples 
  Over a two year period 1,200 bovine fecal and 165 environmental samples were 
collected from 23 different cattle facilities as part of both longitudinal and point 
prevalence studies. All bovine fecal samples were obtained from freshly defecated feces. 
Approximately 40 g of feces was aseptically collected per sample using a sterile tongue 
depressor (Baxter Diagnostics Inc. USA) and transferred to a sterile 80 ml plastic 
container (Starplex, Canada). Typically, 2 to 6 randomly chosen samples were obtained 
per pen so that each pen in multi-pen feedlots was screened for E. coli O157.  Samples 
from lagoons, dugouts and soil were sampled directly using a sterile 80 ml plastic 
container. All samples were stored in a cooler with frozen cold-packs, transported to the 
laboratory, and tested within 2-6 hours of collection. All environmental and bovine fecal 
samples were processed in parallel using cultural methods with and without 
immunomagnetic separation.  
 
3.2.4 Immunomagnetic separation (IMS)  
  Samples (1 g or 1 ml) were aseptically added to 10 ml of Buffered Peptone 
Water (Becton Dickinson and Company, USA) supplemented with cefixime (0.5 mg L-1; 
Rhone-Poulenc Rorer, Canada), vancomycin (8 mg L-1; Sigma-Aldrich Chemie, 
Germany) and cefsuludin (10 mg L-1; Sigma-Aldrich Chemie) (7). After homogenization 
of samples, the suspensions were incubated at 37˚C for 6-8 h without agitation. IMS was 
performed according to the manufacturer’s instructions using a BeadRetriever (Dynal 
Biotech ASA, Oslo, Norway). One hundred microliters of the concentrated bead-bacteria 
complex was plated onto sorbitol MacConkey (SMACct; Becton Dickinson and 
Company) agar plates supplemented with cefixime (0.5 mg L-1) and potassium tellurite 
(2.5 mg L-1, Oxoid LTD, Hampshire, UK). After 24 h of incubation at 37˚C, discrete 
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gray non-sorbitol fermenting colonies were selected and tested by seroagglutination 
using O157 latex reagent (Oxoid LTD). All sero-positive isolates were saved in 10% 
glycerol at -70˚C for further analysis. 
 
3.2.5 Cultural technique 
   Samples (1 g or 1 ml) were aseptically added to 10 ml of modified EC broth 
(Becton Dickinson) containing novobiocin (20 mg L-1, Sigma Chemical Co.) vortexed, 
and then incubated at 37˚C for 18-24 h. After incubation, a 1 ml aliquot of each 
enrichment culture was serially diluted to 10-5 in sterile 0.85% saline to facilitate the 
recovery of isolates. One hundred microliters of the 10-3, 10-4 and 10-5 dilutions were 
spread plated in duplicate onto SMACct agar and incubated at 37˚C overnight. Each 
non-sorbitol fermenting colony with characteristic morphology for E. coli O157 was 
serologically tested for the somatic O157 antigen and sero-positive isolates were saved 
as described above. 
 
3.2.6 Multiplex PCR 
All presumptive E. coli O157-positive isolates were tested for the presence of 
four virulence determinants, including stx1, stx2, eaeA, and hlyA. Template DNA for 
multiplex PCR and RAPD fingerprinting were prepared from isolates that were grown at 
37˚C for 24 h in Lauryl Tryptose broth (Becton Dickinson) with agitation. After 
incubation, the optical density of the culture was standardized at 600 nm by diluting with 
broth. Aliquots (400 µl) of the stationary-phase culture with an optical density value of 
0.6 were centrifuged and total DNA was extracted according to the manufacture’s 
instruction using a DNeasy Tissue kit (QIAGEN Inc. Mississauga, Canada).  For the 
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longitudinal study, multiplex PCR was performed as described by Fagan et al. (12). 
Escherichia coli O157:H7 ATCC 43894 (which possesses the above virulence 
determinants) and Pseudomonas fluorescens strain cc848406E were used as positive and 
negative controls, respectively. In a recent study (11), it was shown that the Fagan PCR 
assay was unreliable for the detection of stx2d -positive STEC strains. Thus, the 
multiplex PCR protocol by Paton and Paton (35), which can identify all known subtypes 
of Shiga toxins, was used during the analysis of isolates obtained from the point 
prevalence study. 
 
3.2.7 Genotyping of E. coli O157 isolates 
In preliminary experiments, four decamer primers were tested against a panel of 
15 different E. coli O157 isolates for the random amplification of polymorphic DNA: 
GEN 15001 (5’-GTGCAATGAG-3’) (39), 1283 (5’-GCGATCCCCA-3’) (15), 1290 
(5’-GTGGATGCGA-3’) (34) and 1254 (5’-CCGCAGCCAA-3’) (1, 2, 26). Primer 1283 
provided the greatest discriminatory ability among the E. coli O157 test isolates, and 
was therefore used in this study. To further validate the reproducibility of this primer 
and procedure, three colonies of the same E. coli O157 isolate were amplified by primer 
1283 in three independent PCR reactions. The band patterns of the three colonies were 
consistent both among each of the colonies as well as within the triplicate PCR 
reactions. Preparation of DNA templates for RADP PCR was described above. PCR was 
carried out in 50 µl reaction volumes containing 5 µl of DNA template, 20 mM Tris-HCl 
(pH 8.4), 50 mM KCl, 3 mM MgCl2, 250 µM of each dNTP, 0.8 µM of primer and 2 
units of Taq polymerase. PCR amplification was performed in a Techne TC-412 thermal 
cycler, as follows: 45 cycles at 94˚C for 1 min, 36˚C for 1 min and 72˚C for 2 min, 
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followed by an elongation step of 72˚C for 5 min. Amplified products were then 
electrophoresed at 90 V for 2 h in 1.5% (w/v) agarose gels containing 0.125 µg ml-1 
ethidium bromide. A 1 Kb Plus DNA ladder was used as a molecular weight marker.  
 
3.2.8 Vero cell cytotoxicity assay 
 The cytotoxicities of the E. coli O157 isolates were determined using the method 
previously described by Roberts et al. (42). Cytopathic effects of the E. coli O157 
isolates were examined using a Zeiss inverted microscope (200X).  
 
3.2.9 Antibiotic susceptibility testing 
 Escherichia coli O157 isolates obtained from the point prevalence study (n=131) 
were examined for antibiotic resistance using Sensititre CMV1AGNF plates (TREK 
Diagnostic Systems, Cleveland, OH) that contained 17 antimicrobial agents dosed in 96 
wells at appropriate dilutions, as specified by NARMS (National Antimicrobial 
Resistance Monitoring System) of the CDC. Each well of the Sensititre microtiter plate 
was inoculated according to the instructions of the manufacturer followed by incubation 
at 37˚C for 24 h. The minimal inhibitory concentration (MIC) was manually determined 
for each isolate as the lowest concentration of each antibiotic that inhibited visible 
growth. The MIC breakpoints were determined according to the National Committee for 
Clinical Laboratory Standards (NCCLS) M100 (30) and M31 (31). 
 
3.2.10 Statistical analysis  
Data were analyzed with SAS (SAS Inst-Inc, Cary, NC) by using multiple 
regression to determine the dependence of prevalence of E. coli O157 on size of 
feedlots, density of cattle in pens, and ratio between housed cattle : feedlot capacity. 
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Each predictor (size of feedlots, density of cattle in pens, and ratio between housed cattle 
: feedlot capacity) was also evaluated using stepwise regression. The analysis of DNA 
patterns obtained using RAPD PCR was performed by using the Numerical Taxonomy 
and Multivariate Analysis System (NTSYSpc, Exeter Software, Setauket, N.Y.). 
Similarities between RAPD patterns were determined based on the Dice similarity 
coefficient. The resulting similarities in the matrix were further processed by employing 
the unweighted par – group method with arithmetic averages (UPGMA) to create a 
dendrogram that graphed the genetic relatedness between E. coli O157 isolates.  
 
3.3.  Results 
3.3.1 Prevalence of E. coli O157: 
3.3.1.1. (i) Longitudinal study 
  A total of 565 fecal bovine and environmental samples were collected over a 10 
month period. Out of 400 fecal samples, E. coli O157 was found in 57 samples (14.2 %). 
At feedlots L and V, E. coli O157 isolates were detected during every visit, and the 
frequency of detection fluctuated from 10-40%, and 30-65%, respectively. The overall 
prevalence of E. coli O157 for feedlots L and V over the 10 month period were 22.5 and 
45%, respectively. Escherichia coli O157 was found at the cow-calf operation WB only 
in August, resulting in an overall prevalence of 1.4%. The occurrence of E. coli O157 at 
all three cattle facilities over the ten collection periods are summarized in Table 3.1. Out 
of 165 environmental samples, none were found to be positive for E. coli O157.  
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Table 3.1. Table summarizing the characteristics of feedlots examined, and the 
prevalence (%) of E. coli O157 detected at each facility. 
Feedlot Diet Capacity Number of cattle 
Housed cattle 
/capacity 
Cattle density 
(# head / 100 m2) 
Prevalence 
% 
Z Concentrate - fed 2000 1000 0.50 4.9 22.5 
T Concentrate - fed 6000 5000 0.83 4.8 10 
P Concentrate - fed 3500 1600 0.45 6.5 42.5 
B Concentrate - fed 8000 3000 0.37 6.7 30 
G Concentrate - fed 3000 200 0.06 3.6 0 
S Concentrate - fed 3500 3500 1 7.4 57.5 
M Concentrate - fed 4000 4000 1 5.8 55 
W Concentrate - fed 3500 1500 0.42 4.3 5 
HM Concentrate - fed 7500 5800 0.77 5.4 40 
PP Pasture - fed 1600 80 ND ND 0 
MT Concentrate - fed 4000 2500 0.62 5.9 32.5 
MO Pasture - fed 800 70 ND ND 0 
K Concentrate - fed 3400 1300 0.38 5 15 
ML Pasture - fed 1000 120 ND ND 0 
SC Concentrate - fed 2500 420 0.16 4.7 0 
H Concentrate - fed 700 100 0.14 3 0 
WE Concentrate - fed 3600 1300 0.36 6.5 17.5 
TK Concentrate - fed 2200 1000 0.45 4.3 0 
SB Pasture - fed 3000 80 ND ND 0 
I Pasture - fed 1500 500 ND ND 2.5 
La Concentrate- fed 28000 15000 0.53 5.6 22.5 
Va Concentrate- fed 17000 12000 0.70 5.8 45 
WBa Pasture - fed 1200 300 ND ND 1.4 
a superscripts refer to feedlots examined during the longitudinal study.  
aWB refers to a cattle research station.  All remaining different letter designations refer 
to different feedlots. 
b ND, not determined.   
3.3.1.2. (ii) Point study  
 The prevalence of E. coli O157 in feedlots located throughout Saskatchewan are 
summarized in Table 3.1. and Figure 3.1. A total of 800 samples were collected from 
20 feedlots during this study. Out of 20 feedlots, twelve were found positive for E. coli 
O157 within which the prevalence of E. coli O157 ranged from 2.5 to 57.5%. A 
significant positive correlation (P=0.003) was observed between the prevalence rate of 
E. coli O157 and density of cattle in pens (Figure 3.2.; constructed using data obtained 
from both point prevalence and longitudinal studies). There was another statistically 
  
Figure 3.1. Map of Saskatchewan showing the prevalence of E. coli O157 detected (see 
color-coded legend) at feedlots/farms examined over a 2-year period. Triangles 
correspond to feedlots/farms examined during the longitudinal study, whereas circles 
represent feedlots examined during the point prevalence study. Note also colored shaded 
regions showing the geographic location of feedlots where E. coli O157 RAPD subtypes 
5 and 19 were detected. 
 
 significant correlation (P=0.006) found between the prevalence rate and a number of 
lots occupied by cattle within a feedlot (expressed as the ratio between the housed cattle: 
feedlot capacity; Table 3.1.). 
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Figure 3.2.  Relationship between the prevalence of E. coli O157 and the density of 
cattle (number of cattle:100 m2) housed at various feedlots (statistically significant at 
P=0.003).   
 
3.3.2. Virulence profile of E. coli O157 isolates 
 Multiplex PCR confirmed that all 194 serological positive isolates (from both 
longitudinal and point studies) were indeed E. coli O157.  These 194 E. coli O157 
isolates exhibited five different virulence profiles. The majority of the isolates (161 or 
82.9%) possessed all four virulence-associated genes (stx1, stx2, eaeA and hlyA). The 
second most predominant virulence profile was a combination of stx2, eaeA and hlyA 
genes, with 22, or 11.4%, of the isolates having these genes. Six isolates (3.1%) 
possessed stx1, eaeA and hlyA genes and 4 isolates (2.1%) were determined to have stx1 
and hlyA virulence markers. A single isolate (0.5%) had a unique virulence profile with 
only the hlyA gene being present. Out of the 194 E. coli O157 isolates obtained from 
across Saskatchewan over the two year study, 193 (99.4%) possessed at least one Shiga 
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toxin gene and 187 (96.4%) had a combination of eaeA and stx1 and or stx2, indicating a 
very high virulence potential of these isolates for humans.  
 
3.3.3 Cytotoxicity 
   The cytotoxicity effects of all 194 E. coli O157 isolates on Vero cells were 
observed and scaled from a value of 0 (no effect) to 10 (greatest effect), and compared to 
the reference strain E. coli O157 ATCC 43894, known to possess all four virulence 
determinants. All isolates from this study expressed cytotoxicity that ranged from 5.1 to 
10. The majority of isolates (n = 107 or 55%) expressed very high toxicity values of 9.1-
10; two other groups (n = 39 or 20% and n = 36 or 19%) had slightly lower 
cytotoxicities, ranging 8.1-9.0 and 7.1-8.0, respectively. Interestingly, the lowest toxicity 
(5.1-6.0) was observed for isolate L-9 (longitudinal study), an isolate that possessed both 
Shiga toxins (data not shown). In contrast, isolate L-12, which possessed only the hlyA 
gene, had a somewhat greater toxic effect (7.1-8.0) (data not shown).  
 
3.3.4  RAPD-PCR 
  The panel of E. coli O157 isolates from the longitudinal and point studies were 
genetically characterized using the RAPD-PCR technique. All isolates were grouped 
into 3 major clusters that encompassed 39 different subtypes or RAPD-PCR patterns. 
Amplification reactions using primer 1283 produced a set of 18 DNA fragments ranging 
from 450 to 4,000 bp in length. Generally, all isolates displayed a basic total DNA 
banding pattern; two doublets migrated at 520-560 bp and 650-700 bp, respectively, one 
triplet at 1,400, 1,500, 1,600 bp and a final band at 2,900 bp. Genetic similarity between 
the E. coli O157 isolates ranged from 0.76 to 1.00. Fourteen isolates from 9 feedlots (B, 
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HM, M, P, MT, WE, K, V and L) exhibited fourteen distinct genetic patterns, whereas 
eleven other subtypes (3, 10, 12, 14, 18, 25, 29, 32, 33, 34 and 35) consisted of groups of 
isolates that were endemic for their feedlots. The two most predominant subtypes, 5 and 
19, were detected at six feedlots each, of which eleven feedlots formed four distinct 
geographic clusters (each < 50 km in diameter) in central and north central 
Saskatchewan (Figure 3.1.).  
 
3.3.5 Antibiotic susceptibility  
 The antibiotic resistance patterns of the 131 isolates from the point prevalence 
study are shown in Table 3.2. Most of the 85 isolates (65%) were resistant to at least one 
antibiotic, whereas 46 isolates (35%) were sensitive to all 17 antibiotics tested. No 
resistance was observed for amikacin, ampicillin, amoxycillin/clavulanic acid, 
ceftriaxone, ciprofloxacin, cefoxitin, gentamicin, kanamycin, nalidixic acid, 
trimethoprim/sulfamethoxazole, and ceftiofur. The antibiotic for which resistance was 
most frequently observed was sulfisoxazole (61%) followed by tetracycline (12%). The 
prevalence rate of resistance to chloramphenicol and streptomycin among the E. coli 
O157 isolates was 2.3%. Two patterns of multidrug resistance, involving: i) 
chloramphenicol, sulfisoxazole, streptomycin, and tetracycline, and ii) sulfisoxazole and 
tetracycline, were observed in 3 (2.3%) and 8 (6%) isolates, respectively (Table 3.2.). 
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Table 3.2. Summary table showing characteristics (isolate number, isolation method, 
virulence profile, RAPD pattern, antibiotic resistance, and cytotoxicity) of E. coli O157 
isolates obtained from point study.   
Isolation 
method 
 Virulence profile 
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Antibiotic 
resistance Cytotoxicity 
Z Z-6 +   + + + + 1 Sulfisoxazole 9.1 - 10 
Z Z-8 +   + + + + 3 Sulfisoxazole 8.1 - 9.0 
Z Z-11 + +  + + + + 1 Sulfisoxazole 9.1 - 10 
Z Z-14 +   + + + + 1 Sulfisoxazole 8.1 - 9.0 
Z Z-19 +   + + + + 3 Sulfisoxazole 8.1 - 9.0 
Z Z-27 + +  + + + + 5 Sulfisoxazole 9.1 - 10 
Z Z-30 + +  + + + + 3 Sulfisoxazole 7.1 - 8.0 
Z Z-37 +   + + + + 3 Sulfisoxazole 7.1 - 8.0 
Z Z-38  +  + + + + 5 Sulfisoxazole 8.1 - 9.0 
T T-16 +   + + + + 1 Susceptible 9.1 - 10 
T T-20a +          
T T-22  +  + + + + 1 Tetracycline 8.1 - 9.0 
T T-33  +  + + + + 5 Sulfisoxazole 8.1 - 9.0 
T T-36 + +  + + + + 5 Sulfisoxazole 9.1 - 10 
B B-1 +   + + + + 5 Susceptible 7.1 - 8.0 
B B-3 + +  + + + + 5 Tetracycline 8.1 - 9.0 
B B-4 +   + + + + 5 Tetracycline 9.1 - 10 
B B-16 +   + + + + 4 Tetracycline 9.1 - 10 
B B-19 + +  + + + + 2 Tetracycline 9.1 - 10 
B B-22 +   + + + + 6 Susceptible 8.1 - 9.0 
B B-23 +   + + + + 6 Susceptible 7.1 - 8.0 
B B-27 +   + + + + 6 Susceptible 9.1 - 10 
B B-30 +    + + + 6 Sulfisoxazole 9.1 - 10 
B B-33 + +  + + + + 6 Sulfisoxazole 9.1 - 10 
B B-36 + +  + + + + 6 Sulfisoxazole; Tetracycline 9.1 - 10 
B B-38 +   + + + + 6 Sulfisoxazole; Tetracycline 7.1 - 8.0 
P P-2 +    + + + 6 Susceptible 7.1 - 8.0 
P P-3 +   + + + + 6 Sulfisoxazole 9.1 - 10 
P P-4 + +   + + + 16 Susceptible 9.1 - 10 
P P-5 +   + + + + 38 Sulfisoxazole 9.1 - 10 
P P-7 +   + + + + 6 Sulfisoxazole 9.1 - 10 
P P-9 +   + + + + 18 Sulfisoxazole 8.1 - 9.0 
P P-11 + +   + + + 17 Sulfisoxazole 9.1 - 10 
P P-13 +   + + + + 18 Sulfisoxazole 9.1 - 10 
P P-16 +    + + + 17 Susceptible 6.1 - 7.0 
P P-21 + +  + + + + 18 Sulfisoxazole 8.1 - 9.0 
P P-26 +    + + + 17 Susceptible 9.1 - 10 
P P-27 +    + + + 17 Sulfisoxazole 9.1 - 10 
P P-28 + +   + + + 17 Sulfisoxazole 9.1 - 10 
P P-29 +   + + + + 18 Sulfisoxazole 9.1 - 10 
P P-36 +   + + + + 18 Sulfisoxazole 9.1 - 10 
P P-37 +   + + + + 18 Sulfisoxazole 9.1 - 10 
P P-40 +    + + + 17 Sulfisoxazole 9.1 - 10 
S S-1a + +         
S S-4 + +  +  + + 5 Susceptible 9.1 - 10 
S S-5 + +  + + + + 5 Susceptible 9.1 - 10 
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Table 3.2. Continued 
Isolation 
method 
 Virulence profile 
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Antibiotic 
resistance Cytotoxicity 
S S-6 + +   + + + 13 
Chloramphenico
l; Tetracycline; 
Streptomycin; 
Sulfisoxazole 
7.1 - 8.0 
S S-7  +  +  + + 5 Susceptible 7.1 - 8.0 
S S-8 + +  + + + + 5 Susceptible 6.1 - 7.0 
S S-10 + +  + + + + 5 Susceptible 6.1 - 7.0 
S S-11  +  + + + + 5 Susceptible 7.1 - 8.0 
S S-14 + +  + + + + 5 Susceptible 6.1 - 7.0 
S S-16 + +  + + + + 5 Susceptible 6.1 - 7.0 
S S-19  +  + + + + 5 Susceptible 7.1 - 8.0 
S S-26 + +  + + + + 7 Susceptible 8.1 - 9.0 
S S-27 +   + + + + 5 Susceptible 9.1 - 10 
S S-28  +  +  + + 5 Susceptible 7.1 - 8.0 
S S-30  +  + + + + 5 Sulfisoxazole 7.1 - 8.0 
S S-32 + +  + + + + 5 Sulfisoxazole 8.1 - 9.0 
S S-33 + +  + + + + 5 Susceptible 7.1 - 8.0 
S S-34  +  + + + + 5 Susceptible 9.1 - 10 
S S-37 + +  + + + + 7 Susceptible 8.1 - 9.0 
S S-38  +   + + + 13 
Chloramphenico
l; Tetracycline; 
Streptomycin; 
Sulfisoxazole 
8.1 - 9.0 
S S-39  +  +  + + 5 Sulfisoxazole 8.1 - 9.0 
S S-40 + +  +  + + 5 Sulfisoxazole 7.1 - 8.0 
M M-2  +  + + + + 7 Susceptible 9.1 - 10 
M M-4 + +   + + + 14 Susceptible 9.1 - 10 
M M-5 +    + + + 14 Susceptible 8.1 - 9.0 
M M-6 + +  +  + + 5 Sulfisoxazole 9.1 - 10 
M M-8  +   + + + 5 
Chloramphenico
l; Tetracycline; 
Streptomycin; 
Sulfisoxazole 
9.1 - 10 
M M-9  +   + + + 5 Susceptible 9.1 - 10 
M M-13  +   + + + 7 Susceptible 9.1 - 10 
M M-14 +    + + + 5 Sulfisoxazole 7.1 - 8.0 
M M-15  +   + + + 10 Susceptible 9.1 - 10 
M M-16  +   + + + 7 Susceptible 6.1 - 7.0 
M M-17 +   + + + + 10 Sulfisoxazole 9.1 - 10 
M M-19  +  + + + + 11 Sulfisoxazole 9.1 - 10 
M M-21  +  + + + + 9 Sulfisoxazole 9.1 - 10 
M M-22 + +  + + + + 19 Susceptible 9.1 - 10 
M M-23 +   + + + + 39 Susceptible 8.1 - 9.0 
M M-26  +  + + + + 19 Sulfisoxazole 7.1 - 8.0 
M M-27 + +   + + + 14 Sulfisoxazole 8.1 - 9.0 
M M-29  +   + + + 19 Sulfisoxazole 8.1 - 9.0 
M M-31  +  + + + + 10 Sulfisoxazole 9.1 - 10 
M M-33  +   + + + 11 Susceptible 9.1 - 10 
M M-34 + +   + + + 15 Susceptible 9.1 - 10 
M M-40 +   + + + + 11 Sulfisoxazole 7.1 - 8.0 
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Table 3.2. Continued 
Isolation 
method 
 Virulence profile 
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Antibiotic 
resistance Cytotoxicity 
W W-12 + +  + + + + 19 Sulfisoxazole 7.1 - 8.0 
W W-37 + +  + + + + 19 Sulfisoxazole 9.1 - 10 
HM HM-3 + +  + + + + 12 Sulfisoxazole 7.1 - 8.0 
HM HM-6  +  + + + + 11 Susceptible 6.1 - 7.0 
HM HM-8  +  + + + + 11 Susceptible 8.1 - 9.0 
HM HM-11  +  + + + + 11 Sulfisoxazole 8.1 - 9.0 
HM HM-13 +   + + + + 11 Sulfisoxazole 9.1 - 10 
HM HM-14 + +  + + + + 11 Sulfisoxazole 8.1 - 9.0 
HM HM-19 + +  + + + + 11 Sulfisoxazole 9.1 - 10 
HM HM-20 + +  + + + + 11 Sulfisoxazole 7.1 - 8.0 
HM HM-22 + +  + + + + 11 Sulfisoxazole 8.1 - 9.0 
HM HM-23 +   + + + + 11 Sulfisoxazole 9.1 - 10 
HM HM-25 + +  + + + + 5 Sulfisoxazole 9.1 - 10 
HM HM-26 +   + + + + 12 Sulfisoxazole 9.1 - 10 
HM HM-27 + +  + + + + 8 Sulfisoxazole 8.1 - 9.0 
HM HM-28  +  + + + + 12 Sulfisoxazole 8.1 - 9.0 
HM HM-34 +   + + + + 12 Sulfisoxazole 7.1 - 8.0 
HM HM-35 + +  + + + + 12 Sulfisoxazole 9.1 - 10 
MT MT-2 + +  + + + + 23 Sulfisoxazole 9.1 - 10 
MT MT-3 + +  + + + + 25 Sulfisoxazole 9.1 – 10 
MT MT-4 +   + + + + 25 Sulfisoxazole 9.1 - 10 
MT MT-6 +   + + + + 25 Sulfisoxazole 9.1 - 10 
MT MT-7 +   + + + + 25 Susceptible 9.1 - 10 
MT MT-9 +   + + + + 26 Susceptible 9.1 - 10 
MT MT-17 + +  + + + + 26 Susceptible 9.1 - 10 
MT MT-18 + +  + + + + 25 Sulfisoxazole 9.1 - 10 
MT MT-21 + +  + + + + 17 Susceptible 9.1 - 10 
MT MT-25  +  + + + + 2 Susceptible 9.1 - 10 
MT MT-30 + +  + + + + 25 Susceptible 9.1 - 10 
MT MT-34  +  + + + + 25 Sulfisoxazole 9.1 - 10 
MT MT-38 + +  + + + + 25 Susceptible 9.1 - 10 
K K-4 +   + + + + 28 Tetracycline; Sulfisoxazole 9.1 - 10 
K K-5 +   + + + + 29 Tetracycline; Sulfisoxazole 9.1 - 10 
K K-7 +   + + + + 29 Tetracycline; Sulfisoxazole 9.1 - 10 
K K-11 + +  + + + + 29 Tetracycline; Sulfisoxazole 9.1 - 10 
K K-12 +   + + + + 29 Tetracycline; Sulfisoxazole 9.1 - 10 
K K-28 +   + + + + 29 Tetracycline; Sulfisoxazole 8.1 - 9.0 
WE WE-4 +   + + + + 26 Sulfisoxazole 8.1 - 9.0 
WE WE-14 + +  + + + + 26 Sulfisoxazole 9.1 - 10 
WE WE-18  +  + + + + 26 Sulfisoxazole 9.1 - 10 
WE WE-23 + +  + + + + 19 Sulfisoxazole 9.1 - 10 
WE WE-27  +  + + + + 26 Sulfisoxazole 9.1 - 10 
WE WE-28  +  + + + + 26 Sulfisoxazole 9.1 - 10 
WE WE-29 +   + + + + 24 Sulfisoxazole 9.1 - 10 
I I-31 + +  + + + + 17 Susceptible 9.1 - 10 
a E. coli O157 isolates that could not be subcultured after initial recovery. 
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3.4.  Discussion 
The combined prevalence rate of E. coli O157 (15.6%) for the longitudinal and 
point prevalence studies was slightly higher than that of a recent study conducted in 
Canada (22). However, it is generally difficult, and sometimes impossible, to extrapolate 
results obtained from different studies due to a large variety of screening procedures for 
E. coli O157 survey. As reported by Sanderson et al. (43), using large-volume (10-g) 
fecal samples increased the detection sensitivity by 5.4% over cotton-tipped swabbing of 
fecal samples. To increase the survey sensitivity, we tested two small fecal samples per 
sampling unit in parallel by using two different enrichment steps with and without IMS. 
Our combined approach (which involved using both cultural and cultural-IMS methods) 
increased the sensitivity of E. coli O157 detection in the longitudinal and point studies 
by 19.3% and 25.2%, respectively, over the use of culture-IMS alone. The results from 
this study confirmed recently findings of Pearce et al. (38) who noted a marked 
improvement in the sensitivity of detection via testing multiple small fecal samples per 
fecal sampling unit.  
The frequency of occurrence of the E. coli O157 among surveyed feedlots 
showed high variability, ranging from 0 to 57.5%, without any geographic distribution 
pattern (Figure 3.1.). Two determinants were found to have an important impact on the 
prevalence of E. coli O157 in Saskatchewan feedlots. Statistically, the most significant 
correlation (P = 0.003) was observed between density of cattle in pens (Figure 3.2.) and 
the prevalence rate of E. coli O157. The second statistically significant correlation (P = 
0.006) was found between the ratio between the housed cattle: feedlot capacity and the 
prevalence of the pathogen (Table 3.1.). The effects of these two densities on the 
prevalence of E. coli O157 among feedlot cattle may be illustrated by an example. The 
feedlots “S” and “M”, which operated at full capacity with 13.6 and 17.3 m2 / head, 
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resulted in the highest prevalence rates (57.5 and 55%), respectively. In contrast, 
feedlots “H” and “G”, which operated at 14 and 6% of capacity (33.2 and 27.8 m2 / 
head), respectively, resulted in no detectable E. coli O157 samples. Performing stepwise 
regression statistical analyses, we found that the percentage of variance (R2) in the 
prevalence explained by the effect of cattle density in pens alone was 62.6%, whereas 
the percentage of variance in the prevalence explained by both densities was 78.7%. 
These results suggest that both densities had an additive effect on spreading of pathogen 
among feedlot cattle. The high pen density increases contact between infected and non-
infected animals as well as poses a stressful condition for cattle, resulting in a higher 
shedding rate of the pathogen. Another density-related factor (the housed cattle : feedlot 
capacity) most likely accelerates dissemination of E. coli O157 between pens via some 
other mechanism (air dust, runoff, etc.). To avoid diet effect on the analyses of the 
prevalence distribution rates, all results obtained from pasture fed cattle were not 
statistically processed.  
  Results from multiplex PCR analyses indicate that the majority of E. coli O157 
isolates obtained from this study likely represent a significant public health risk. Several 
authors have previously pointed out that EHEC isolates able to produce functional stx2 
toxin and intimin are strongly associated with human morbidity (6, 14, 36). Out of 194 
E. coli O157 isolates recovered from Saskatchewan cattle, 94% (n = 183) harbored both 
eaeA and stx2 genes, two of the most potent EHEC virulence determinants. Two recent 
studies carried out in Australia (13) and at three large Midwestern beef processing plants 
in the USA (3) reported a prevalence of 56% and 64%, respectively, among the E. coli 
O157 isolates for both stx1 and stx2, whereas in the present study, 83% of the isolates 
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carried the same combination of toxins. These results suggest that the virulence potential 
of isolates from Saskatchewan cattle herds is relatively high.  
A Vero cell assay confirmed this assumption; all E. coli O157 isolates expressed 
a strong cytopathic effect against Vero cells. We further observed a high cytotoxicity, 
ranging from 7.1-8.0, for one stx1/stx2 negative isolate (data not shown). This 
paradoxical situation has been observed elsewhere (19, 27) and suggests that pathogenic 
mechanisms of E. coli O157 are not completely understood. 
 Based on genetic diversity that arose from the E. coli O157 isolates, we 
classified Saskatchewan’s feedlots into 3 categories. The first category represented 
feedlots having an indigenous population of E. coli O157 where no genetically divergent 
isolates were observed to be present. The RAPD-PCR patterns of E. coli O157 isolates 
recovered from the K feedlot displayed only two unique genetic subtypes (subtypes 28 
and 29; Table 3.2.) indicating their endemic character. The majority of feedlots (Z, HM, 
P, S, L and V) were classified into a second category, where genetically more or less 
unrelated isolates were introduced and combined with a group of endemic isolates. It is 
possible that genetically more related isolates evolved from an existing endemic 
population. The third observed category of feedlots were those with high numbers of 
genetically unrelated E. coli O157 subtypes, implying that genetically diverse isolates 
originated from different ancestors (21) and were introduced into the feedlot, most 
probably by incoming cattle. Feedlot M, which included 9 different genetic subtypes (7, 
14, 5, 10, 11, 9, 19, 39 and 15) that were found in all three clusters, provides an example 
of this.   
The use of antibiotics in food producing animals for growth promotion, 
chemotherapy and prophylaxis is linked to the emergence and dissemination of 
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antibiotic resistance genes (49). Although Shiga toxin producing E. coli infections do 
not involve the use of antimicrobial therapy (8, 50), E. coli O157 may easily acquire 
drug resistance genes in their natural habitat and transfer them to other organisms of 
clinical relevance. Herein we provide insight of antibiotic profiles of E. coli O157 
isolates collected over a considerable geographical area that comprised a cattle 
population originating from across Canada and the USA. The most prevalent antibiotic 
determinant was sulfisoxazole resistance. Our RAPD-PCR results suggest that resistance 
to this drug was widely distributed among 22 different subtypes of E. coli O157 found in 
all three genetic clusters. The ubiquitous dissemination of sulfisoxazole resistance 
among genetically-diverse E. coli O157 isolates clearly suggests the convergent 
acquisition of drug resistance genes by these different isolates, rather than the clonal 
spread of a sulfisoxazole-resistant isolate across this geographic region. The high rate of 
resistance to sulfisoxazole may be attributed to the long history of sulfa drug use (since 
the mid-1930s) in the treatment of infectious diseases. Furthermore, the sul gene that 
encodes dihydropteroate (sulfonamide inhibitor) has been found within the conserved 
segments of several types of integrons (9, 25), implying the effective flux of sul in the 
microbial population. The prevalence rate of tetracycline resistance (12%) in E. coli 
O157 isolates from this study was similar to findings of another study carried out in the 
USA (44). Based on examination of 361 E. coli O157 isolates recovered from humans, 
cattle, swine and food, Schroeder et al. (44), observed 9 % resistance to tetracycline in 
STEC O157 organisms. Three isolates obtained during this study (S-6, S-38 and M-8) 
were found in two separate feedlots with multi-antibiotic resistance to chloramphenicol, 
tetracycline, streptomycin and sulfisoxazole. The same virulence profiles and multidrug 
resistance traits of these organisms could indicate epidemic spread of a multidrug 
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resistant organism through herds in this region. Based on genetic typing, isolates S-6 and 
S-38 comprised a distinct genetic subtype (subtype 13), confirming the above-mentioned 
indication. In contrast, isolate M-8 was genetically different from isolates S-6 and S-38. 
Interestingly, isolate M-8 had the same RAPD-PCR pattern (subtype 5) as most isolates 
from the feedlot S, indicating a possible ancestral source of multidrug resistance 
determinants for all three isolates. Most of the surveyed feedlots used the ionophore 
antibiotic, Rumensin™ (monensin; personal communication). Monensin inhibits Gram-
positive microflora that tend to proliferate under concentrate (high starch) diets, and 
because of its general mode of action (at the level of the cell membrane), acquired 
mechanisms of resistance doubtful. The use of monensin was not likely to have 
contributed to any of the antibiotic resistance profiles observed in this study. 
 In conclusion, this study clearly demonstrates a high impact of cattle density, and 
ratio between housed cattle : feedlot capacity on the prevalence rate of E. coli O157, and 
thus may serve as a baseline for risk assessment modeling and reducing the prevalence 
rate of E. coli O157 among cattle in feedlots. Furthermore, in addition to providing 
current insight into the antibiotic susceptibility of E. coli O157 isolates originating from 
across Canada and the USA, this work also illustrates how combining antibiotic 
resistance and genetic profiles provides a more comprehensive basis for comparing the 
relatedness and dissemination of pathogenic (resistant) E. coli strains. 
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BRIEF INTRODUCTION TO CHAPTER 4 
Research in this chapter was performed to determine the sensitivity and 
reliability of two different techniques for detecting E. coli O157 from naturally infected 
samples. The two techniques, (i) buffered peptone water containing vancomycin, 
cefsulodin and cefixime followed by immunomagnetic separation (IMS-VCC), and (ii) 
modified Escherichia coli broth supplemented with novobiocin, both followed by 
culturing on cefixime tellurite sorbitol McConkey agar plates, were employed in parallel 
during a two-year study. Furthermore, when the results of this study were examined in 
combination with the genetic clustering of isolates data from Chapter 3, new information 
on the high fluctuation rate of the sensitivity of the IMS-VCC technique was revealed.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 4. SENSITIVITY OF TWO TECHNIQUES TO DETECT ESCHERICHIA 
COLI O157 IN NATURALLY-INFECTED BOVINE FAECAL SAMPLES 
 
Abstract 
The aim of this study was to investigate the sensitivity and reliability of two 
techniques commonly used for the isolation of Escherichia coli O157: i) buffered 
peptone water (BPW) containing vancomycin, cefsulodin and cefixime followed by 
immunomagnetic separation (IMS-VCC) and ii) modified Escherichia coli (EC) broth 
supplemented with novobiocin (m ECn), both followed by culturing on cefixime tellurite 
sorbitol McConkey (ctSMAC) agar plates. Over a two-year period, 24 feedlots/farms 
located over a large geographical area (~600 x 450 km) were screened for the presence 
of Escherichia coli O157. A total of 194 E. coli O157 isolates were identified; 151 
(77.4%) using IMS-VCC and 108 (55.4%) using m ECn. The recovery rates of IMS-
VCC varied from 100 to 47%, whereas for m ECn ranged from 100 to 16%. All isolates 
were grouped, using randomly amplified polymorphic DNA – polymerase chain reaction 
(RAPD-PCR), into 3 major clusters that comprised 39 different subtypes, providing 
evidence of considerable genetic heterogeneity. 
The results from this study revealed false negatives in IMS-VCC technique, most 
probably due to the high genetic diversity of environmental E. coli O157 isolates and 
antibiotic sensitivity. Using only IMS-VCC as a method for detection may result in 
significant underestimation of the pathogen. Performing two different enrichment steps 
in parallel can lead to markedly improved recovery rates of E. coli O157 isolates from 
naturally-infected samples.  
 
Reprinted with permission from Food Microbiology, 24: 633-639, 2007 
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4.1. Introduction 
Escherichia coli O157:H7 has emerged as a zoonotic pathogen of increasing 
public health concern. The low infectious dose (Willshaw et al., 1994) and a wide range 
of clinical manifestations, including life – threatening hemolytic uremic syndrome 
(HUS) (Griffin et al., 1991; Karmali et al., 1985) make human infections of particular 
concern. Ruminants, especially cattle, have been implicated as the primary reservoir of 
E. coli O157:H7 (Chapman et al., 1993; Wells et al., 1991) from where it can enter the 
environment and the food chain. Jones (1999) and Meng and Doyle (1998) underlined 
that E. coli O157:H7 outbreaks have been attributed to a diverse range of sources, 
including swimming pools, water supplies, raw vegetables and more commonly beef 
products. In view of the low infectious dose and the potential severity of infections 
caused by E. coli O157:H7, it is imperative that sensitive methods are employed in 
detection of the organism in its natural reservoir and the food chain in order to reduce 
human exposure to the pathogen as well as to establish food safety controls. 
The application of immunomagnetic separation (IMS) has increased the rate of 
E. coli O157 isolation from human specimens (Karch et al., 1996), food (Ogden et al., 
2001) and bovine feces (Heuvelink et al., 1998; Sanderson et al., 1995). Heuvelink et al. 
(1998) showed that use of modified E. coli broth containing novobiocin (20 mg/liter) (m 
ECn) followed by immunomagnetic separation (IMS) technique resulted in a sevenfold 
increase in the rate of isolation of E. coli O157 from adult cattle (naturally colonized by 
E. coli O157) compared with the recovery rate after plating onto cefixime tellurite 
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sorbitol McConkey (ctSMAC) following selective enrichment (m ECn). In contrast, 
Sanderson et al. (1995) found that use of tryptic soy broth supplemented with cefixime 
(50 ng/ml) and vancomycin (40 μg/ml) (TSBcv) in conjunction with IMS was only 
slightly more sensitive (79%) than broth enrichment (TSBcv) followed by plating (71%) 
for samples from calves orally inoculated with E. coli O157:H7. 
This study was designed, in part, to examine the sensitivity of IMS-VCC 
(vancomycin, cefsulodin, and cefixime) and modified Escherichia coli broth 
supplemented with novobiocin (m ECn) followed by plate culture. The different 
methods were compared during a longitudinal and large-scale point prevalence study 
that involved the analysis of >1400 samples of water, soil, manure slurry and cattle feces 
collected over a two year period. In addition, to investigate the relationship between 
genetic traits of E. coli O157 isolates and recovery method, we characterized all isolates 
by using randomly amplified polymorphic DNA PCR (RAPD-PCR). 
 
4.2. Material and methods 
4.2.1 Study design and collection of samples 
  The longitudinal study was performed at four cattle facilities over a ten-month 
period. A total of 610 bovine fecal and environmental samples were obtained from 
November 2002 to the end of August 2003. The point prevalence study was conducted 
during the summer of 2004 (from late June to the end of September). This study 
extended the sampling base by an additional 880 bovine fecal samples collected from 20 
different feedlots. Approximately 40 g of freshly defecated feces was aseptically 
collected using a sterile tongue depressor (Baxter Diagnostics Inc. USA) and transferred 
to a sterile 80 ml plastic container (Starplex, Canada). Samples from lagoons, dugouts 
and soil were sampled directly using a sterile 80 ml plastic container. All samples were 
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stored in a cooler with frozen cold-packs, transported to the laboratory, and tested within 
2-6 h of collection. 
 
4.2.2 Sensitivity of enrichment broth-cultural methods 
  To determine the most sensitive enrichment broth for the cultural method, we 
conducted a preliminary experiment where three common enrichment broths for E. coli 
O157 were tested. A set of vials which contained 31 g. of non-sterile sieved (3 mm) silty 
clay loam soil (60% water capacity) were spiked with serial 10-fold decreasing inocula 
of E. coli O157:H7 ATCC 43894 cells ranging in concentration from 1.7 x 107 to 1.7 x 
101 cfu/ml. The spiked soils were mixed thoroughly and then incubated overnight at 
room temperature.  Enumeration of E. coli O157:H7 cells in the soil microcosms was 
performed by adding 50 mL of sterile water to 31 g. of spiked soil followed by ~ 2 min. 
of vigorous shaking until a homogeneous soil/liquid suspension was obtained. After soil 
homogenization,1 ml of well-mixed suspension of water and spiked soil was added to: i) 
9 ml of plain Trypticase Soy Broth (Difco), ii) 9 ml of Trypticase Soy Broth 
supplemented with cefixime (50 ng ml-1) and vancomycin (40 µg ml-1; Sigma Chemical 
Co., St. Louis, Mo.) (Sanderson et al., 1995), and iii) 9 ml of mEC broth (Difco 
Laboratories) with novobiocin 20 µg ml-1 (Sigma Chemical Co.) (McDonough et al., 
2000). After overnight incubation at 37˚C, 0.1 ml of the 103, 104 and 105 dilutions of the 
above enrichment cultures were spread plated in triplicate onto 150 mm sorbitol 
MacConkey plates (Becton Dickinson and Company) containing cefixime (0.5 mg L-1) 
and potassium tellurite (2.5 mg L-1) (ctSMAC). After 24 h of incubation at 37˚C, 
discrete gray non-sorbitol fermenting colonies with a black point in the center were 
selected as suspect E. coli O157.  
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4.2.3 Immunomagnetic separation (IMS) – cultural technique 
  Samples (1 g or 1 ml) were aseptically added to 10 ml of Buffered Peptone 
Water (BPW) (Becton Dickinson and Company, USA) supplemented with cefixime (0.5 
mg L-1; Rhone – Poulenc Rorer, Canada), vancomycin (8 mg L-1; Sigma – Aldrich 
Chemie, Germany) and cefsulodin (10 mg L-1; Sigma – Aldrich Chemie) (VCC) 
(Chapman et al., 1994). After samples were homogenized, the suspensions were 
incubated at 37˚C for 6 – 8 h without agitation. IMS was then performed using a 
BeadRetriever (Dynal Biotech ASA, Oslo, Norway) by adding 1 ml of the BPW-VCC 
enrichment culture to 20 µl of anti-O157 immunomagnetic beads (Dynal Biotech ASA) 
followed by incubation, mixing and 2x washing of the immobilized immunomagnetic 
beads in 1 ml of PBS containing 0.05% Tween 20 (Sigma Chemical Co. St. Louis, 
USA). After the last wash step, the immunomagnetic beads were released into a final 
tube containing 100 µl of wash buffer (PBS/0.05% Tween 20). From the concentrated 
bead – bacteria complex, 100 μl was then gently resuspended and plated onto ctSMAC 
agar plates, as outlined in the previous section. After 24 h of incubation at 37˚C, discrete 
gray non-sorbitol fermenting colonies were selected as suspect E. coli O157.  
 
4.2.4 m ECn cultural technique 
  From each sample, 1 g or 1 ml, was aseptically suspended in 10 ml of m ECn 
broth, vortexed, and then incubated at 37˚C for 18 – 24 h without agitation. After 
incubation, a 1 ml aliquot of enrichment culture was serially diluted to 10-5 in sterile 
0.85% saline. From the 10-3, 10-4 and 10-5 dilutions, 100 μl was plated in duplicate onto 
ctSMAC agar and incubated at 37˚C overnight. Non-sorbitol fermenting colonies with 
characteristic morphology and appearance of E. coli O157 were serologically tested for 
somatic O157 antigen, as described in the following section.  
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4.2.5 E. coli O157 confirmation 
  Up to 10 suspect E. coli O157 colonies from each ctSMAC plate were tested by 
using O157 latex reagent (Oxoid LTD). All sero-positive isolates obtained from the 
longitudinal and point prevalence studies were then tested by multiplex PCR for the 
presence of four virulence determinants (stx1, stx2, eaeA, and hlyA) using assays 
described by Fagan et al. (1999) and Paton and Paton (1998). 
 
4.2.6 Genomic fingerprint analyses  
  The discriminatory ability and stability of randomly amplified polymorphic DNA 
(RAPD) patterns were tested in a preliminary study against a panel of 15 different E. 
coli O157 isolates with four decamer primers: GEN 15001 (5’-GTGCAATGAG-3’) 
(Radu et al., 2001 ), 1283 (5’-GCGATCCCCA-3’) (Galland et al., 2001), 1290 (5’-
GTGGATGCGA-3’) (Pacheco et al., 1997) and 1254 (5’-CCGCAGCCAA-3’) 
(Akopyanz et al., 1992; Aslam et al., 2003; Makino et al., 1994). Primer 1283 showed 
the greatest stability and discriminatory ability among the E. coli O157 test isolates, and 
was therefore used in this study. The RAPD analysis of E. coli O157 isolates was 
performed using the method previously described by Vidovic and Korber (2006).  
 
4.2.7 Statistical analysis 
The analysis of DNA patterns obtained using RAPD PCR was performed by 
using the Numerical Taxonomy and Multivariate Analysis System (NTSYSpc, Exeter 
Software, Setauket, N.Y.). Similarities between RAPD patterns were determined based 
on the Dice similarity coefficient. The resulting similarities in the matrix were further 
processed by employing the unweighted par – group method with arithmetic averages 
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(UPGMA) to create a dendrogram that graphed the genetic relatedness between E. coli 
O157 isolates.  
 
4.3. Results 
 The efficiency of the three enrichment broths to recover E. coli O157:H7 from 
spiked soil samples are shown in Table 4.1. The m ECn was determined to be the most 
sensitive of the broth-based enrichment methods, and thus was selected to compare with 
the IMS-VCC method.  
Table 4.1. Recovery of spiked E. coli O157 from soil by using three different 
enrichment procedures. 
 Detection of E. coli O157 with the following enrichment broths: 
 
 
Spiked soil cfu g-1 
 
TSBa 
TSB + cefixime and 
vancomycin 
 
m EC + novobiocin 
540000 + + + 
54000 + + + 
5400 + + + 
540 + + + 
54 + + + 
5  + + 
0.5   + 
0.05    
a TSB = trypticase soy broth 
 
 During the longitudinal study, 57 E. coli O157 isolates were obtained from the 445 
bovine fecal samples using both the m ECn and IMS-VCC enrichment and isolation 
methods, resulting in an overall prevalence rate of 12.8%. Of these 57 isolates, 47 
(82.4%) were detectable by IMS in conjunction with culturing, whereas 20 (35%) 
isolates were recoverable by the m ECn followed by culturing on ctSMAC agar. During 
the longitudinal study, 165 environmental samples were also screened for E. coli O157; 
none were found to be positive for E. coli O157 by either method. 
   During the point prevalence study, a total 138 E. coli O157 isolates were 
recovered from 880 bovine fecal samples using both methods, resulting in an overall 
prevalence rate of 15.7%. These 138 isolates were obtained from 15 different feedlots 
located over a large geographical area (~600 x 450 km). The IMS-VCC enrichment 
accounted for the recovery of 104 (75.3%) of these 138 E. coli O157 isolates, whereas 
the m ECn enrichment method followed by ctSMAC plating accounted for 88 (63.7%) 
of the total E. coli O157 isolates obtained. The recovery rates (the number of isolates 
obtained using a particular enrichment/isolation method/total number of isolates 
obtained using both enrichment/isolation methods) of E. coli O157 using IMS-VCC 
enrichment fluctuated from 100 to 45 % among these fifteen feedlots, whereas for 
enrichment using m EC broth with novobiocin the recovery rates ranged from 100 to 
16%. An overall recovery of E. coli O157 isolates for IMS-VCC enrichment followed by 
ctSMAC was 77.4% of the total number of E. coli O157-positive fecal samples 
identified during this study, compared to m ECn which accounted for the recovery of 
55.4% of samples (Figure 4.1.). 
 
Figure 4.1. Overall comparison of the sensitivity of IMS-VCC and m ECn enrichment 
procedures followed by culturing on SMACct agar plates to isolate E. coli O157 from 
naturally infected bovine feces. 
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  All 194 isolates of E. coli O157 obtained from the longitudinal and point studies 
were grouped into 3 major clusters (Figure 4.2.) consisting of 39 different subtypes or 
RAPD PCR patterns (Figure 4.3.). Amplification reactions using decamer primer 1283 
produced a set of 18 DNA fragments ranging from 450 to 4, 000 bp in length. Genetic 
similarity between the E. coli O157 isolates ranged from 0.81 to 1.00. Based on genetic 
relatedness and dissemination of pathogen, RAPD typing revealed the existence of two 
groups of E. coli O157 isolates. The first group of isolates was characterized by their 
unique genetic subtypes (for example, subtype 28 and 29), indicating their endemic 
nature.  In this case, these two highly related sub-types made up a single type (95% 
similarity) on the dendrogram shown in figure 2, which were only detected on one 
feedlot. The second group of isolates (representing the more common situation) was 
widespread among surveyed feedlots, implying transient introduction. For example, the 
two most predominant subtypes, 5 and 19, were detected at six feedlots each in central 
and north-central Saskatchewan.  
 
  
Figure 4.2 Relatedness of 194 isolates of E. coli O157 from the longitudinal and point 
studies. The dendogram was created by using the Dice coefficient and UPGMA analysis. 
The numbers on the scale at the bottom of the dendogram indicate the degree of 
similarity between E. coli O157 isolates. Colour coded dendogram showing: (●) isolates 
that were captured by both methods, (●) isolates captured only by IMS and (●) isolates 
captured only by cultural method. Blowout section shows details of genetic subtype 5. 
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 4.4. Discussion 
 In the current study, large numbers of samples (bovine feces, soil etc.) collected 
from 24 feedlots/farms and their surrounding areas were tested in parallel using IMS-
VCC and m ECn enrichment procedures followed by culturing on ctSMAC agar plates. 
BPW-VCC (conventional IMS broth) followed by IMS is a widely-used enrichment 
procedure and recommended by the U. S. Food and Drug Administration for detection of 
E. coli O157; it is generally considered to be the “gold standard” approach. 
Alternatively, m ECn enrichment is a less-expensive, alternative technique that has seen 
use in several studies (Okrend et al. 1990; Faith et al. 1996; Heuvelink et al. 1998). 
 
 
Figure 4.3 RAPD profiles of E. coli O157 isolates obtained from the central – southern 
region of Saskatchewan over two year period. Different RAPD patterns shown in the 
figure represent 39 genetic subtypes (the numbers above lanes indicating number of 
genetic subtype). Lane M contains the 1 kb Plus DNA ladder molecular weight marker. 
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 Using a large sampling base of naturally-infected cattle, the current study confirmed 
that IMS-VCC enrichment followed by ctSMAC plating was a more sensitive recovery 
technique. However, the ability of IMS-VCC to recover E. coli O157 isolates from 
bovine feces was highly variable among certain feedlots included in our survey. For 
example, the two feedlot operations designated “S” and “M” (Table 4.2.) housed a high 
proportion of infected cattle. IMS-VCC enrichment and isolation was able to detect 65 
and 45% of the total number of E. coli O157 isolates determined to be present at these 
feedlots, respectively; whereas, m ECn enrichment recovered 96 and 77% of the total 
isolates, respectively. This inconsistent performance of IMS-VCC was unlikely to be 
due to differences in pathogen distribution within the fecal samples, as the inocula for 
both techniques were taken from the same portion of fecal sample. Furthermore, this 
paradoxical result occurred despite the fact the m ECn method required a dilution step 
prior to plating where either 10 or 1 µl of enrichment culture was tested in order to 
facilitate the recovery of isolates, compared to the use of 1000 μl of IMS-VCC 
enrichment broth prior to recovery with beads. Genomic fingerprinting analysis of E. 
coli O157 isolates recovered from feedlots “S” and “M” revealed the heterogeneous 
nature of these isolates, consisting of 10 different subtypes (Table 4.2.), with the most 
predominant E. coli O157 isolate being subtype 5 (Figure 4.3.) which accounted for 50 
% (22/44) of the total population. Furthermore, it was observed that the subtype 5 
isolates were more efficiently recovered (90.9 %) using m ECn compared to IMS-VCC 
(59.0 %). Failure of IMS-VCC to actually recover the majority of E. coli O157 isolates 
at particular feedlots was most likely associated with the inhibitory effects of 
vancomycin, cefixime and cefsulodin (VCC) on the most prevalent E. coli O157 isolate 
subtype 5 found at these two feedlots. These findings suggest a “chink in the gold- 
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Table 4.2 Summary of characterization of E. coli O157 isolates obtained from the two 
feedlot operations “S “ and “M”. 
Isolation method  Virulence profile Feedlot Isolate 
IMS Cultural  stx1 stx2 hlyA eaeA 
RAPD pattern 
S S-1a + +       
S S-4 + +  +  + + 5 
S S-5 + +  + + + + 5 
S S-6 + +   + + + 13 
S S-7  +  +  + + 5 
S S-8 + +  + + + + 5 
S S-10 + +  + + + + 5 
S S-11  +  + + + + 5 
S S-14 + +  + + + + 5 
S S-16 + +  + + + + 5 
S S-17 + +  + + + + 5 
S S-19  +  + + + + 5 
S S-26 + +  + + + + 7 
S S-27 +   + + + + 5 
S S-28  +  +  + + 5 
S S-30  +  + + + + 5 
S S-32 + +  + + + + 5 
S S-33 + +  + + + + 5 
S S-34  +  + + + + 5 
S S-37 + +  + + + + 7 
S S-38  +   + + + 13 
S S-39  +  +  + + 5 
S S-40 + +  +  + + 5 
M M-2  +  + + + + 7 
M M-4 + +   + + + 14 
M M-5 +    + + + 14 
M M-6 + +  +  + + 5 
M M-8  +   + + + 5 
M M-9  +   + + + 5 
M M-13  +   + + + 7 
M M-14 +    + + + 5 
M M-15  +   + + + 10 
M M-16  +   + + + 7 
M M-17 +   + + + + 10 
M M-19  +  + + + + 11 
M M-21  +  + + + + 9 
M M-22 + +  + + + + 19 
M M-23 +   + + + + 39 
M M-26  +  + + + + 19 
M M-27 + +   + + + 14 
M M-29  +   + + + 19 
M M-31  +  + + + + 10 
M M-33  +   + + + 11 
M M-34 + +   + + + 15 
M M-40 +   + + + + 11 
a Isolate of E. coli O157 that could not be subcultured after first recovery. 
 
 
  105
standard armour” of IMS-VCC, and revealed a complicating factor for the identification 
of E. coli O157 from naturally-contaminated samples due to the high genetic diversity of 
this organism and possible different sensitivities to particular antibiotics used during 
enrichment. Our combined approach which involved using both mECn – ctSMAC and 
IMS-VCC methods increased the sensitivities of E. coli O157 detection in the 
longitudinal and point studies by 19.3 and 25.2 %, respectively, over the use of the IMS-
VCC alone. Ogden et al. (2001) found that the presence of cefixime and cefsulodin in 
the enrichment media may potentially be inhibitory to some strains of E. coli O157, 
supporting our assumption that the IMS-VCC “false negative” results seen during our 
study may have occurred because of strong antibiotic inhibition. In another study, Foster 
et al. (2003) using 721 cattle faecal samples from 43 farms, compared the sensitivity of 
BPW-VCC and BPW without antibiotics (BPW-WOA) prior to IMS. The authors 
clearly demonstrated that BPW-WOA was the superior pre-enrichment medium for the 
isolation of E. coli O157 from bovine faeces. In addition, they reported poor 
performance of the BPW-VCC in recovering the most common E. coli O157 isolate 
(phage type 21/28) in cattle faeces. This finding is of particular concern as phage type 
21/28 has been most frequently associated with human E. coli O157 cases in the UK. 
Hepburn et al. (2002) used soils spiked with a cocktail of four atoxigenic E. coli O157 
strains to compare the recovery efficacy of using BPW and BPW supplemented with 
vancomycin (with or without one quarter strength cefixime and cefsulodin). The authors 
determined that BPW supplemented with vancomycin (with or without one quarter 
strength cefixime and cefsulodin) was superior in terms of recovery compared to BPW 
with the full strength vancomycin, cefixime and cefsulodin. 
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In conclusion, this study provides evidence that the high genetic diversity of 
naturally-occurring E. coli O157 isolates have differing responses to the enrichment 
conditions in IMS-VCC and m ECn. The application of two different enrichment steps 
in parallel may lead to significant improvements in E. coli O157 detection sensitivity.  
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BRIEF INTRODUCTION TO CHAPTER 5 
In order to facilitate the interpretation of the prevalence data reported in chapter 
3, an examination of the factors that affect microbial survival was needed. Accordingly, 
experiments were designed to qualitatively and quantitatively determine the biotic and 
abiotic factors that influenced the survival of E. coli O157 in soil environments. To 
achive this goal, E. coli O157:H7 bacteria were incubated over time in two types of soil 
microcosms: (i) sterile soil under controlled conditions of moisture, sterility, and 
temperature, and (ii) cattle manure amended soil under controlled conditions of moisture 
and temperature. In addition, the survival of this organism was examined in situ during 
the growing season. The in situ experiments included the survival of E. coli O157:H7 in 
manure amended soil and plain soil, both with and without drainage of naturally 
precipitated water. 
Since there has been virtually no data on the prevalence and survival of E. coli 
O157 in Saskatchewan, the analysis obtained from these studies have fundamental 
research and applied value.  
 
 
 
 
 
 
 
 
 
 5.  EFFECT OF SOIL COMPOSITION, TEMPERATURE, INDIGENOUS 
MICROFLORA AND ENVIRONMENTAL CONDITIONS ON THE 
SURVIVAL OF ESCHERICHIA COLI O157:H7 
 
Abstract 
The survival of Escherichia coli O157:H7 in replicate soil microcosms was 
quantified in two types of silty clay loam soil (high-carbon and low-carbon) under either 
sterile or non-sterile conditions.  Microcosms were held at -21°C, 4°C, and 22°C under 
constant soil moisture content. Differences existed (P<0.05) in survival of E. coli 
O157:H7 in low- and high-carbon soil at all temperatures indicating an important role of 
soil composition on the survival of this pathogen. The highest death rate of E. coli 
O157:H7 in sterile soil occurred in the low-carbon soil at 4˚C, whereas in non-sterile 
soil the highest death rate was observed in the low-carbon soil at 22˚C. These results 
suggest that the most lethal effects on E. coli O157:H7 in the sterile system occurred via 
the synergy of nutrient limitation and cold stress; whereas, in the non-sterile system 
lethality was due to inhibition by indigenous soil microorganisms and starvation. Results 
obtained from an in situ field survival experiment demonstrated the apparent sensitivity 
of E. coli O157:H7 cells to dehydration, information that may be used to reduce 
environmental spread of this pathogen as well as formulate appropriate waste 
management strategies.  
 
 
 
Reprinted with permission from Canadian Journal of Microbiology, 53:822-829, 
2007 
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5.1 Introduction 
Human infection with E. coli O157:H7 has been associated with various 
transmission routes including direct exposure to infected animals (Renwick et al. 1993), 
person-to-person passage (Belongia et al. 1993) and most typically by the consumption 
of contaminated undercooked ground beef (Armstrong et al. 1996; Doyle et al. 1997). 
Serious outbreaks or sporadic E. coli O157 infections could potentially originate with 
ready-to-eat products contaminated by raw vegetables or fruits previously exposed 
(directly or indirectly) to animal manure (Fukushima et al. 1997; Islam et al. 2004; 
Mohle-Boetani et al. 2001). For example, in 1996 a large outbreak of E. coli O157 took 
place in Japan among elementary school children where over 6,000 and 100 cases of 
hemorrhagic colitis and hemolytic-uremic syndrome were reported, respectively 
(Fukushima et al. 1997). The source of infection was traced to radish sprouts that most 
likely had contact with contaminated manure. The major transmission routes of E. coli 
O157 from agriculture lands into surface or ground waters occurs via the application of 
manure as a soil amendment, defecation of grazing cattle and sheep, and the improper 
storage of manure on soil (Fenlon et al. 2000; Guselle and Olson 2004).   
Although E. coli O157:H7 associated outbreaks of gastrointestinal illness 
continue to attract worldwide attention (most recently linked with fresh spinach 
produced in California), the survival of the pathogen in soil and the influence of 
environmental conditions on E. coli O157:H7 remains poorly understood. The study 
conducted by Kudva et al. (1998) revealed that E. coli O157:H7 is able to survive for 
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more than 1 year in a non-aerated ovine manure pile exposed to environmental 
conditions. Jiang and colleagues (2002) investigated the survival of E. coli O157:H7 in 
manure-amended autoclaved and unautoclaved soil held at 5°, 15° and 21˚C. The 
authors found that the pathogen population declined more rapidly in manure-amended 
unautoclaved soil under the same conditions due to antagonistic interactions with 
indigenous soil microorganism and were therefore unable to observe an influence of 
abiotic factors on the survival of E. coli O157:H7.  
The objective of this study was to isolate the effect of abiotic factors (soil 
composition and temperature), as well as a combination of abiotic and biotic (indigenous 
soil and manure microorganisms) factors and adverse environmental conditions, on the 
survival of E. coli O157:H7 in soil. Accordingly, we used sieved-packed soil 
microcosms with high- and low-carbon sterile silty clay loam soils as well as the same 
unautoclaved soils amended with fresh bovine manure to assess how soil composition, 
temperature and indigenous soil microorganisms affected survival of E. coli O157:H7. 
Lastly, the influence of environmental conditions on the survival of the pathogen was 
investigated in situ, using clay loam soil with and without manure and drainage. 
 
5.2 Materials and methods 
5.2.1. Inoculum preparation 
Escherichia coli O157:H7 ATCC 43894 was used as the test organism in these 
studies. Inocula were prepared from stock cultures kept in 10 % (vol/vol) glycerol at  –
70˚C by streaking onto Tryptic Soy agar (EMD Chemicals Inc., Germany), followed by 
incubation at 37˚C for 24 hours. Three well-isolated colonies were inoculated into 50 
mL of tryptic soy broth and incubated overnight at 37˚C with constant agitation (150 
rpm). After incubation, 50 mL of the culture was centrifuged (4000 x g for 10 min.) and 
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washed three times with sterile reverse osmosis grade (RO) water. Cells were 
resuspended in RO and adjusted to a 0.5 McFarland standard (~1.5 x 108 cells mL-1). 
Cell density of the inoculum was determined in triplicate by serial dilutions and spread 
plating on Tryptic Soy agar, followed by incubation at 37˚C for 24 hours.  
 
5.2.2 Manure 
All bovine fecal materials used in these studies were obtained from a dairy farm 
located at the University of Saskatchewan. Fresh feces from healthy cattle with no E. 
coli O157 history were collected aseptically in sterile plastic bags. Feces were tested 
once again for the presence of E. coli O157 by the methods described elsewhere 
(Vidovic and Korber 2006). Fecal material was transported to the laboratory 
immediately and used within 2 hours of collection.  
 
5.2.3 Autoclaved soil microcosms 
The soil used in these studies was a silty clay loam (Laura, Saskatchewan) 
collected from the surface (5 cm depth) and subsurface (approximately 30 cm depth). 
Soils obtained from different depths were distinct in their chemical compositions; the 
surface soil had 21.87 organic carbon g. / 1000 g. (hereafter referred to as high-carbon 
soil); 1.98 total nitrogen g. / 1000 g., and 0.345 total sulfur g. / 1000 g., whereas the 
subsurface soil had 10.03 organic carbon g. / 1000 g. (hereafter referred to as low-carbon 
soil) 1.01 total nitrogen g. / 1000 g., and 0.00 total sulfur g. / 1000 g. Both soils were 
separately passed through a 3 mm pore diameter sieve and autoclaved at 121˚C for 30 
minutes on three successive days. Aliquots of 25 g. of each sterile soil type were 
aseptically transferred into sterile 5 x 7.5 cm (80 mL) polypropylene vials (Starplex, 
Canada). A 1 mL aliquot of E. coli O157:H7, diluted to result in ~1.5 x 106 cfu per g.  of 
  117
soil, was then added to each vial. Inoculated soils were mixed thoroughly using a sterile 
wooden stick and then the appropriate amount of sterile (RO) water was added to each 
vial to adjust the soil water moisture to 60 % holding capacity (Cassel and Nielsen 
1990). Soil microcosms were then capped, placed in the biohazard bags and stored in the 
dark at -21°C, 4°C and 22˚C. 
 
5.2.4 Unautoclaved manure-amended soil microcosms 
High- and low-carbon silty clay loam soils (as described above) were used in the 
manure-amended unautoclaved soil microcosm study. Soils were sieved through a 3 mm 
pore diameter screen and 25 g. aliquots placed into sterile 80 mL plastic containers. 
Fresh unautoclaved bovine manure (0.57 g. or 2.3 % w/w) was incorporated into each 25 
g. of soil, which was equivalent to a typical bovine manure application rate (30 tonnes / 
ha.) used in Canada (Schoenau and Assefa 2004). The E. coli O157:H7 inoculum was 
diluted to 8.8 x 105 cfu mL-1 and then 1 mL of this suspension was added to 25 g. soil. 
The final concentration of E. coli O157:H7 in each inoculated soil microcosm was 2.7 x 
104 cfu g-1, a concentration chosen to simulate the maximum possible number of E. coli 
O157:H7 in the soil through contact with naturally-contaminated bovine manure 
(Robinson et al. 2004). The inoculated soils were mixed thoroughly using sterile wooden 
sticks, and then sterile (RO) water was added to obtain 60% of the soil water holding 
capacity. Soil microcosms were capped and stored under the same conditions as 
described above (-21°C, 4°C and 22˚C). 
 
5.2.5 In situ E. coli O157:H7 survival assay 
The soil used for the in situ E. coli O157:H7 survival assay was a clay loam 
excavated from a field located in Alvena, Saskatchewan, with a known history of 
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agriculture use. The texture of this soil was determined to contain 43.6% silt, 39.9% clay 
and 16.5% sand with an average value of 16.6 g. / 1000 g. soil of organic carbon. The 
soil was sieved as described above and then 11 kg aliquots were transferred to eight 
sterile polypropylene trays (54x43x13 cm). Four approaches were employed for 
studying the survival of E. coli O157:H7 under field conditions. In the first approach, 
200 mL of the E. coli O157:H7 suspension (7x107 cfu mL-1) was inoculated into 
duplicate trays containing 11 kg of soil, with one of the trays being perforated to allow 
water drainage. The inoculum was incrementally incorporated into the soils by repeated 
cycles of wetting followed by mixing.  In the second approach, manure was added to soil 
incubated in two trays (with and without drainage), followed by mixing and 
incorporation of 200 mL of the E. coli O157:H7 suspension (7x107 cfu mL-1). Manure 
application rates were the same as described above. As a control, the distribution of E. 
coli O157:H7 in soil containers following inoculation were determined by taking twelve 
random 10 g. samples from each tray (6 each from the soil surface and 6 from the 
bottom), and then serially diluting and plating onto 150 mm Sorbitol MacConkey plates 
(Becton Dickinson and Company) containing cefixime (0.5 mg L-1) and potassium 
tellurite (2.5 mg L-1) (ctSMAC). Plates were incubated at 37˚C for 24 hours. Additional 
controls included manure-amended soil as well as E. coli O157:H7- free soil (the last 
two approaches), both incubated with and without drainage. All eight test systems were 
immediately transported to the field site where they were incubated under field 
conditions. These experiments were initiated in May 2004 and sampled over a four 
month period to assess survival of E. coli O157:H7 in soil during the growing season.  
During sampling, soil moisture was qualitatively assessed with respect to the presence of 
visible zones of moisture or drying, or whether standing water (or a visible water table) 
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was evident. Experiments were conducted in an enclosed area inside of a no-trespassing 
area of the farm; the University’s biosafety office provided warning signs and labels that 
were displayed at the study site during the study. 
 
5.2.6 Sampling and enumeration of E. coli O157:H7, coliforms and heterotrophs 
  Viable E. coli O157:H7 cell counts in the autoclaved and unautoclaved manure-
amended soil microcosms were determined at day 0 (post-inoculation), days 4 and 8 and 
then on a biweekly basis. Enumeration of viable E. coli O157:H7 cells for the in situ 
assay was carried out at 0, 4, 7, and 13 days post-inoculation, and thereafter every ten 
days over a four month period. Enumeration of E. coli O157:H7 cells in the microcosms 
was performed by adding 50 mL of sterile water to 25 g. of soil followed by ~ 2 min. of  
shaking until soil was completely resuspended. A 1 mL aliquot of the soil suspension 
was then serially diluted (1:10) in saline and 0.1 mL of the appropriate dilutions were 
spread plated in triplicate onto ctSMAC agar plates, and incubated for 24 hours at 37˚C. 
After incubation, discrete gray non-sorbitol fermenting colonies with a black point in the 
center were randomly selected and tested for the presence of the somatic O157 antigen 
by the O157 latex reagent (Oxoid LTD). In addition, E. coli O157:H7 cell counts in 
sterile (autoclaved) soil were performed by the pour plating method using MacConkey 
agar (Becton Dickinson and Company) when cell numbers declined to ~ 1 x 101 cfu g-1. 
All lactose-positive colonies were counted. Enumeration of total heterotrophic and total 
coliform bacteria were performed in triplicate by spread plating a 0.1 mL aliquot of an 
appropriate dilution onto R2A (Difco) and MacConkey agar plates followed by 
incubation at 20˚C for 5 days and at 37˚C for 24 hours, respectively. Cell counts for the 
in situ survival assay were performed by aseptically collecting six 10 g. soil samples 
from each of the eight treatments (three each from the surface and the bottom at the 
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same x-y coordinates). For each sampling period, a total of 48 samples were collected, 
placed in a cooler with frozen cold-packs, transported to the laboratory and processed 
within 2-3 hours of collection, as described above. 
 
5.2.7 Statistical analyses 
All data used in statistical analyses with sterile and unautoclaved amended soils 
were averages of triplicate measurements, expressed as log10 cfu per g. of soil for each 
treatment x time combination. This approach resulted in only a single value for each 
combination of factors but avoided pseudo-replication. Results were analyzed as a 2 
(soil sterility) × 2 (soil carbon level) × 2 (linear or quadratic effect of incubation 
temperature) × 2 (linear or quadratic effect of incubation time) factorial treatment 
structure in a completely randomized experimental design using the mixed models 
procedure of SAS (SAS Institute, Inc., Cary, NC). Having only a single value for each 
combination of treatments would normally result in inadequate replication for evaluation 
of treatment effects and interactions. However, limiting the evaluation for effect of 
incubation time to linear or quadratic effects avoids this limitation with the added 
advantages of simplifying results interpretation and allowing comparisons to be made 
across soil sterility treatments (autoclaved versus unautoclaved soils) where sampling 
times were staggered. Additionally, for illustrative purposes, within a given sterility × 
carbon level × temperature combination, the linear or quadratic effect of incubation time 
on viable bacterial counts were determined using the regression procedure of SAS. To 
explain treatment interactions, simple effect comparisons were made amongst 
parameters from regression equations evaluating the linear effect of incubation time 
using unpaired T-tests. Measurements of E. coli O157:H7 in situ survival were 
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replicated six times (each in triplicate) for each soil treatment. An average of six 
readings with standard error bars was reported. 
 
5.3 Results 
5.3.1 Survival E. coli O157:H7 in sterile soils  
In order to isolate abiotic effects on the survival of E. coli O157:H7 in soil 
systems, we controlled environment parameters (temperature, sterility, soil moisture and 
known soil composition) so that viability/survival of cells would only reflect soil 
composition and temperature. Initial plate counts of E. coli O157:H7 for high-and low-
carbon soils were 1.5 x 106 cfu g-1 and 1.6 x 106 cfu g-1, respectively. After 390 days of 
incubation at -21˚C, only a slight decline in the number of viable E. coli O157:H7 cells 
was observed, resulting in a death rate of 0.0013 log10 cfu g-1 per day and 0.0009 log10 
cfu g-1 per day, respectively (Fig. 5.1.A). The number of E. coli O157:H7 cells present in 
high- and low-carbon sterile soils held at 4°C decreased slightly for both soils over the 
first 138 days of incubation (Fig. 5.1.B). After this slow die off period, E. coli O157:H7 
cells incubated in the sterile low-carbon soil entered a rapid death phase (biweekly 
mortality rate = 0.43 log10 g-1) such that no viable cells remained following day 306. In 
contrast, the number of viable E. coli O157:H7 cells in the high-carbon soils decreased 
slowly (biweekly mortality rate = 0.08 log10 g-1) until the end of the experiment (390  
  
A 
B 
 
C 
Figure 5.1 Survival of E. coli O157:H7 in autoclaved high-carbon soil (●) and low-
carbon soil (○) microcosms. Viable counts of E. coli O157:H7 were determined in 
triplicate by using the non-enrichment culture spread and pour plating methods. Values 
are averaged and expressed as log10 cfu per gram.  
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days), at which time 1.8 x 103 cfu g-1 still remained. The mortality rate was higher 
(P<0.01) in the low-carbon soil with a decline rate of 0.0203 log10 cfu g-1 per day 
compared to a decline rate of 0.0076 log10 cfu g-1 per day in the high-carbon soil (Fig. 
5.1.B). The survival pattern of E. coli O157:H7 incubated at 22˚C was significantly 
different from that at 4˚C (Fig. 5.1.C). The number of E. coli O157:H7 cells in both soil 
types incubated at 22˚C increased over the first 26 days by 2 logs, and then declined 
over the next 152 days to approximately initial cell (T = 0 days) concentration levels 
(~1.6 x 106 cfu g-1) (Fig. 5.1.C). Following day 180, bacteria held in both soils at 22˚C 
entered a sharp decline phase resulting in a decrease in viable cell number of 3 logs10 g-1 
over 70 days. After this period, the number of viable cells remained relatively constant 
in the high-carbon soil but continued to decline in the low-carbon soil.  
 
5.3.2 Survival E. coli O157:H7 in unautoclaved manure-amended soils – influence 
of biotic effects  
To determine additional effect of indigenous soil and manure microorganisms, 
we used unautoclaved high-and low-carbon soil amended with bovine manure incubated 
under the same conditions as described above. The number of viable E. coli O157:H7 
cells incubated at -21˚C in both the manure-amended high- and low-carbon soils 
declined over time (Fig. 5.2.A, B); whereas, in the autoclaved soils held at -21˚C, E. 
coli O157:H7 numbers showed almost no decline. The lethal effect at -21˚C was greater 
in the low-carbon soil (0.0158 log10 cfu g-1 per day), where E. coli O157:H7 became 
undetectable after 220 days; whereas, in the high-carbon soil E. coli O157:H7 numbers 
declined to 2 x 102 cfu g-1 (0.0084 log10 cfu g-1 per day). The survival curves of total 
   
Figure 5.2 Persistence of E. coli O157:H7 (●), total coliforms (∆), and total heterotrophs 
(◊) in unautoclaved high-carbon and low-carbon soils supplemented with 2.3 % (w/w) 
fresh bovine manure. Viable cell counts of E. coli O157:H7, total coliforms, and total 
heterotrophs were determined in triplicate by using the non-enrichment culture spread 
plating method. Plate count values are expressed as log10 cfu per gram. 
 
coliforms introduced into the soils by bovine feces were almost identical to that of E. 
coli O157:H7 (Fig. 5.2.A, B). However, indigenous soil microorganisms remained 
constant at ~1 x 106 cfu g-1 over the duration of the experiment. In both unautoclaved, 
high- and low-carbon manure-amended soils held at 4˚C, the number of coliform and E. 
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coli O157:H7 bacteria decreased by ~1 log g-1 after 70 days, while heterotrophic counts 
increased by 1.5 logs g-1 over the same period (Fig. 5.2.C, D).  Escherichia coli 
O157:H7 cells incubated at 4° C in the low-carbon soil died off more rapidly compared 
with those incubated in the high-carbon soil. The sharp decrease in the number E. coli 
O157:H7 cells in the low-carbon soil resulted in no organisms being detected by day 154 
(Fig. 5.2.D). In contrast, 2 x 102 cfu g-1 E. coli O157:H7 cells were found in the high-
carbon soil by the completion of the experiment. Once again, the concentration of 
indigenous soil microorganisms in both types of soils held at 4˚C was determined to 
remain constant at ~ 5 x 106 cfu g-1 while E. coli O157:H7 and coliforms both declined 
at the same rate. The survival pattern of E. coli O157:H7 incubated at 22˚C in both 
types of manure-amended soils was similar to the pattern observed in the autoclaved soil 
held at the same temperature. A distinct characteristic of the survival curve for E. coli 
O157:H7 cells at 22˚C in both the autoclaved and unautoclaved manure-amended soils 
was an initial 2 log g-1 increase in cell number (Fig. 5.1.C and 5.2.E, F). However, the 
time during which E. coli O157:H7 cells proliferated in the unautoclaved manure-
amended soil was much shorter (4 days) compared to the sterile soil (26 days). After this 
initial cell growth period, E. coli O157:H7 cells entered a die-off phase in both manure-
amended soil types, with a higher mortality rate seen in the low-carbon soil (Fig. 5.2.E, 
F). Lethality of E. coli O157:H7 in non-sterile soils at all incubation temperatures was 
higher (P<0.01) in the low-carbon soil than in the high-carbon soil. The ability of E. coli 
O157:H7 to survive in unautoclaved soil treated with cattle manure was reduced 
(P<0.01) at all temperatures compared to survival in autoclaved soil. For non-sterile 
soils, the effect of temperature on the rate of population decline was linear and showed 
  126
the greatest rate of decline (P<0.01) for viable E. coli O157:H7 cells in the low-carbon 
soil incubated at 22˚C (0.037 log10 cfu g-1 per day) (Fig. 5.2.F).  
 
5.3.3 In situ survival of E. coli O157:H7  
 Escherichia coli O157:H7 was applied to test soil systems in relatively high 
numbers, ranging from 1.9 x 105 to 7.1 x 105 cfu g-1, as determined by immediately 
enumerating cell numbers following inoculation (day 0). Climatic conditions during the 
experiment (the 2004 growing season) were compiled from the Environment Canada 
website (http://www.climate.weatheroffice.ec.gc.ca) for total precipitation (mm) and 
mean temperature (C˚), respectively, as follows: May 17.2 / 12.6°C, June 58 / 13°C, 
July 20.6 / 16.6°C, August 68.4 / 13.9°C and September 33.6 / 10.9°C. Considerable 
rainfall over the first part of the study period resulted in visible standing water or a water 
table in all of the undrained microcosms (which remained for 34-43 days), versus the 
drained microcosms, where surface soil drying was evident after 24 days and subsurface 
drying by 34 days. Three distinct phases of E. coli O157:H7 survival were observed in 
all soil treatments (manure-amended and plain soil under drained and undrained 
conditions). The first phase was characterized by high persistence, but for differing 
lengths of time, in drained compared to undrained soils. Escherichia coli O157:H7 cell 
numbers remained constant (~ 104 – 105 cfu g-1) in drained manure-amended and plain 
soil over the first 23 days; whereas, in the same type of undrained soil, E. coli O157:H7 
cell numbers remained constant for 43 days (Fig. 5.3.). After the high persistence phase, 
E. coli O157:H7 entered a sharp decline phase where the number of viable cells 
decreased by 2.1 and 1.6 log10 cfu g-1 in drained manure-amended and plain soil, 
respectively, over a 10 day period (Fig. 5.3.). 
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Figure 5.3 Survival of E. coli O157:H7 in manure-amended drained soil (S), manure-
amended undrained soil (♦), drained soil (z), and undrained soil () incubated under 
ambient field conditions during the growing season. Each point is the mean of six 
sample values (three from the surface and three from the bottom). The error bar 
represents the standard deviation between the six sample readings. 
 
 The high rate of E. coli O157:H7 cell death initially occurred in the upper surface layers 
(from 0 - 5 cm) of the soil (Table 5.1.). Despite the strong surface lethality, high 
numbers of viable cells persisted in subsurface soil layers, resulting in high overall 
standard deviation values for viable E. coli O157:H7 cell numbers (Fig. 5.3. and Table 
5.1.). Death of the pathogen was observed in drained soils over the next twenty days, 
resulting in a further 2 log10 g-1 decline. A similar high death rate phase was observed in 
undrained manure-amended and plain soils, reducing cell numbers by 2.8 logs10 g-1 in 
both types of soil over the same period of time (Fig 5.3.). The third phase of pathogen 
survival was characterized by a slow die-off of cells. For example, viable cell counts in 
drained manure-treated and plain soil declined over 70 days by 1.1 and 0.4 log10 g-1, 
respectively (Fig. 5.3.). Similar slow, lethal effects were observed in undrained soils, but 
were seen to be of a shorter duration (Fig. 5.3.). 
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5.4 Discussion 
Findings from these experiments clearly demonstrated a great effect of soil 
nutrient composition and temperature on pathogen survival. While incubation at -21˚C 
had a protective effect on E. coli O157:H7 cells in both types of autoclaved soils, 
incubation at 4˚C, in combination with the low-carbon soil, resulted in the greatest 
lethal effect on the pathogen. An explanation for this significantly-higher mortality rate 
may include multiple stress factors existing in the low-carbon soil at low temperature.  
For instance, the low-carbon soil, which contained 1% organic carbon, 0.1 % total 
nitrogen and 0.000 % total sulfur was nutrient-limiting when compared with the high-
carbon soil (2.1 % organic carbon, 0.198 % total nitrogen and 0.034 % total sulfur).  In 
addition, 4˚C is markedly different from the temperature of the natural gastrointestinal 
that E. coli O157:H7 inhabits (37˚C), and thus poses a significant temperature stress for 
this organism (Jones et al., 1987). The combination of nutrient-limitation and cold stress 
most likely act synergistically, resulting in the highest mortality rate against E. coli 
O157:H7 cells. Nonetheless, results from this study revealed that E. coli O157:H7 may 
remain viable over 390 days in the autoclaved high-carbon soil incubated at either 4˚C 
or  22˚C.  
Despite increasing the nutritional value of unautoclaved soil by addition of cattle 
manure (2.3 % by weight), the death rate of E. coli O157:H7 remained higher (P<0.01) 
than in autoclaved soil. Heterotrophic cell numbers remained high over time (~1 x 106 
cfu g-1) whereas coliforms and E. coli O157:H7 sharply declined over the same period. 
Roszak and Colwell (1987) found that more than 90% of viable naturally-occurring soil 
bacteria are not culturable and therefore have remained undetected, implying that E. coli 
O157:H7 likely faced much stronger competition in soil than indicated by the total 
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heterotrophic cell count. In contrast to the situation in autoclaved soil, a greater lethal 
effect on this pathogen was observed at 22˚C than at 4˚C in both unautoclaved high- 
and low-carbon soils (Fig. 5.2.C, D, E and F). Results from this study confirm the 
earlier findings of Jiang et al. (2002) who observed that the antagonistic effect of 
indigenous soil and manure microorganisms to E. coli O157:H7 was expressed more 
greatly at 21˚C than at 5˚C. In addition, we observed that soil composition in the 
unautoclaved manure-amended soil still played a role (P<0.01) in the survival of the 
pathogen, with greater cell death occurring in the nutrient-limited soils.  It is noteworthy 
that lethal effects of indigenous soil microbes against E. coli O157:H7 were also 
observed at -21° C for both unautoclaved high- and low-carbon soils, an effect that was 
absent in the pure culture (sterile soil) condition. 
One of the most informative approaches for studying the survival of E. coli 
O157:H7 in soils is to release known numbers of the organism onto a test plot exposed 
to environmental oscillations, and then directly sample over time. A trend common to 
the survival of E. coli O157:H7 in all treatments exposed to the environmental 
conditions was a 30 day period of high mortality (Fig. 5.3.). The most important 
observation was that these high mortality rate periods could be correlated with soil 
drying (Table 5.1.), suggesting that desiccation had a significant impact on E. coli 
O157:H7 survival. 
 
 Table 5.1. In situ survival of E. coli O157:H7 cells sampled from the surface and bottom soil layers over the most lethal period (June 
10 to August 20). 
Mortality rates (log cfu/10day) 
Drained  Undrained 
Soil  Manure-amended soil  Soil  
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June 10-20 13-23 0.01 + 0.08c  + 0.97c  0.02  0.5e 0.07e  1.64e 0.26e 11.9 44.6 
June 21-30 24-33 2.0d 1.24  4.12d 0.07  0.71 0.35e  + 1.47c + 0.17ce 13.9 1.6 
July 01-10 34-43 2.4d 0.14d  0.74d 2.69d  + 0.51c 0  0.5 + 0.25ce 14.3 3.6 
July 11-20 44-53 + 0.3cd 1.94d  + 0.33cd 0.47d  1.65d 0.28  1.6d 1.35 18 2.6 
July 21-30 54-63 0.3d + 0.54cd  0.79d 0.42d  1.44d 0.47  1.7d 0.47 15.7 14.4 
July 31-
August 10 64-73 0
bd 1.19d  0bd 0.52d  0.65d 1.05d  0.46d + 0.29cd 16 16.8 
Aug. 11-20 74-83 0bd 0.31d  0bd 0.17d  0bd 0.37d  + 0.01cd 2.17d 13.8 9 
 
a Each value is an average of three independent samples performed in triplicate.  
b No detection of E. coli O157:H7.  
+ c Numbers of E. coli O157:H7 cfu g-1 increase. 
d Soil samples that visibly appeared dry.  
e Standing water, or a sub-surface water table, present. 
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Dehydration was qualitatively observed to initially occur more rapidly (by days 24-33) 
on the surface of drained soils, and along with factors like solar irradiation and 
increasing salt concentration, caused increased E. coli O157:H7 cell lethality (Table 
5.1.).  
The process of soil dehydration continued over the next twenty days, further 
causing a high decline in cell viability. It has been documented that E. coli O157:H7 
may leach through soil (Gagliardi and Karns 2000) and therefore the sharp decline of 
viable cells in drained soils may also have been due to cell leaching. Artz et al. (2005) 
have shown that leaching of E. coli O157:H7 through a soil matrix with a bulk density of 
1.15 g cm-3 was very low, demonstrating a clear effect of bulk density on leachability of 
E. coli O157:H7 in repacked core experiments. Soil used in this in situ assay was a clay 
loam, and clay particles generally impart a fine texture and a heavy nature to soil 
(England et al. 1993) suggesting a low leaching potential. Parallel experiments 
performed with undrained soils, however, revealed the same pattern of lethality on E. 
coli O157 survival triggered by soil dehydration (after 44-53 days of incubation; Table 
5.1.). Accordingly, in undrained manure-amended and plain soil where E. coli O157:H7 
cells were not subject to leaching by rainfall, a sharp decline in viable cell number (2.8 
log10 g-1 over 30 days) was observed, suggesting a strong lethal effect of dryness on the 
pathogen. Losses of E. coli O157:H7 cell viability in drained soils were more rapid than 
in undrained soils (Fig. 5.3.), indicating the existence of a strong lethal effect caused by 
more intensive and complete desiccation of drained soil and also partial cell leaching.  
In conclusion, the present study revealed that soil composition played an 
important role on E. coli O157:H7 survival indicating that nutritionally-rich soil, in 
combination with moisture, may significantly extend the viability of E. coli O157:H7 in 
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soil environments. Considered together with competition by indigenous microbes and 
soil temperature, nutrient levels may have a considerable effect on E. coli O157:H7 
survival. Lastly, there seemingly was an overriding influence of desiccation on the 
overall persistence of E. coli O157:H7 in soil environments. These results provide 
evidence that within soil types found in Saskatchewan, the survival of this pathogen is 
strongly influenced by moisture and soil nutrients and thus these factors should be a 
consideration in any management strategy. 
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BRIEF INTRODUCTION TO CHAPTER 6 
This chapter represents a natural extension of the previous studies that, in part, 
examined the survival of E. coli O157:H7 in soils under various nutritional, temperature 
and environmental regimes. In this chapter, a more detailed investigation was 
undertaken to determine the underlying role of the global stress response of E. coli O157 
to prolonged heat and cold shocks, and also to characterize the regulatory role of RpoS 
sigma factor during these stress situations. Comparative proteomic analyses of the hypo- 
and hyperthermally adapted wild-type and rpoS mutant E. coli O157 strains allowed the 
identification and description of crucial proteins involved in growth resumption during 
extreme temperature conditions. 
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6. GLOBAL STRESS RESPONSE OF ESCHERICHIA COLI O157 AND THE 
ROLE OF RPOS SIGMA FACTOR DURING PROLONGED HEAT AND 
COLD SHOCKS 
 
Abstract 
Escherichia coli O157, a mesophile that primarily inhabits the gastro-intestinal 
tract, responds to temperature down or up-shifts with transient expression of adaptive 
proteins that allow survival of the organism under unfavorable temperature conditions 
followed by growth resumption. The purpose of this study was to identify heat and cold 
adaptive proteins induced during transition from growth arrest to growth resumption 
with specific focus on the role of the RpoS sigma factor. Using the comparative 
proteomic analysis of hypo- and hyper-thermally adapted wild type and rpoS null mutant 
E. coli O157 cells, we identified 56 protein spots that underwent significantly different 
expression upon temperature shock or rpoS mutation. All identified proteins of cold and 
heat post-acclimation stimulons fell into two large sub-groups: i) stress proteins and ii) 
housekeeping proteins. Proteomic analysis revealed that GroEL/S chaperonin complex 
plays a crucial role in growth resumption during elevated temperature, and also confirms 
an essential role of Pnp ribonuclease in transition from growth arrest to cell division in 
hypothermally adapted cells. In addition, we found that RpoS has no control over the 
key stress proteins in either stress stimulons. However, RpoS was shown to regulate the 
expression of a key protein involved in homoeoviscous adaptation, as well as various 
proteins involved in central metabolic pathways of both stress stimulons. 
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6.1. Introduction 
Escherichia coli O157:H7 is a human pathogen known worldwide as a cause of 
life-threatening illnesses that include: haemolytic uraemic syndrome (Riley, 1983) and 
thrombotic thrombocytopaenic purpura (Su and Brandt, 1995). The majority of 
infections with E. coli O157:H7 are the result of food contamination, commonly 
undercooked red meat. A critical element in the emergence of E. coli O157:H7 as a 
foodborne pathogen was lateral gene transfer that resulted in over 1380 new genes being 
encoded in strain-specific clusters that are absent in the non-pathogenic strain E. coli K-
12 (Perna et al., 2001).  It is important to note that many clusters have no obvious role in 
virulence, but may confer strain-specific abilities to survive in different stress conditions 
(Perna et al., 2001), as already shown in a case of acid stress (Arnold and Kaspar, 1995) 
where the survival of E. coli O157:H7 cells greatly exceeded non-pathogenic E. coli 
controls. 
Changing between different unfavorable environmental conditions trigger bacterial 
responses by replacing the sigma subunit in the RNA polymerase (RNAP) causing a 
shift in protein synthesis, typically towards different stress proteins. Escherichia coli 
possess seven sigma (σ) species that bind RNAP and then subsequently direct 
transcription initiation by recognizing promoters of specific groups of genes. During 
exponential growth, most of the cell’s housekeeping genes are transcribed by the 
holoenzyme containing σD (RpoD), while upon entry into stationary phase the 
holoenzyme σS (RpoS) is essential for transcription of certain stationary-phase specific 
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genes (Lange and Hennge-Aronis, 1991). The synthesis of RpoS is also induced when E. 
coli cells are exposed to various stress conditions, for example, high osmolarity, 
starvation, low pH and non-optimal high or low temperature. By using genome-wide 
expression analysis, more than 480 genes of the E. coli genome have been identified to 
be under regulatory control of σS, with a set of 140 core genes being expressed under all 
stress conditions tested (Weber et al., 2005). The expression of the σS-dependent core 
genes follows the entry into stationary phase and provides the cells with the ability to 
survive stationary phase stress, as well as additional stresses not yet encountered, a 
phenomenon known as “cross-protection”. In contrast to the core genes, the majority of 
the σS-controlled genes may be recognized by the σS subunit only under specific 
environmental conditions or in the presence of specific factors (Ishihama, 2000), 
allowing cells to respond in a highly precise manner. The dual nature of the σS stress 
response is opposite to other specific stress responses, which are triggered by a single 
stress signal and result only in the induction of highly-specific proteins designed to 
overcome a specific stress situation. The RpoS subunit of RNAP is therefore considered 
to be a master regulator of the general stress response in the γ branch of the 
proteobacteria, a group of Gram-negative bacteria that includes many human pathogen 
species such as E. coli O157 and also some beneficial organisms. 
In the present study, the role of the σS was investigated under a range of temperature 
stress conditions in enterohaemorrhagic E. coli O157. The objective of this study was to 
determine the impact of σS on the survival of E. coli O157 under cold and heat stress 
conditions, as well as to reveal key stress proteins that may be different from those in 
non-pathogenic E. coli.  
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6.2 Experimental procedures 
6.2.1  Preliminary study 
A preliminary study was performed to determine mutations at the rpoS locus in 
48 E. coli O157 strains that were isolated from bovine feces during the summer of 2004. 
Each strain possesses different genetic signatures based on random amplification of 
polymorphic DNA and virulence profiles (Vidovic and Korber, 2006). Escherichia coli 
O157 strains were streaked onto Luria-Bertani (LB) agar from stock cultures kept in 
10% (vol/vol) glycerol at -70˚C, and then incubated at 37˚C for 24 hours. After 
incubation, the panel of E. coli O157 isolates was tested for glycogen synthesis, as 
described below in the glycogen assay. 
 
6.2.2 Bacterial strains, plasmids and growth conditions 
Escherichia coli K-12 strain DH5α was used as the host for the recombinant 
plasmids pSV1, pSV2 and pSV4, while E. coli SM10 λpir was used to maintain the 
recombinant plasmid pSV3. Wild type E. coli O157 strain B-1 possesses four virulence-
associated genes (stx1, stx2, hlyA and eaeA) and expresses a relatively high cytotoxicity 
effect of 7.1-8.0, as determined by polymerase chain reaction (PCR) analysis and the 
Vero cells toxicity assay, respectively (Vidovic and Korber, 2006). A wild type nalidixic 
acid-resistant E. coli O157 B-1 is a spontaneous mutant obtained in our laboratory. 
Plasmids pUC19 (Vieira and Messing, 1982), pRE112 (Edwards et al., 1998) and 
pACYC184 (Chang and Cohen, 1978) were used as a cloning vectors. Plasmid pBSL130 
(Alexeyev et al., 1995) was used as a source for the streptomycin resistance gene 
cassette. The bacterial strains were grown at 37˚ or 30˚C in LB broth. Growth media 
were supplemented with chloramphenicol (30 μg ml-1), ampicillin (100 μg ml-1), 
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nalidixic acid (75 μg ml-1) and streptomycin (35 μg ml-1) for maintenance of 
recombinant plasmids and selection of the bacterial strains, as required. 
 
6.2.3 General recombinant DNA techniques 
Plasmid DNA and DNA fragments from agarose gels were purified using a 
commercial PCR purification kit (Qiagen). All PCR amplifications were performed 
using Phusion high fidelity DNA polymerase (New England BioLabs, Pickering, 
Canada) according to manufacturer’s instructions. Restriction enzymes, T4 DNA ligase 
and alkaline phosphatase were purchased from New England BioLabs and Invitrogen 
(Burlington, Canada), respectively. Standard DNA cloning procedures were carried out 
as described elsewhere (Sambrook et al., 1999). 
 
6.2.4 Construction of the rpoS insertion null allele 
The rpoS gene was amplified by PCR from the E. coli O157-B1 strain using the 
forward primer (5’-GTT GGA TCC CCC CCG GGA TCA CGG GTA GGA GCC ACC 
TT-3’) and the reverse primer (5’-GAT GAA TTC TCC CCC CGG GGG GAT TAC 
TCG CGG AAC AGC GCT TCA G-3’), clamps shown in italics, the EcoRI and BamHI 
sites are underlined, respectively. The 1204 bp PCR product was cloned into the pUC19 
vector, yielding the recombinant plasmid pSV1. The rpoS gene was confirmed by 
sequencing and then interrupted by insertion of the streptomycin resistance (Strr) gene 
cassette at a unique EagI site (position 760 bp of the coding sequence), generating 
pSV2. A 2.5 kb rpoS::str fragment was amplified from pSV2 using the primers RPOS3F 
(5’-GGC GGT ACC CCC CCG GGA TCA CGG GTA GGA GCC ACC TT-3’) and 
RPOS4R (5’-GGC GAG CTC TCC CCC CGG GGG GAT TAC TCG CGG AAC AGC 
GCT TCA G-3’) which introduced the restriction sites KpnI and SacI, respectively. This 
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PCR product was then double-digested with KpnI and SacI restriction enzymes and then 
ligated into the corresponding sites of the suicide vector pRE112 (Cmr), resulting in 
plasmid pSV3. The recombinant plasmid pSV3 was introduced into E. coli SM10 λpir 
(Miller and Mekalanos, 1988) and transformants were selected on LB agar plates 
containing both streptomycin and chloramphenicol, resulting in strain SV519. Strain 
SV519 then served as the donor during conjugation with the nalidixic acid-resistant wild 
type E. coli O157 B-1 strain. The resulting exoconjugants were selected on LB agar 
plates containing nalidixic acid, chloramphenicol and streptomycin, yielding strain 
SV520 which was then plated onto modified LB agar (no NaCl) containing 5% sucrose 
and incubated overnight at 30° C. Sucrose-resistant colonies were screened for 
sensitivity to chloramphenicol due to the loss of the suicide vector. The 
chloramphenicol-sensitive streptomycin-resistant transconjugants represent the second 
homologous recombination event where the wild-type rpoS gene of E. coli O157 B-1 
was replaced with the interrupted rpoS gene, resulting in strain SV521 with a null rpoS 
allele. The genotype of strain SV521 was confirmed by both PCR analysis and DNA 
sequencing.  
 
6.2.5 Glycogen assay 
To confirm the RpoS status, E. coli O157 rpoS null mutants (~50 strains) 
obtained as described above, were tested for glycogen production, a trait known to be 
under control of RpoS (Hengge-Aronis and Fisher, 1992; Wei et al., 2000). Both E. coli 
O157 B-1 wild-type and putative rpoS – mutant strains were streaked on LB agar plates 
and incubated overnight at 37˚C. After incubation, plates were left at 4˚C for 24 h 
before they were flooded with concentrated iodine. Glycogen-deficient rpoS – mutants 
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gave a negative staining reaction (white colonies), whereas the wild-type glycogen-
excess strains generated a positive staining reaction (dark brown colonies).  
 
6.2.6 Complementation study  
A ~1.2 kb DNA fragment containing an intact promotorless rpoS gene with its 
ribosome binding site was amplified by PCR with the following primers; RPOS5F (5’-
GTT GGA TCC AAG GCC AGC CTC GCT TGA GAC TG -3’) and RPOS6F (5’-CTC 
GTC GAC AAG GGA TCA CGG GTA GGA GCC ACC TT -3’) to which BamHI and 
SalI sites were introduced (as underlined), respectively. Genomic DNA from the E. coli 
O157 B-1 strain was used as a template. The amplified rpoS gene was cloned 
downstream of the tet promoter into the corresponding BamHI and SalI sites of 
pACYC184, resulting in plasmid pSV4. The correct insertion and orientation of the rpoS 
gene in pSV4 was confirmed by double digestion and DNA sequencing of pSV4, 
respectively. Both the E. coli O157-B1 wild type (positive control) and its rpoS null 
mutant strains were transformed with the recombinant plasmid pSV4. The 
complemented strains were grown overnight in LB broth supplemented with 
chloramphenicol, then washed twice with sterile water and further used, as described 
below.  
 
6.2.7 Stress Assays 
Stress assays were performed using overnight cultures of the wild type E. coli 
O157 B-1 and its rpoS null mutant that had been grown in LB at 37 ˚C with constant 
shaking ~190 r.p.m. The seed cultures were diluted 1/100 in 50 mL of freshly prepared 
LB and grown at 37 ˚C to an optical density at 600 nm of 0.4 (early mid-exponential 
growth phase). Flasks containing cultures reaching their mid-exponential phase were 
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immediately transferred to a water bath15 ˚C, a treatment hereafter referred to as cold 
stress and 45 ˚C, hereafter referred to as heat stress; flasks were maintained with 
constant shaking at 190 r.p.m. (Brunswick RF-10 Frigidflow bath circulator; temperature 
± 0.2 ˚C). Cells were incubated for an additional 6 hours. Viable cell counts were 
performed by tenfold serial dilutions in pre-cooled or pre-warmed 0.9% NaCl at time 
zero and then at every hour of the incubation. Aliquots of 0.1 mL were plated on LB 
agar in triplicate and then incubated at 37 ˚C for 24 hours.  
 
6.2.8 Two-dimensional gel electrophoresis 
Wild type E. coli O157 B-1 and rpoS mutant strains SV521 were grown 
overnight in LB at 37 ˚C with constant agitation (~190 rpm). Cultures were diluted 
1:100 into fresh LB and then propagated at 37 ˚C to the mid-exponential phase (OD600 – 
0.4). Both wild type and rpoS mutant strains were transferred at mid-exponential phase 
to 15 ˚C (cold stress), 45 ˚C (heat stress) and 37 ˚C (control) conditions and then held 
at these temperatures for 60 minutes. Total protein was extracted from 10 mL of culture 
by centrifugation (14000 rpm for 3 minutes) followed by extraction of the resuspended 
cell pellets in 1 mL of lysis buffer (9.8 M urea, 4% CHAPS, 2% IPG buffer pH 3-10, 1.5 
mM phenylmethylsulfonylfluoride) at room temperature for 2 hours with occasional 
vortexing. The cell-lysis solution was then centrifuged at 12000 r.p.m. for 5 minutes. 
The resulting supernatant was resuspended in 3 x volume of ice-cold acetone, mixed 
vigorously and then incubated overnight at -21 ˚C to precipitate proteins. The 
precipitated protein was isolated by centrifugation at 4000 r.p.m. for 15 minutes and 
then resuspended in 300 μl of protein rehydration solution (9.8 M urea, 4% CHAPS, 2% 
IPG buffer pH 3-10, 100 mM DL-Dithiothreitol [DDT]) following incubation at room 
  145
temperature for 1 hour with repeated vortexing. Protein concentration was determined 
by using a dye-binding assay (Bradford, 1976) and a protein assay kit (Bio-Rad 
Laboratories, Hercules, CA). The total protein from wild-type and rpoS mutant strains 
was then analysed by high-resolution 2D PAGE, using Immobiline DryStrips (pI 4.0 to 
7.0) and a Multiphor II electrophoresis unit (GE Healthcare Bio-Sciences Little 
Chalfont, UK). First dimension electrophoresis was performed by dehydration of the 
immobilized pH gradient strip with 130 μl of rehydration solution (9.8 M urea, 2% 
CHAPS, 2% IPG buffer pH 3-10,100 mM DDT, 0.005% bromophenol blue) containing 
10 μg of protein at room temperature for ~20 hours. Isoelectric focusing was performed 
at 200 V for 1 min., 0-3500 V running time 2800 kVh, and 0-3500 V running time 5200 
kVh, using a Multiphor II electrophoresis unit. Before running the second dimension, the 
strips were equilibrated for 15 minutes sequentially in two equilibration buffers (50 mM 
Tris-HCl pH 8.8, 6 M urea, 30% (v/v) glycerol, 2% SDS and 0.002% bromophenol blue) 
with addition of 100 mg DDT in the first buffer and 250 mg of iodoacetamide in the 
second buffer per 10 mL of equilibration buffer. Second dimension electrophoresis was 
carried out by placing the equilibrated strips in the well of 14% (wt/vol) sodium dodecyl 
sulfate-polyacrylamide gel, overlaying the strip with 0.5% agarose and running at 100 V 
for 2 hours. After electrophoresis, the gels were silver stained following the 
manufacturer’s (GE Healthcare Bio-Sciences) instructions. The stained gels were 
scanned on an Epson 1200C scanner with a transparency adapter as 8-bit greyscale 300-
dot/in. images. Quantitatively-different proteins that were expressed within the wild-type 
in all three temperature treatments, and also between the wild-type and rpoS mutant 
strains within the same temperature treatment, were analysed by using Phoretix 2D 
version 2004 software (Nonlinear Dynamics Ltd., Newcastle upon Tyne, United 
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Kingdom). A protein spot volume that increased by ≥ 2-fold was considered as up-
regulation; while a protein spot volume that decreased by ≥ 2-fold was interpreted as 
down-regulation. 
 
6.2.9 Protein identification 
 Protein spots were excised from the gel, and digested with trypsin according to the 
protocols for the MassPrep robotic workstation (Waters-Micromass, Manchester, United 
Kingdom). Liquid chromatography tandem mass spectrometry (LC-MS/MS) analysis 
was carried out with a capLC liquid chromatograph inter-faced to a Q-ToF Ultima 
Global hybrid tandem mass spectrometer fitted with a Z-spray nanoelectrospray ion 
source (Waters-Micromass, Manchester, United Kingdom). The LC-MS/MS data were 
processed with ProteinLynx software (Waters-Micromass) and then screened against the 
NCBInr, MSDB and Swiss-Prot/TrEMBL protein databases using Mascot Search 
(Matrix Science Ltd., London, United Kingdom). 
 
6.2.10 Fatty acid profile analysis  
Fatty acid methyl esters (FAME) analysis was conducted as described elsewhere 
(Annous et al., 1997) using 40 mg of washed cell pellets that had been exposed to 
different temperature treatments, as described above. A Hewlett Packard 5890 series 2 
gas-liquid chromatograph (Hewlett Packard, Avondale, Pa.) equipped with a flame 
ionization detector and a 25 m x 0.2 mm methyl phenyl silicone fused silica capillary 
column (Ultra 2; Hewlett Packard) was used for identification of FAMEs. Results were 
automatically integrated by the Hewlett Packard 3365 series II ChemStation software 
version A.03.21, and FAMEs were identified with the MIDI Microbial Identification 
Software (Sherlock TSBA Library version 4.1; Microbial ID, Inc., Newark, Del.). 
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6.2.11 Experimental replication 
Data from all experiments, including control treatments (37 ˚C) for both the wild 
type and the rpoS null mutant, represent the averages of at least three independent 
experiments. The differential expression of each protein spot of interest was determined 
from averaged spot volumes from four gels independently replicated, with a maximum 
variation of 30% in spot volume between the gels.  
 
6.3 Results and discussion 
6.3.1 Preliminary study and confirmation of rpoS mutant status 
 The high polymorphism rate of the rpoS locus from enterohemorrhagic E. coli 
strains may easily result in a non-functional RpoS sigma factor (Waterman and Small, 
1996). To ensure that the E. coli O157 test-strain used in these studies possessed a 
functional rpoS sigma factor, 48 genetically-different E. coli O157 isolates from our 
laboratory collection were screened for their ability to synthesize glycogen (Notley-
McRobb et al., 2002), as glycogen synthesis is under the direct control of RpoS 
(Hengge-Aronis and Fischer, 1992). Among all tested strains, the most pronounced 
glycogen production was exhibited by E. coli O157 strain B-1 (data not shown), and 
therefore it was chosen for further experimenation. As shown in the Fig. 6.1., the 
glycogen synthesis in the E. coli O157 rpoS null mutant (white colonies indicate the 
absence of glycogen) was aborted due to a dysfunctional RpoS sigma factor, while the 
wild type strain was shown to be glycogen-positive (dark colonies).  
 
  
Figure 6.1. Glycogen phenotypes of wild-type E. coli B-1 strain and rpoS null mutant 
SV521 strains reveal a functional status of RpoS sigma factor. Colonies were grown 
overnight at 37˚C and then stored at 4˚C for another 24 h. Intracellular glycogen in 
colonies was stained with iodine, resulting in two phenotypes: (i) dark brown colonies 
indicate glycogen-contaning cells with a functional σS (wild type) and (ii) white colonies 
indicate glycogen-deficient cells with non-functional σS (mutant).  
 
 
6.3.2 Response to cold~heat stress 
 Cultures of E. coli O157 B-1 wild type and its rpoS mutant were exponentially 
grown at 37˚C and then subjected to temperature shifts to 15˚ and 45˚C. The growth 
curves shown in Fig. 6.2. indicate that both heat and cold shock had a more substantial 
effect on the viability of the rpoS mutant than on that of the wild type strain. 
Furthermore, the rpoS mutant showed greater sensitivity to the cold stress than to the 
heat stress; results are presented in panels A and B of Fig. 6.2.  
 To determine whether the reduced viability of the mutant was caused by a 
dysfunctional rpoS gene or was due to polar effects on downstream genes, the plasmid 
pSV4 containing the intact rpoS coding sequence was introduced into E. coli O157 B-1 
wild type and rpoS mutant strains for complementation study. Figure 6.2.C clearly 
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indicates that all changes in the viability of the mutant were due to loss of rpoS function, 
as cold tolerance was completely restored in the complemented mutant compared to that 
of the complemented wild type strain. It is important to point out that introduction of the 
low-copy pSV4 plasmid (~15 copies per a cell) will normally result in reduced growth 
rates of transformed cells and consequently only transformed strains were comparable in 
our stress assay. The growth curves of the wild type and its rpoS null mutant strains 
showed two distinct phases at both temperature extremes: (i) the first hour of incubation 
was characterized by growth arrest, (ii) after an hour of acclimation, the growth phase 
was restored, indicating a new phase in the stress response of E. coli O157. The main 
focus of this study was the post-acclimation phase, which started after approximately 
one hour of incubation at both extremes of temperatures; therefore, one hour of 
incubation was chosen as the sampling time for subsequent experiments (see Fig. 6.2.A 
and B). 
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Figure 6.2. Stress growth assays and complementation study. (A) Heat-stress growth 
assay. (B) Cold-stress growth assay. Symbols: ● strain B-1 (wild type) and ■ strain 
SV521 (rpoS ::str). All strains were grown to early mid-exponential phase in LB broth 
and then subjected to different temperature shocks. Viable counts of strains were 
determined in triplicate for each experimental reading; the error bar represents the 
standard deviation between three experimental readings. Sampling time (S) for the 
proteome and fatty acid analysis is shown by arrows. (C) Complementation study. The 
experiment was carried out as in A and B except that two additional strains were used. 
Symbols: ♦ strain B-1 (wild type), ■ strain SV521 (rpoS ::str), S the wild type 
complemented with rpoS in plasmid pSV4 (positive control) and ● the rpoS mutant 
complemented with rpoS in plasmid pSV4. 
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Figure 6.2. Continued 
 
6.3.3 Global protein analysis 
  With an aim to specifically identify cold and heat-stress induced proteins of E. 
coli O157 that are regulated by RpoS, we performed a comparative analysis of the total 
proteome of wild type and mutant strains that have been grown under the same heat or 
cold stress conditions. Furthermore, to elucidate a total heat and cold stress stimulon of 
E. coli O157, we compared the total proteome of the wild type grown at different 
temperature stress conditions to the proteome of the same organism grown at 37˚C. 
Mid-exponential phase cultures exposed to different temperature regimes were used, as 
imposed stress at this growth phase results in induction of proteins specific to these 
stress situations with no induction of cross-protective proteins. Proteins were separated 
by 2D PAGE across a pH range of 4-7 and proteins induced ≥2-fold based on six master 
gel image analysis were identified. In total, 67 spots from all six gels (Fig. 6.3.) were 
found to satisfy the ≥2-fold up- or down- regulation requirements of which 56 spots 
were identified using LC-MS/MS (Tables 6.1. and 6.2.). The 56 identified proteins were 
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classified into nine categories based on their function: (i) adaptation to stress, (ii) global 
regulatory function, (iii) metabolism and transport, (iv) energy production and 
conversion (v) amino acid metabolism, (vi) nucleotides and phosphate metabolism, (vii) 
lipid metabolism, (viii) motility and (ix) unknown function.  
 
6.3.4 Response to heat post-acclimation phase 
6.3.4.1 RpoS-independent proteins   
  One hallmark of the heat stress response in E. coli is its transient nature (Zhao et 
al., 2005); the early phase is characterized by growth arrest followed by restoration of 
growth. Our results reflect a state of hyperthermally-adapted cells entering into a phase 
of restored growth. The RpoS-independent stress proteins that were identifed (Table 
6.2.) fell into three main classes: (i) molecular chaperones / protease (GroEL, GroES, 
HchA and serine protease), (ii) DNA/RNA stabilizing enzymes (elongation factor EF-
Tu, 50S ribosomal protein L25), and (iii) an anti-oxidative protein (a probable 
peroxidase).  
  Among the RpoS-independent heat stimulon, the most dramatic induction was 
observed for the chaperonin GroEL and its co-chaperonin GroES (Spots 9, 10 and 2). 
Both chaperonins form a fully functional 1:1 GroEL-GroES complex that is essential in 
protein folding under all cell conditions (Horwich et al., 1993).  
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.3. Comparative 2-D PAGE proteome analysis of E. coli O157 B-1 strain (wild 
type) and rpoS null mutant SV521 strain designed to reveal proteins induced at transition 
from the growth arrest to resumption of growth (see sampling time at Fig. 6.2.) during 
cold and heat shock. Also a control was included for both organisms (non-stressful 
condition i.e. 37˚C). Four independent experiments were carried out for each 
strain/temperature condition, resulting in 24 electrophoregrams that were processed by 
Phoretix 2D software. One representative electrophoregram is presented for each 
strain/temperature condition. Spots of indentifed proteins are indicated by arrows and 
presented in Tables 6.1. and 6.2.  
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Figure 6.3. Continued 
 
 154
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.3. Continued 
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Table 6.1. List of proteins found to be RpoS-dependent. 
Induction of 
proteins Name Function Accession name Spot 
p/ 
the. 
MW 
the. wt rpoS 
Funct. 
categorya 
Proteins under positive/negative control of σS at 45˚C 
OsmY Osmotic adaptation gi/15804947 1 5.9 21.0 4.2 / AS 
SspA Stringent starvation 
protein A 
gi/15803763 21 5.2 24.3 2.6 / GR;AS 
TalB Chain A, transaldolase B gi/1941982 22 5.1 35.2 2.3 / AM 
GlpQ Glycerophosphodiester 
phosphodiesterase 
gi/15802788 23 5.4 40.8 3.2 / MT 
GlpQ Glycerophosphodiester 
phosphodiesterase 
gi/15802788 24 5.4 40.8 3.5 / MT 
YfiD Putative formate 
acetyltransferase 
gi/15803106 25 5.1 14.2 2.5 / E 
YdjA Hypothetical protein 
Nitroreductase-like family 
gi/15802176 26 6.3 20.0 2.0 / E 
Rp1I 50S ribosomal protein L9 gi/15804792 27 6.2 15.7 2.1 / GR 
GuaB IMP dehydrogenase gi/15803032 28 5.9 54.5 / 4.4 NPM 
GuaB IMP dehydrogenase gi/15803032 29 5.9 54.5 / 3.8 NPM 
Proteins under positive/negative control of σS at 37˚C 
YfiD Putative formate 
acetyltransferase 
gi/15803106 32 5.1 14.2 3.3 / E 
YdjA Hypothetical protein 
Nitroreductase-like family 
gi/15802176 33 6.3 20.0 2.6 / E 
RbsB D-ribose periplasmic 
binding protein 
gi/15804351 36 6.8 30.9 3.2 / MT 
GlpQ Glycerophosphodiester 
phosphodiesterase 
gi/15802788 37 5.4 40.8 6.1 / MT 
FliC Flagellar biosynthesis gi/15802358 34 4.7 59.9 Pres-
ent 
/ M 
ManX PTS system mannose-
specific EIIAB component 
gi/15802230 39 5.7 35.0 2.6 / MT 
MglB Galactose-binding 
transport protein 
gi/15802706 35 5.6 35.7 2.6 / MT 
Tpx Thiol peroxidase gi./15801846 40 4.7 17.8 / 4.0 AS 
HchA Chaperone Hsp31 gi/15802400 41 5.5 31.8 / 2.8 AS 
PurH Phosphoribosylaminoimid
azolecarboxamide 
formyltransferase, IMP 
cyclohydrolase 
gi/15804597 42 5.5 57.3 / Pres-
ent 
NPM 
GuaB IMP dehydrogenase gi/15803032 43 5.9 54.6 / 6.5 NPM 
GuaB IMP dehydrogenase gi/15803032 44 5.9 54.6 / 10.1 NPM 
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Table 6.1. Continued  
Induction of 
proteins 
Funct. 
categorya Name Function Accession name Spot 
p/ 
the. 
MW 
the. 
wt rpoS  
Proteins under positive/negative control of σS at 15˚C 
MalE Maltodextrin-binding 
protein 
gi/15804627 52 5.5 43.3 3.5 / MT 
GlpQ Glycerophosphodiester 
phosphodiesterase 
gi/15802788 53 5.4 40.8 18.2 / MT 
FusA Elongation factor G gi/15803853 47 5.2 77.5 3.1 / GR 
FusA Elongation factor G gi/15803853 46 5.2 77.5 Present / GR 
AtpA ATP synthase subunit 
alpha 
gi/15804334 58 5.8 55.2 Present / E 
RbsB D-ribose periplasmic 
binding protein 
gi/15804351 56 6.8 30.9 4.2 / T 
FabD Malonyl CoA-acyl 
carrier protein 
transacylase 
gi/15801209 51 5.0 32.4 6.8 / LM 
FabD Malonyl CoA-acyl 
carrier protein 
transacylase 
gi/15801209 50 5.0 32.4 3.2 / LM 
MalM Periplasmic protein of 
mal regulon 
gi/15834274 57 7.7 31.9 Present / U 
PurH Phosphoribosylaminoi
midazolecarboxamide 
formyltransferase, IMP 
cyclohydrolase 
gi/15804597 61 5.5 57.3 / 3.8 NPM 
GuaB IMP dehydrogenase gi/15803032 62 5.9 54.5 / 3.4 NPM 
GuaB IMP dehydrogenase gi/15803032 63 5.9 54.5 / 4.6 NPM 
GuaB IMP dehydrogenase gi/15803032 64 5.9 54.5 / 4.2 NPM 
GlyA Serine 
hydroxymethyltransfera
se 
gi/15803076 65 6.0 45.3 / 2.2 AM 
GuaB IMP dehydrogenase gi/15803032 67 5.9 54.5 / 2.8 NPM 
RpiA Ribose-5-phosphate 
isomerase A 
gi/15803449 66 5.2 22.8 / 2.1 NPM 
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Table 6.2. List of proteins found to be RpoS-independent 
Induction 
of proteins Name Function Accession name Spot 
p/ 
the. 
MW 
the.  
45˚C 
Control 
37˚C 
Functio. 
categorya 
Proteins induced in the wild type at 45˚C 
GroES Chaperonin gi/15599582 2 5.1 10.4 Present / AS 
 Probable peroxidase gi/15598725 4  21.9 Present / AS 
HchA  Chaperone Hsp31 gi/15802400 5 5.5 31.2 6.7 / AS 
Ndk Nucleoside diphosphate 
kinase 
gi/1353658 6 5.4 15.5 Present / NPM 
RplY 50S ribosomal protein 
L25 
gi/15599866 8 5.8 22.0 Present / GR; AS 
GroEL Chaperonin HSP60 
family 
gi/15599581 9 4.8 57.3 Present / AS 
GroEL Chaperonin HSP60 
family 
gi/576779 10 4.8 57.3 Present / AS 
GroEL Chaperonin HSP60 
family 
gi/576779 11 4.8 57.3 Present / AS 
ArcA Arginine deiminase gi/42543632 12 5.7 45.9 Present / AM 
MglB Galactose-binding 
transport protein 
gi/15802706 15 5.7 35.7 Present / MT 
YahI Carbamate kinase-like 
protein 
gi/15600366 16 5.7 33.9 5.8 / E 
GuaB IMP dehydrogenase gi/15598965 17 6.0 51.9 Present / NPM 
AlgY Serine protease gi/15595963 18 7.7 50.3 Present / AS 
FabF Putative beta-ketoacyl-
ACP synthase 
gi/15801212 19 5.2 44.1 Present / LM 
TufA Elongation factor Tu gi/15599461 20 5.3 43.3 Present / GR; AS 
Proteins induced in the wild type at 15˚C 15˚C 37˚C  
FusA Elongation factor G gi/15803853 47 5.2 77.6 Present / GR; AS 
Pnp Polynucleotide 
phosphorylase 
gi/15803706 49 5.3 79.8 3.6 / GR; AS 
AtpD ATP synthase subunit 
beta 
gi/15804332 55 4.9 50.3 5.8 / E 
a Proteins were categorized as follows: AS, adaptation to stress; GR, global regulation; 
MT, metabolism and transport; E, energy production and conservation; AM, amino acid 
production; NPM, nucleotides and phosphate metabolism; LM, lipid metabolism; M, 
motility; U, unknown function. 
 
The GroEL/S complex promotes folding by binding a wide variety of non-native 
polypeptides (Hlodan et al., 1995), diminishing irreversible aggregation and unfolding 
kinetically-trapped intermediates (Weissman et al., 1994), followed by the release of the 
polypeptide into the central cavity of the chaperonin complex and its accurate folding 
 (Mayhew et al., 1996). An abundance of the GroEL/S in hyperthermally-adapted cells 
indicates, in part, an increased level of misfolded proteins, as well as conditions where 
the native form of proteins is not achievable without assistance of the GroEL/S 
chaperonin machine. Guisbert et al., (2004) showed that the GroEL/S: like heat shock 
protein (Hsp) DnaK, is involved in the regulation of heat shock sigma factor (RpoH). 
Overexpression of GroEL/S results in inhibition of RpoH activity in vivo with the same 
efficiency as that of DnaK (Guisbert et al., 2004), giving a new functional insight of this 
chaperonin system. Overexpression of GroEL/S in heat adapted cells results in silencing 
of the RpoH regulon, which is crucial in the early phase of heat stress response, 
indicating that the GroEL/S chaperonin machine is a key molecule of the post-
acclimation stress phase. Another significant up-regulation was observed in the heat-
inducible chaperone A (HchA), resulting in 6.7 and 5.0-fold increases in both wild type- 
and rpoS null mutant-stressed cells compared to that of wild type non-stressed cells 
(Table 6.2.). This thermal pattern of HchA induction (Fig. 6.4.) in both genetic 
backgrounds can be explained by an existence of dual hchA promoters, recognizable by 
the σD and σS subunits of RNA polymerase (Mujacic and Baneyx, 2006).  
 
 
 
Figure 6.4. Influence of dual promoters, recognized by σD and σS, on expression of HSP 
HchA in exponentially grown E. coli O157 cells exposed to prolonged heat shock. 
Arrowheads indicate the level of HchA in enlarged regions of 2-D gels: (A) control-wild 
type at 37˚C, (B) rpoS mutant at 45˚C and (C) wild type at 45˚C. The level of HchA 
was increased for 5.0-fold and 6.7-fold in rpoS mutant and wild type backgrounds, 
respectively, compared to that in control, indicating a major role of σD-dependent 
promoter in transcription of HchA in E. coli O157 cells exposed to prolonged heat 
shock. 
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Recent work by Mujacic and Baneyx (2006) showed that hchA thermal induction 
primarily relies on the relief of H-NS-mediated silencing of σD-dependent transcription, 
which is in agreement with our data where significant induction (5.0-fold) of HchA was 
observed in the rpoS null background. The comparative analysis of the E. coli O157 
proteome allowed the quantitive determination of the contribution of σS in thermal 
induction of HchA; our data suggests that σS contributed ~25% (based on fold-increase) 
of the protein level increase in the wild type background compared to that rpoS null 
mutant, suggesting a minor role of σS in the thermal expression of HchA. Induction of 
HchA, a holding molecular chaperone (holdase) which stabilizes unfolding 
intermediates (Sastry et al., 2002) in heat adapted cells, indicates an increased level of 
heat damaged proteins. Here it is important to note that the induction of hchA is 
kinetically distinct from that of other heat shock genes, for instance, the level of the Hsp 
DnaK increases following a 15 minute heat shock but returned to basal levels after 60 
minutes of high temperature incubation; whereas, HchA remains elevated even after 60 
minutes (Mujacic and Baneyx, 2006). Taken together, our proteomic data revealed that 
the chaperone machines GroEL/S, in concert with HchA, play a crucial role in coping 
with prolonged heat shock. While overexpressed GroEL/S in part, silences a subset of 
the heat stimulon of hyperthermally adapted cells, it alternativly promotes crucial 
protein folding in times of severe and prolonged thermal stress. The unique HchA 
chaperone is designed to be stable over longer periods of heat stress, and prevents 
overloading of the GroEL/S protein folding machinery (Mujacic and Baneyx, 2006).  
 Furthermore, proteomic analysis showed that the σS-independent heat stimulon in 
hyperthermally-adapted E. coli O157 cells was not only confined to stress adaptive 
proteins (molecular chaperone, RNA/DNA stabilizing enzymes and anti-oxidant protein) 
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but also included proteins that regulate central metabolic pathways and structural 
modifications of the cell wall. The induction of proteins involved in central metabolic 
pathways significantly included: a galactose-binding transport protein, a carbamate 
kinase-like protein, a nucleoside diphosphate kinase, an IMP dehydrogenase, an arginine 
deiminase and putative beta-ketoacyl-ACP synthase, enzymes/proteins that correspond 
to transport, energy production, nucleotides and phosphate metabolism, amino acid 
synthesis and fatty acid metabolism. Significantly-higher expression of enzymes 
involved in the central metabolic pathways clearly suggest that growth of stressed cells 
had become restored; indeed, the growth curves in our stress assay show a sharp increase 
in growth rate following the sampling time for cellular protein, (Fig. 6.2.A), confirming 
the proteomic results. 
 
6.3.4.2 RpoS-dependent proteins 
  Using comparative proteomic analysis of both organisms grown under non-
stressful conditions, we observed that the rpoS mutation had an effect on the proteome 
of exponentially-growing E. coli O157 (control), resulting in two overlaps with heat and 
cold shock responses (see Fig. 6.5.A). The first overlap between the heat shock response 
and the control response included the up- regulation of the putative formate 
acetyltransferase YfiD, a hypothetical protein YdjA, and glycerophosphodiester 
phosphodiesterase GlpQ, as well as down- regulation of IMP dehydrogenase (Fig. 
6.5.B), clearly suggesting that these proteins are not induced by elevated temperature.  
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Figure 6.5. (A) The number of RpoS-dependent proteins significantly up- or down-
regulated under three temperature conditions are presented in a Venn diagram. (B) 
Overlaps of heat and cold RpoS-dependent proteins with control. Qualitative and 
quantitative presentation of color-coded proteins follows: ■ GlpQ, ■ GuaB, ■ Yfid, ■ 
YdjA, ■ RbsB and ■ PurH. 
 
A study performed by Rahman and colleagues (2006) using DNA microarray and RT-
PCR techniques confirms our observation; they found that 72 and 25 genes of 
exponentially grown rpoS-deficient mutant of E. coli at 37˚C were down- or up- 
regulated, respectively, implying the existence of an rpoS regulatory role during 
exponential growth despite a lower expression level.  
 The most pronounced up-regulation (4.2-fold) of an RpoS-dependent protein in 
response to heat stress was the periplasmic protein encoded by the σS-dependent core 
gene, osmY (see Table 6.1.). It has been shown that periplasmic OsmY protein is 
strongly induced by σS in specific environmental conditions such as: the stationary phase 
(Yim et al., 1994), hyperosmotic stress (Barron et al., 1986) and a low pH (Weber et al., 
2005), showing its multifunctional nature in stress responses. Our report indicates a 
protective role of the periplasmic OsmY protein in hyperthermally-adapted E. coli O157 
cells, adding this protein to the list of proteins in the heat post-acclimation stimulon. The 
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function of this protein is unknown; however, it is believed that OsmY is a binding 
protein with possible function in the transport of different osmolytes (Yim and Villarejo, 
1992). Clearly, more studies are warranted to elucidate the exact protective mechanisms 
of the OsmY, which is also known to be involved in coping with various stresses. 
Another σS-dependent protein induced during heat stress was the stringent starvation 
protein A (SspA), which has dual function in E. coli: (i) the transcriptional activation of 
phage P1 late genes (Hansen et al., 2003), and (ii) the repression of histone-like protein 
(H-NS) (Hansen et al., 2005). The nature of SspA induction in E. coli O157 exposed to 
heat stress remains elusive. In this study, it was also shown that a housekeeping protein, 
TalB, and the 50S ribosomal protein L9, were induced during the heat post-acclimation 
phase, reflecting a general up-regulation of the non-oxidative branch of the pentose 
phosphate pathway, as well as further protection of heat damaged RNA-binding 
proteins, respectively. It is noteworthy that the heat shock protein 31 (HchA), which was 
up-regulated 1.7-fold in the wild type relative to the rpoS mutant, was just under 
proposed fold-factor of regulation cut-off (>2.0), and therefore it was not included in 
Table 5.1.  
 
6.3.5 Response to cold post-acclimation phase  
6.3.5.1 RpoS-independent proteins 
  Temperature downshift of exponentially growing E. coli O157 culture from 37˚C 
to 15˚C resulted in rapid growth arrest, a phenomenon known as the acclimation phase, 
followed by a resumption of exponential growth, but at a slower rate compared to that at 
37˚C. During the acclimation phase, cold shock proteins (CSPs) essential for cellular 
adaptation to low temperature are transiently expressed, with a dramatic increase at the 
beginning of cold acclimation (induction stage) followed by their repression at the end 
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of this phase. To study the role of σS factor in the regulation of proteins expressed at the 
post-acclimation phase, proteins of crucial importance for cell growth at low 
temperature, we analyzed the proteome of the control and hypothermally- adapted cells 
of the wild-type and RpoS deficient mutant (see sampling time in Fig. 6.2.B).  
 Among the RpoS-independent cold stimulon (Table 5.2), polynucleotide 
phosphorylase (Pnp), a key protein for the resumption of growth of hypothermally-
adapted cells, was found to be up-regulated by 3.6-fold. Polynucleotide phosphorylase is 
a cold shock-inducible bifunctional enzyme with a phosphorolytic 3’ to 5’ 
exoribonuclease activity involved in mRNA degradation and 3’ terminal oligonucleotide 
polymerase activity (Bijoy and Kushner 2000). The induction of Pnp at the end of the 
acclimation phase is in agreement with previous studies where it was shown that Pnp 
plays a critical role during transition from the acclimation phase to cell growth 
resumption after cold shock (Yamanaka and Inouye 2001; Neuhaus et al., 2000). Cells 
encountering cold shock initially induce a family of CSPs, with the predominant 
production of CspA, the major cold-shock protein, making up more than 10% of total 
cellular protein synthesis (Goldstain et al., 1990). After cold adaptation, degradation of 
CspA mRNAs becomes esssential for the cells, as high expression of CspA prevents 
translation of bulk mRNAs, thus blocking cell growth (Neuhaus et al., 2000). To 
promote proliferation of hypothermally-adapted cells, Pnp antagonize CspA by the 
selective degradation of its mRNAs at the stage of repression during the end of 
acclimation phase (Yamanaka and Inouye 2001), which is in full correlation with our 
proteomic results. Importantly, it has been reported that the function of Pnp is not only 
restricted to mRNA turnover, but also extends to cell replication efficiency at low 
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temperature (Clements et al., 2002), emphasizing the importance of this molecule during 
the cold post-acclimation phase. 
 Besides expression of the cold shock-inducible Pnp, it was observed a significant 
induction of the ATP synthase β subunit (5.8-fold) and elongation factor G in an RpoS-
independent manner. Induction of these two enzymes corresponded to energy production 
and protein synthesis, reflecting the entry into a new phase characterized by resumption 
of growth after cold shock. 
 
6.3.5.2 RpoS-dependent proteins 
  The second overlap of the proteome (Fig. 6.5.B) of cold stress and control 
included: the D-ribose periplasmic binding protein and glycerophosphodiester 
phosphodiesterase, as up-regulated proteins, and phosphoribosylaminoimidazole 
carboxamide formyltransferase, IMP cyclohydrolase and IMP dehydrogenase as down-
regulated proteins, indicating that they were not part of the cold stimulon. 
 The most pronounced induction of an RpoS-dependent protein (6.8-fold) in 
hypothermally- adapted cells was malonyl CoA-acyl carrier protein (ACP) transacylase 
(Table 6.1), encoded by fabD, an enzyme that plays a key role in fatty acid synthesis 
(FAS) and polyketide synthase (PKS). The malonyl CoA-ACP transacylase catalazyes a 
thioesterification of malonate from CoA to ACP, providing malonyl-ACP precursors for 
both PKS and FAS (Florova et al., 2002). In both processes, malonyl-ACP functions as 
a two-carbon donor in the chain elongation process to generate the appropriate product. 
In type II PKS, this product is elongated without modification of the β carbon, whereas 
in FAS, the elongation process occurs after the β carbon has been fully reduced (Zhou et 
al., 1999). The PKS and FAS systems use separate ACPs and β ketoacyl ACP synthases 
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to generate significantly-different products, but use malonyl ACP as a substrate, 
suggesting that FabD represents a link between the processes of polyketide and fatty 
acid biosynthesis (Summers et al., 1995). It has been reported that low cultivation 
temperature increases the rigidity of the cell membrane, further compromising cellular 
diffusion rates and causing cluster formation of integral membranous proteins (Hazel, 
1995). The significant induction of FabD in hypothermally-adapted cells may be 
associated with the production of long-chain fatty acids, a strategy employed to maintain 
optimal membrane fluidity at low temperatures (known as homeoviscous adaptation) 
(Sinensky, 1974).  
 Another set of RpoS-dependent proteins induced at the post-acclimation phase 
includes the maltodextrin-binding protein, elongation factor G, ATP synthase α−subunit 
and the periplasmic protein of the mal regulon, proteins involved in transport, synthesis 
of proteins and production of energy, clearly reflecting the growth restoration of these 
hypothermally-adapted cells. The proteins serine hydroxymethyltransferase and ribose-
5-phosphate isomerase A were also found to be down-regulated, indicating in a change 
in amino acid synthesis. 
 
6.3.6 Fatty acid analysis 
  To determine whether significant up-regulation of malonyl CoA-ACP 
transacylase, the enzyme involved in fatty acid synthesis, had an impact on membrane 
fluidity, the fatty acid profile of the hypothermally-adapted cells was determined. As 
malonyl CoA-ACP transacylase showed RpoS dependency, a fatty acid analysis of the 
wild type and its rpoS null mutant was performed.  
 Comparative lipid analysis revealed that the malonyl CoA-ACP transacylase 
significantly modified membrane composition, resulting in a shift in lipid production 
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towards long-chain fatty acids (Fig. 6.6.). The concentration of short-chain fatty acids 
(12:0 and 14:0) in membranes of both organisms was found to be approximately equal, 
whereas the level of longer-chain fatty acids (16:0) increased by 59% in the wild type 
compared to the rpoS mutant, further confirming the involvement of the malonyl CoA-
ACP transacylase in the process of homeoviscous adaptation. Interestingly, a constant 
peak corresponding to cyclopropane fatty acid (CFA) was observed in the wild type, 
while the rpoS mutant showed a deficiency in CFA production (Fig. 6.6.). Formation of 
CFA is, in part, dependent on the RpoS sigma factor, and is considered to be a 
conditional and post-synthetic modification of membrane lipid bilayers, which results in 
an increased membrane fluidity (Chang and Cronan, 1999). This suggests that both 
FabD and Cfa work in concert to increase membrane fluidity of hypothermally-adapted 
cells. It has been reported that CFA plays protective roles in other stress conditions: for 
example, it is induced during the development of acid tolerance response in E. coli 
(Chang and Cronan, 1999) and Lactococcus lactis (Budin-Verneuil et al., 2007).  
 
 
 
 
 
 
 
  
 
 
Figure 6.6. Lipid profiles of membranes of the hypothermally-adapted E. coli O157 
wild type and rpoS mutant strains. Tested strains were sampled at the begining of growth 
resumption during cold shock (see Fig. 6.2.). 
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6.4 Concluding remarks 
 It has been shown that both cold and heat shock responses are characterized by 
their transient nature with an initial growth arrest in the acclimation phase followed by 
growth resumption in the post-acclimatation phase. Although the heat and cold shock 
responses in E. coli have been extensively studied, little is known about the molecular 
mechanisms that govern survival, and in particular proliferation of cells exposed to these 
stress conditions.  
 This study, using the comparative proteomics approach for hypo- and hyper-
thermally-adapted cells, demonstrated that both the cold and heat post-acclimation 
stimulon consisted of two large sub-groups: i) stress proteins, and ii) housekeeping 
proteins.  In addition, the cold stimulon possessed an enzyme involved in homeoviscous 
adaptation. Proteomic results also revealed that the GroEL/S molecule plays an essential 
role in heat stress post-acclimation by silencing the heat shock sigma factor (not a single 
member of RpoH regulon was identified) and promoting accurate protein folding during 
prolonged heat shock. A specific ribonuclease, Pnp, was identified, confirming previous 
findings (Yamanaka and Inouye 2001; Neuhaus et al., 2000) which emphasized a critical 
role for Pnp in cold adaptation. Interestingly, both GroEL/S and Pnp play a similar role 
in different shock conditions, silencing previously-expressed stress proteins, and 
therefore may be considered functional homologues. Furthermore, proteomic analysis, 
backed by fatty acid analysis, clearly indicate an important role of FabD in 
homeoviscous adaptation during cold-shock. 
 Through examination of the rpoS mutant proteome profile, the role of RpoS sigma 
factor in adaptation and proliferation of hypo- and hyper-thermally adapted cells was 
determined. As illustrated in Fig. 6.7., the RpoS sigma factor has no control over the key 
 stress proteins (GroEL/S and Pnp) in both temperature shock conditions, suggesting a 
minor role of the general stress regulon in these instances. However, the RpoS sigma 
factor showed a more pronounced role in cold shock, regulating a key enzyme involved 
in conditional modification of membrane lipid bilayers of hypothermally-adapted cells. 
Factor RpoS also exhibited regulatory control over numerous proteins mainly involved 
in the central metabolic pathways in both stress stimulons, reflecting its specific 
importance in promoting resources (energy, protein synthesis, etc.) during proliferation 
of the hypo- and hyper-thermally-adapted cells. 
 
 
Figure 6.7. Model of cold and heat post-acclimation response and the role of RpoS in 
regulating these responses. Prolonged heat and cold shocks induce two large groups of 
stress and housekeeping proteins, marked with red arrows. There is also an additional 
response in the cold shock marked with blue arrow, indicating proteins involved in 
homeoviscous adaptation. RpoS showed control over various housekeeping and 
homeoviscous adaptive proteins, while key stress proteins remained independent from 
RpoS regulation. 
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7. GENERAL DISCUSSION 
Escherichia coli O157:H7 is recognized world-wide as a significant food-borne 
pathogen that poses a serious threat to public health. The low infectious dose and high 
virulence of E. coli O157:H7 make human infections particularly severe. The primary 
route of E. coli O157 infection to humans has been associated with consumption of 
inadequately cooked minced beef. Ruminants, especially cattle, have been implicated as 
the primary reservoir of E. coli O157:H7 (Chapman et al., 1993; Wells et al., 1991). 
This pathogen resides harmlessly in the digestive system of cattle until excretion in 
animal feces, after which it can enter the environment and the food chain. This has 
serious implications for the land-based disposal of organic wastes such as cattle manure, 
cattle slurry, and abattoir waste. As intensive livestock industry expands in 
Saskatchewan, it is important to have a documented understanding not only of the 
prevalence of E. coli O157, but its survival in native soil and climate conditions. Herein, 
the most important findings in chapters three, four and five relate to the prevalence and 
survival of E. coli O157 in soil, while in the sixth chapter the focus was shifted towards 
understanding the molecular response of this pathogen to prolonged cold and heat 
shocks. 
Using a combined longitudinal and point prevalence study approach, where 23 
feedlots and cattle operations scattered across Saskatchewan were examined for the 
presence of E. coli O157, several important conclusions were drawn. A salient 
observation was that cattle density was the most important determinant in E. coli O157 
prevalence. Statistically-processed data showed that the prevalence of E. coli O157 in 
various feedlots could be explained by the effect of cattle density 78.7% of the time. In 
addition, characterization of all E. coli O157 isolates revealed two important 
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characteristics: (i) from a clinical point of view, the majority of E. coli O157 strains 
recovered in this study pose a high health threat to humans, as the majority of these 
strains have an exceptionally-high virulence potential, as determined by multiplex PCR 
and Vero-cell assay, and (ii) from an ecological point of view, the population of E. coli 
O157 isolates examined during my study consisted of indigenous and transient groups, 
implying a dynamic nature of existing populations of this human pathogen. 
 Another important observation was that inconsistent recovery from naturally-
contaminated samples using IMS-VCC was related to the high genetic diversity of E. 
coli O157 isolates. Genomic fingerprint analysis of E. coli O157 isolates revealed that 
the high percentage of false-negative results was due to the same isolate, implying the 
existence of inhibitory effects of antibiotics used in the selective enrichment procedures 
on certain E. coli O157 isolates. Use of two different enrichment broths in parallel 
resulted in a significant increase (~ 20%) in the sensitivity of E. coli O157 detection in 
longitudinal and point studies over the IMS-VCC use alone.  
Using comparative in situ assays, where the survival of E. coli O157:H7 was 
examined in manure-amanded and plain soils with and without drainage revealed that 
desiccation posed the most lethal threat to a population of this pathogen in the soil 
environment. In addition, it was determined that soil composition played an important 
role in E. coli O157:H7 survival, indicating that nutritionally-rich soils may be 
protective of E. coli O157:H7 populations. The fact that desiccation imposes the most 
lethal effect on this pathogen and that nutrients from soil may extend the survival times 
of E. coli O157:H7 cells, can serve as baseline data that may be used to predict the 
survival of this pathogen under a range of environmental conditions.  
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The final chapter deals with the role of RpoS sigma factor under prolonged heat 
and cold shock conditions, as well as the general response of E. coli O157 to these 
stressful situations. This chapter was designed to be a focused extension of chapter four, 
which describes the effect of various nutritional, temperature and environmental 
conditions on the survival of E. coli O157:H7 in soil. In contrast to the fourth chapter, 
where various conditions were examined without understanding the molecular 
mechanisms involved in the response to these stresses, in the fifth chapter, the focus was 
shifted to understanding the molecular mechanisms employed by E. coli O157 in coping 
with prolonged heat and cold shocks. Previous studies related to the heat and cold stress 
responses were focused on the acclimation phase, a phase characterized by growth 
arrest. The present work has advanced our understanding of cell proliferation under cold 
and heat shock by examining acclimatized cells during these stress conditions. The main 
characteristic of heat and cold post-acclimation phases was growth resumption of stress-
adapted organisms and therefore the primary interest was in the global stress response of 
E. coli O157 in transition from growth arrest to growth resumption. As the RpoS sigma 
factor is known to be a master regulator of the general stress response, special attention 
was directed at investigation of a possible role of this sigma factor during prolonged heat 
and cold shocks. A global picture of the E. coli O157 response and the regulatory 
function of RpoS under stress conditions was derived using comparative proteomic 2D 
PAGE of the wild-type E.coli O157 B-1 and rpoS null mutant SV521 strains exposed to 
prolonged heat and cold temperatures. The general stress response to both prolonged 
heat and cold shocks resulted in a heterologous stimulon, with the two most predominant 
groups being: (i) stress proteins, and (ii) housekeeping proteins. As reported earlier 
(Yamanaka and Inouye 2001; Neuhaus et al., 2000) and also confirmed here, the Pnp 
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molecule plays a key role in prolonged cold shock. Ribonuclease Pnp selectively 
degrades mRNAs of CSP, resulting in their repression. As the overproduction of CSP 
proteins have deleterious effect on the hypothermally adapted cells, the ribonuclease Pnp 
modifies the cold stimulon in acclimatized cells and promotes the necessary conditions 
for synthesis of a new set of proteins which promote proliferation of these cells. A 
functional homologue of Pnp during prolonged heat stress was also indentifed. 
Dramatically-high induction of GroEL/S and no induction of the RpoH regulon was 
demonstrated in these experiments. This result, together with an earlier report (Guisbert 
et al., 2004) which indicated that overexpression of GroEL/S may silence the RpoH 
regulon, led to the conclusion that the GroEL/S complex modifies the heat stimulon in a 
transition phase during heat shock when cell-division is again restored. Comparing the 
proteomes of the wild-type and mutant, It was determined that RpoS has no control over 
key stress proteins under these stress conditions. RpoS showed a more pronounced role 
in hypothermally adapted cells than in hyperthermally-adapted cells, as evidenced by 
regulating key enzymes involved in homeoviscous adaptation. Generally, RpoS showed 
control over numerous housekeeping proteins under both stress stimulons, suggesting 
that RpoS has a more significant role in proliferation of hypo- and hyperthermally-
adapted cells than in their adaptation during these stress conditions.  
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8. CONCLUSIONS AND FUTURE DIRECTIONS 
1. Cattle density has the most pronounced effect on the prevalence rate of E. coli O157, 
2. Isolates of E. coli O157 from Saskatchewan feedlot cattle have a high virulence 
potential, 
3. The combined employment of two enrichment broths, i) modified Escherichia coli 
broth supplemented with novobiocin and ii) buffered peptone water containing 
vancomycin, cefsulodin and cefixime, increased the sensitivity of E. coli O157 
detection by 22%, 
4. Physical desiccation poses the most lethal effect on the viability of E. coli O157 cells 
exposed to soil environments,  
5. GroEL/S plays a crucial role in growth resumption of E. coli O157 cells during 
prolonged heat shock, 
6. FabD is a key enzyme employed in homeviscous adaptation of hypothermal 
acclimatized E. coli O157 cells, 
7. RpoS has no control in E. coli O157 cells over key proteins in prolonged heat and 
cold stimulons, and 
8. The chaperonin GroEL/S and ribonuclease Pnp may be considered as functional 
homologues, playing key roles in two different stress stimulons.  
 
The laboratory collection of approximately 200 E. coli O157 isolates that were 
collected from feedlots scattered across Saskatchewan presents a valuable source for 
further research. Determination of minimal inhibitory concentration of these E. coli 
O157 isolates for several antibiotics that were employed in enrichment broths 
(novobiocin, vancomycin, cefsulodin and cefixime) may establish a new, more reliable 
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and sensitive enrichment procedure for the isolation of E. coli O157 cells from natural 
samples. 
 To the best of the author’s knowledge, the study examining the global stress 
response of E. coli O157 to prolonged heat and cold shocks is the first report describing 
key proteins involved in bacterial proliferation during these stress conditions. This study 
may have important applied value, especially from a biotechnological point of view. 
Further research related to bacterial proliferation under extreme temperature conditions 
may include some important species that have been extensively used in fermentation 
processes designed to generate various products. Understanding the molecular 
mechanisms involved in propagation of beneficial microorganisms exposed to prolonged 
heat or cold shocks may enable advances in genetic engineering leading to significantly 
higher productivity. 
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